{"meta":{"query_hash":"7a5a072c5a75","filters":{"venue":"Neurotherapeutics"},"cohort_total":147,"direct_labels_cover":1,"predictions_cover":147,"exported":147,"export_cap":100000,"truncated":false,"label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12"},"permalink":"https://metacan.xera.ac/q/7a5a072c5a75","api":"https://metacan.xera.ac/api/v1/cohort?venue=Neurotherapeutics"},"results":[{"id":"W1144717940","doi":"10.1007/s13311-015-0385-3","title":"Neuroinflammation: Ways in Which the Immune System Affects the Brain","year":2015,"lang":"en","type":"review","venue":"Neurotherapeutics","topic":"Neuroinflammation and Neurodegeneration Mechanisms","field":"Neuroscience","cited_by":243,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Montreal Neurological Institute and Hospital","funders":"","keywords":"Neuroinflammation; Microglia; Immune system; Neuroscience; Multiple sclerosis; Central nervous system; Immunology; Blood–brain barrier; Neurology; Biology; Medicine; Inflammation","score_opus":0.1417155307898226,"score_gpt":0.33436999872060214,"score_spread":0.19265446793077953,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1144717940","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00010412824,0.9760536,0.00036643588,0.0053318636,0.0042035524,0.007543377,0.000059162685,0.00076882954,0.005569058],"genre_scores_gemma":[0.0007052089,0.9933862,0.000016816868,0.0033689048,0.0006334631,0.00060793734,0.000015870211,0.00030603787,0.00095952913],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9921102,0.0038635624,0.001248657,0.0010248129,0.0011073126,0.00064546644],"domain_scores_gemma":[0.99444354,0.0025214024,0.00087880006,0.0019148216,0.00010858987,0.00013286152],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0014148381,0.0008306998,0.0012220498,0.00031850845,0.0005551943,0.00052692584,0.0019531446,0.00030584633,0.000033823995],"category_scores_gemma":[0.00067562435,0.00047297974,0.00039646207,0.0022061926,0.0001574567,0.00021385231,0.00019560065,0.0016030485,0.0005872414],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000054999266,0.0001706704,5.903703e-7,0.00710961,0.00004018074,0.00040316596,0.0010070837,0.00061099237,0.01482629,0.2609288,0.002080849,0.71276677],"study_design_scores_gemma":[0.00037323302,0.00010634569,0.0000011767721,0.00073743705,0.000117928095,0.00060432835,0.000021139173,0.0019259448,0.0046412223,0.000098280805,0.99095625,0.0004166983],"about_ca_topic_score_codex":0.0000025941263,"about_ca_topic_score_gemma":0.000022800097,"teacher_disagreement_score":0.9888754,"about_ca_system_score_codex":0.0001535838,"about_ca_system_score_gemma":0.0005137441,"threshold_uncertainty_score":0.9997722},"labels":[],"label_agreement":null},{"id":"W1917519329","doi":"10.1007/s13311-015-0360-z","title":"Behavioral and Neuroanatomical Phenotypes in Mouse Models of Autism","year":2015,"lang":"en","type":"review","venue":"Neurotherapeutics","topic":"Genetics and Neurodevelopmental Disorders","field":"Biochemistry, Genetics and Molecular Biology","cited_by":139,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"Simons Foundation Autism Research Initiative; Ontario Brain Institute; Simons Foundation; Canadian Institutes of Health Research; Autism Speaks","keywords":"Autism; Autism spectrum disorder; Neuroscience; Phenotype; Rett syndrome; Psychology; Neurology; Tuberous sclerosis; Biology; Genetics; Psychiatry; Gene","score_opus":0.06826193036893986,"score_gpt":0.3302942967016729,"score_spread":0.262032366332733,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1917519329","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.01546758,0.98368514,0.000020445037,0.000010795493,0.000095370364,0.0004513201,0.000067647736,0.0000072397115,0.00019444004],"genre_scores_gemma":[0.0058198175,0.9935316,0.00018437309,0.00011243657,0.0000090522135,0.000025494917,0.00006157748,0.000087006454,0.00016863355],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9986723,0.000115965115,0.00041148736,0.00043464074,0.00014612079,0.00021949038],"domain_scores_gemma":[0.9994361,0.000008967767,0.00013612183,0.0003114769,0.000025712428,0.000081626524],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00007803784,0.0003123773,0.00062758045,0.00010762737,0.000016127833,0.000014356202,0.00023117574,0.00028830237,0.0000024719932],"category_scores_gemma":[0.0000045702327,0.00029875897,0.00011628327,0.00010672371,0.000103667735,0.000002423834,0.0001251717,0.00020427092,0.0000016914694],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000354092,0.00032081513,0.000037299727,0.001544235,0.000060269176,0.00001055333,0.00008216678,0.00003865359,0.004261766,0.00020745659,0.00011050206,0.9932909],"study_design_scores_gemma":[0.00049904495,0.00036134323,0.000036513717,0.00019275611,0.00013008811,0.000027816686,0.000009203353,0.00009680544,0.00031518075,0.00019263092,0.99771726,0.00042137134],"about_ca_topic_score_codex":0.000009678971,"about_ca_topic_score_gemma":0.000019031535,"teacher_disagreement_score":0.99760675,"about_ca_system_score_codex":0.000010505228,"about_ca_system_score_gemma":0.00018696117,"threshold_uncertainty_score":0.9999465},"labels":[],"label_agreement":null},{"id":"W1945601059","doi":"10.1007/s13311-015-0373-7","title":"Early Phase in the Development of Cannabidiol as a Treatment for Addiction: Opioid Relapse Takes Initial Center Stage","year":2015,"lang":"en","type":"review","venue":"Neurotherapeutics","topic":"Cannabis and Cannabinoid Research","field":"Medicine","cited_by":169,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal","funders":"National Center for Research Resources; National Institute on Drug Abuse; National Institutes of Health; Georgia Clinical and Translational Science Alliance","keywords":"Cannabidiol; Addiction; Medicine; Cannabis; Opioid; Psychiatry; Pharmacology; Drug; Internal medicine","score_opus":0.18807594811141629,"score_gpt":0.46181922278803417,"score_spread":0.27374327467661785,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1945601059","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0010904518,0.9880383,0.000047746846,0.00054602546,0.00036343295,0.0074353693,0.0006486497,0.0000320095,0.0017979895],"genre_scores_gemma":[0.00008290985,0.98234063,0.00024223463,0.0005166061,0.0005291527,0.0033182257,0.00042023568,0.00016770622,0.012382287],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9973687,0.000242456,0.0008939659,0.00041883378,0.00063859555,0.0004374617],"domain_scores_gemma":[0.99870783,0.000050726794,0.0002650866,0.0005755877,0.00023617892,0.00016461177],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00047976474,0.00043892066,0.001278131,0.0003043062,0.00008089424,0.00004276966,0.00027535603,0.00026079675,0.000097334516],"category_scores_gemma":[0.000042723226,0.00026801787,0.0004440625,0.00037176517,0.00010967214,0.00003656376,0.000020107309,0.0004244971,0.000016953569],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00044812314,0.0012854344,0.000007860034,0.003066789,0.00026458612,0.000068002824,0.0029130788,1.6945093e-7,0.0000069797984,0.000041931144,0.0034920175,0.98840505],"study_design_scores_gemma":[0.0049631936,0.0037358291,0.00001530424,0.0013846604,0.00043848375,0.000084286265,0.00017164317,0.0000044855606,0.000047197205,0.000004848155,0.98895097,0.0001991298],"about_ca_topic_score_codex":0.000046542813,"about_ca_topic_score_gemma":0.000064862885,"teacher_disagreement_score":0.9882059,"about_ca_system_score_codex":0.00043253927,"about_ca_system_score_gemma":0.0034841467,"threshold_uncertainty_score":0.99997723},"labels":[],"label_agreement":null},{"id":"W1965273729","doi":"10.1016/j.nurt.2009.01.021","title":"The Ketogenic Diet: Proposed Mechanisms of Action","year":2009,"lang":"en","type":"review","venue":"Neurotherapeutics","topic":"Diet and metabolism studies","field":"Medicine","cited_by":47,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canada Research Chairs; University of Toronto","funders":"Savoy Foundation; Cancer Care Ontario","keywords":"Ketogenic diet; Ketone bodies; Anticonvulsant; Neurochemistry; Action (physics); Neurology; Internal medicine; Endocrinology; Neuroscience; Medicine; Pharmacology; Biology; Epilepsy; Metabolism","score_opus":0.12782323337973028,"score_gpt":0.38737697038707586,"score_spread":0.2595537370073456,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1965273729","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000002867774,0.9952564,0.00008826511,0.00016875645,0.00077152764,0.0013698324,0.0000077694995,0.00005550334,0.0022790316],"genre_scores_gemma":[0.000024099723,0.996715,0.00014167369,0.00035099182,0.0002501009,0.000035449353,0.000007559576,0.000070090195,0.0024050283],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99852234,0.0001213286,0.00051073555,0.00024767756,0.0003360021,0.00026190595],"domain_scores_gemma":[0.99885136,0.00013237233,0.0003515777,0.0005107159,0.00009876996,0.000055231678],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018283479,0.0003341916,0.001326765,0.00008735643,0.00012193313,0.000017229473,0.00018298114,0.00019451696,0.00001215856],"category_scores_gemma":[0.000035899855,0.00018328478,0.0005961297,0.00026809968,0.00009475862,0.000018863457,0.000023489745,0.00038273266,0.000026209289],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000060981074,0.00007976022,7.2183724e-7,0.0028549107,0.00031640052,0.000004072946,0.00003090218,1.7392626e-8,0.0000906539,0.0014768963,0.00016754854,0.99491715],"study_design_scores_gemma":[0.0002623647,0.00060114125,0.000027682674,0.0013105868,0.0027641251,0.000015912718,0.00001668104,0.0000011443724,0.000108018234,0.00048041652,0.9942759,0.00013597167],"about_ca_topic_score_codex":0.000001218928,"about_ca_topic_score_gemma":0.0000024518217,"teacher_disagreement_score":0.99478114,"about_ca_system_score_codex":0.000028960903,"about_ca_system_score_gemma":0.00020678886,"threshold_uncertainty_score":0.74741364},"labels":[],"label_agreement":null},{"id":"W1966845103","doi":"10.1007/s13311-012-0152-7","title":"Remyelination Therapy for Multiple Sclerosis","year":2012,"lang":"en","type":"review","venue":"Neurotherapeutics","topic":"Neurogenesis and neuroplasticity mechanisms","field":"Neuroscience","cited_by":65,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"Alberta Innovates; Multiple Sclerosis Society; Multiple Sclerosis Society of Canada","keywords":"Remyelination; Multiple sclerosis; Myelin; Neuroscience; Oligodendrocyte; Medicine; Demyelinating disease; Central nervous system; Immunology; Biology","score_opus":0.49271582450879153,"score_gpt":0.37234516148504193,"score_spread":0.1203706630237496,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1966845103","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00007028884,0.9925498,0.0013396835,0.000035235196,0.0018095695,0.003570868,0.00021206657,0.00030440488,0.00010809507],"genre_scores_gemma":[0.00028603387,0.9948177,0.00020998028,0.00264498,0.0006375927,0.00069866696,0.000016479375,0.00039752646,0.00029103705],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99651223,0.0005799977,0.0007237409,0.0009921538,0.00045959165,0.00073230756],"domain_scores_gemma":[0.99603444,0.0025002772,0.0005287817,0.0006986129,0.00006177208,0.00017610451],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00022263295,0.0007388794,0.0011987335,0.00027655208,0.00032167032,0.00014098767,0.00070602004,0.0003649557,0.000054419994],"category_scores_gemma":[0.00023015878,0.0006172725,0.00078332145,0.00048242442,0.000080949656,0.00014858601,0.000052673706,0.00041241513,0.00019196457],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000031534444,0.00023527948,6.9105545e-7,0.0013687048,0.000016906704,0.0000030548576,0.000019424444,8.1462707e-7,0.01792232,0.0009935511,0.00005704233,0.9793507],"study_design_scores_gemma":[0.0005024144,0.0002701519,0.0000012155159,0.00043281095,0.00028539772,0.00004251974,6.943597e-7,0.00007256912,0.06586994,0.000030956668,0.93200284,0.0004884585],"about_ca_topic_score_codex":4.9960977e-7,"about_ca_topic_score_gemma":6.321481e-7,"teacher_disagreement_score":0.9788622,"about_ca_system_score_codex":0.000050559796,"about_ca_system_score_gemma":0.00010967231,"threshold_uncertainty_score":0.9996279},"labels":[],"label_agreement":null},{"id":"W1969202288","doi":"10.1007/s13311-014-0311-0","title":"Early-Stage Treatment with Withaferin A Reduces Levels of Misfolded Superoxide Dismutase 1 and Extends Lifespan in a Mouse Model of Amyotrophic Lateral Sclerosis","year":2014,"lang":"en","type":"article","venue":"Neurotherapeutics","topic":"Amyotrophic Lateral Sclerosis Research","field":"Medicine","cited_by":65,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval; Institut Universitaire en Santé Mentale de Québec","funders":"Canadian Institutes of Health Research; ALS Society of Canada; Fonds de Recherche du Québec - Santé; Muscular Dystrophy Association","keywords":"SOD1; Amyotrophic lateral sclerosis; Withaferin A; Superoxide dismutase; Transgene; Neuroprotection; Genetically modified mouse; Neuroinflammation; Heat shock protein; Oxidative stress; Medicine; Biology; Cell biology; Pharmacology; Immunology; Endocrinology; Internal medicine; Biochemistry; Pathology; Gene; Inflammation; Disease; Withania somnifera","score_opus":0.08241947683989194,"score_gpt":0.2955812567577607,"score_spread":0.21316177991786878,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1969202288","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99846184,0.00007233651,0.00016187945,0.00048447994,0.000010542807,0.0006176979,0.00010296466,0.00003067052,0.000057601832],"genre_scores_gemma":[0.9968537,0.00041378094,0.0013566066,0.00018809237,0.000024668512,0.000050320872,0.000004127547,0.00007596194,0.0010327118],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9981058,0.0001559473,0.00045766766,0.0004072339,0.00045598907,0.00041734145],"domain_scores_gemma":[0.9990149,0.0000781371,0.00012553632,0.00047723507,0.000096042866,0.00020814527],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015651064,0.000292751,0.0006451052,0.0002302769,0.000036181435,0.00002041266,0.00013392582,0.00011463904,0.000030146744],"category_scores_gemma":[0.000017686018,0.00020698599,0.00007793128,0.00024431568,0.00033275638,0.000103993894,0.000040359824,0.00020743345,0.0000013027028],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015147142,0.0005185771,0.040605202,0.00011729513,0.00010228665,0.00001051713,0.0014513156,0.00058183825,0.94658065,0.00008069064,6.1078384e-7,0.008436332],"study_design_scores_gemma":[0.010919689,0.009159277,0.5473953,0.00041868325,0.0001526998,0.000017503864,0.0000653921,0.051877998,0.37948474,0.00008010884,0.000046814654,0.00038180192],"about_ca_topic_score_codex":0.00045262673,"about_ca_topic_score_gemma":0.000070198934,"teacher_disagreement_score":0.5670959,"about_ca_system_score_codex":0.00007129158,"about_ca_system_score_gemma":0.00010765177,"threshold_uncertainty_score":0.84406435},"labels":[],"label_agreement":null},{"id":"W1970967952","doi":"10.1007/s13311-011-0060-2","title":"Antiplatelet Agents for Stroke Prevention","year":2011,"lang":"en","type":"review","venue":"Neurotherapeutics","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":29,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Aspirin; Medicine; Clopidogrel; Stroke (engine); Dipyridamole; Neurology; Cardiology; Ischemic stroke; Ticlopidine; Internal medicine; Etiology; Intensive care medicine; Ischemia","score_opus":0.20949609005289802,"score_gpt":0.40766244407330166,"score_spread":0.19816635402040364,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1970967952","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000022455542,0.99333334,0.0015126267,0.000007795117,0.00043566976,0.0032036502,0.00015552684,0.00013514498,0.001193806],"genre_scores_gemma":[0.000009311591,0.99207115,0.00036016645,0.00042536188,0.00043095366,0.00027677615,0.00028146396,0.00021452583,0.005930273],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9981838,0.00014876656,0.0005278817,0.00051706465,0.0002429206,0.0003796039],"domain_scores_gemma":[0.9987578,0.00006812947,0.0002502321,0.0006904426,0.00008152702,0.0001518622],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00017259273,0.000499698,0.0017811082,0.00017989444,0.00009063824,0.000029667415,0.00020368038,0.00042804467,0.00021923428],"category_scores_gemma":[0.000015825535,0.00040928606,0.00275518,0.00015962667,0.000063257125,0.00004997454,0.000020097885,0.0003184471,0.00010227731],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000117310876,0.00021835104,0.000007513059,0.009683956,0.0021718184,0.000037857586,0.000015907975,8.198737e-8,0.0000014647021,0.00019101275,0.00041840845,0.9871363],"study_design_scores_gemma":[0.0013826791,0.00051379105,0.00001017022,0.0032458089,0.007148709,0.00027582762,0.0000036720658,0.0000043803843,0.000013276737,0.0000539426,0.98702365,0.0003240975],"about_ca_topic_score_codex":7.853777e-7,"about_ca_topic_score_gemma":2.9476135e-7,"teacher_disagreement_score":0.98681223,"about_ca_system_score_codex":0.00004017923,"about_ca_system_score_gemma":0.000259709,"threshold_uncertainty_score":0.9998359},"labels":[],"label_agreement":null},{"id":"W1974827178","doi":"10.1007/s13311-014-0332-8","title":"Challenges in the Understanding and Treatment of Amyotrophic Lateral Sclerosis/Motor Neuron Disease","year":2015,"lang":"en","type":"review","venue":"Neurotherapeutics","topic":"Amyotrophic Lateral Sclerosis Research","field":"Medicine","cited_by":36,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Amyotrophic lateral sclerosis; Motor neuron; Disease; Neuroscience; Neurology; Medicine; Motor neurone disease; Focus (optics); Neurosurgery; Psychology; Pathology; Psychiatry","score_opus":0.6034035303435227,"score_gpt":0.41924749887634966,"score_spread":0.18415603146717302,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1974827178","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0017884665,0.9941386,0.0000014197078,0.0013685414,0.000092167604,0.0022819587,0.000035949473,0.00002668913,0.00026618416],"genre_scores_gemma":[0.010959666,0.98830646,0.000014552778,0.00015847295,0.00018622533,0.00016362849,0.000017005603,0.000103996805,0.000090002366],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99724996,0.0006366591,0.00054305186,0.0005288514,0.0006186449,0.00042282496],"domain_scores_gemma":[0.99854773,0.00025382463,0.00018348057,0.0007240488,0.00004643924,0.00024447066],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00026027797,0.0004713234,0.0014121699,0.00027539168,0.0000524059,0.000044056545,0.00023864862,0.00020496061,0.000013848054],"category_scores_gemma":[0.000024506075,0.0002666138,0.00028968853,0.00028144722,0.00022441693,0.000050846247,0.000043961252,0.00040060803,0.0000079763595],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00026075717,0.00058795174,0.00021347235,0.0064241523,0.00017042088,0.00021204185,0.0006368215,7.2328226e-7,0.000026149959,0.0005178609,0.000016161308,0.9909335],"study_design_scores_gemma":[0.002639818,0.0038854957,0.02202899,0.008271086,0.0015024329,0.00012509245,0.00007958932,0.00009730496,3.622877e-7,0.0003103648,0.960627,0.00043243807],"about_ca_topic_score_codex":0.000015999738,"about_ca_topic_score_gemma":0.000012487812,"teacher_disagreement_score":0.99050105,"about_ca_system_score_codex":0.0004206804,"about_ca_system_score_gemma":0.0003077198,"threshold_uncertainty_score":0.9999786},"labels":[],"label_agreement":null},{"id":"W1975566596","doi":"10.1016/j.nurt.2009.09.025","title":"Platform presentation—Early Defect of Transforming Growth Factor β1 Formation in Huntington's Disease","year":2010,"lang":"en","type":"article","venue":"Neurotherapeutics","topic":"Genetic Neurodegenerative Diseases","field":"Neuroscience","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Huntington's disease; Neuroinflammation; Neuroprotection; Huntingtin; Neurotrophic factors; Microglia; Biology; Striatum; Glutamate receptor; Neurodegeneration; Neuroscience; Receptor; Pathology; Internal medicine; Medicine; Inflammation; Immunology; Disease","score_opus":0.04228108631448468,"score_gpt":0.28983218306837355,"score_spread":0.24755109675388887,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1975566596","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99770164,0.000008553039,0.0006149057,0.00014774612,0.0002612382,0.00064869673,0.00007055512,0.000055982673,0.0004906733],"genre_scores_gemma":[0.9990801,0.000027563068,0.0001181314,0.0006132743,0.000043163873,0.00004369752,0.0000034365328,0.000040195293,0.000030387417],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9985127,0.000093366296,0.00036545817,0.00033252485,0.00039956794,0.0002964092],"domain_scores_gemma":[0.99913555,0.00025708976,0.00013785233,0.0002747366,0.000065918124,0.00012883169],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000054052838,0.00019211968,0.00016322432,0.00020012907,0.00008710693,0.000057883502,0.0002769017,0.000051650833,0.0000553727],"category_scores_gemma":[0.00028716907,0.00018742237,0.00012474634,0.00034941087,0.000115971845,0.00048089476,0.000019935076,0.00025868168,0.000013132308],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008027444,0.00013576224,0.020421574,0.00005668064,0.0000021346318,0.000004554978,0.0007657534,0.00005913337,0.97447586,0.0015903714,0.0000024035678,0.00240548],"study_design_scores_gemma":[0.00058523536,0.00008433293,0.0885225,0.000009896576,0.000016041427,0.000002171645,0.000021033758,0.00092466804,0.90889275,0.00065251335,0.00013954409,0.00014930553],"about_ca_topic_score_codex":0.000015221881,"about_ca_topic_score_gemma":0.000044720637,"teacher_disagreement_score":0.06810093,"about_ca_system_score_codex":0.000012042773,"about_ca_system_score_gemma":0.00005604558,"threshold_uncertainty_score":0.7642863},"labels":[],"label_agreement":null},{"id":"W1976637617","doi":"10.1016/j.nurt.2008.10.005","title":"Poster 4: The Functional Rating Scale Taskforce for Pre-Huntington's Disease: An Empirically-Driven Initiative for New Scale Development","year":2008,"lang":"en","type":"article","venue":"Neurotherapeutics","topic":"Genetic Neurodegenerative Diseases","field":"Neuroscience","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre for Movement Disorders","funders":"","keywords":"Rating scale; Scale (ratio); Multidisciplinary approach; Clinical trial; Disease; Medicine; Huntington's disease; Psychology; Clinical psychology; Pathology; Developmental psychology","score_opus":0.11962910072004286,"score_gpt":0.32642162617152726,"score_spread":0.2067925254514844,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1976637617","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9512474,0.000047321366,0.043433696,0.001891822,0.0004427833,0.002465722,0.00022205032,0.00012759201,0.00012160126],"genre_scores_gemma":[0.9670251,0.000024355772,0.0052472083,0.024359383,0.0006083278,0.00069199153,0.000056896646,0.0001280265,0.0018587213],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99754983,0.00023488603,0.00040182637,0.0007963479,0.00049495196,0.00052214443],"domain_scores_gemma":[0.9980607,0.0008031065,0.00018992978,0.00044301365,0.00019711872,0.00030611336],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00009950954,0.00033493046,0.00021778759,0.000068743284,0.0011389899,0.00011787677,0.00045002226,0.00005703424,0.000042627722],"category_scores_gemma":[0.00028141137,0.00026654548,0.00016415276,0.00021656688,0.0002464232,0.00021681885,0.000070598835,0.00015836983,0.000014403515],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0032193025,0.0017523025,0.059074912,0.00020766693,0.00008579295,0.000011275062,0.011420938,0.008572711,0.8882783,0.00064400985,0.008816187,0.017916588],"study_design_scores_gemma":[0.0017987088,0.00053328514,0.095801026,0.00002066166,0.00007890953,0.000012702191,0.000063555206,0.006956671,0.83869565,0.00031136064,0.05521783,0.0005096348],"about_ca_topic_score_codex":0.0000017737993,"about_ca_topic_score_gemma":0.000020952168,"teacher_disagreement_score":0.049582653,"about_ca_system_score_codex":0.000043214706,"about_ca_system_score_gemma":0.0006450189,"threshold_uncertainty_score":0.99997866},"labels":[],"label_agreement":null},{"id":"W1977855918","doi":"10.1007/s13311-013-0200-y","title":"Transcranial Direct Current Stimulation Enhances Recovery of Stereopsis in Adults With Amblyopia","year":2013,"lang":"en","type":"article","venue":"Neurotherapeutics","topic":"Transcranial Magnetic Stimulation Studies","field":"Neuroscience","cited_by":113,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"Canadian Institutes of Health Research; U.S. Public Health Service; National Natural Science Foundation of China; Auckland Medical Research Foundation","keywords":"Visual cortex; Transcranial direct-current stimulation; Monocular; Neuroscience; Audiology; Stimulation; Psychology; Monocular deprivation; Stereoscopic acuity; Binocular vision; Medicine; Visual acuity; Ocular dominance; Ophthalmology; Artificial intelligence","score_opus":0.03136100911033193,"score_gpt":0.2731526888737632,"score_spread":0.24179167976343127,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1977855918","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9955451,0.00014991475,0.0011511906,0.00018054176,0.00028419748,0.000938059,0.000017833738,0.00006675576,0.0016664331],"genre_scores_gemma":[0.99903256,0.00030279066,0.00027579613,0.00020458417,0.000037339425,0.000068551875,8.7318193e-7,0.00003081841,0.0000466606],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9984121,0.00015538704,0.00040804074,0.00039350925,0.00037762654,0.0002533405],"domain_scores_gemma":[0.9990565,0.0004793506,0.00012567188,0.0002190749,0.0000751985,0.00004418658],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000051449148,0.00020571103,0.00028787652,0.00015877002,0.000051978368,0.000030350362,0.00016952866,0.000048266415,0.00016630474],"category_scores_gemma":[0.000047235466,0.00017225306,0.000060613333,0.00049197476,0.00014937666,0.00023052214,0.000008417418,0.00014590289,0.000026255924],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016848688,0.0006490288,0.027999358,0.00023961665,0.000016496633,0.000004805308,0.0034280086,0.0035520147,0.76017094,0.00022781375,0.000013260846,0.2020138],"study_design_scores_gemma":[0.008658467,0.0027280822,0.8816118,0.0004603071,0.000070085,0.000006418613,0.000104799976,0.010949297,0.09245166,0.00058423163,0.0016950001,0.0006798145],"about_ca_topic_score_codex":0.00007611452,"about_ca_topic_score_gemma":0.00009089934,"teacher_disagreement_score":0.8536125,"about_ca_system_score_codex":0.000017404855,"about_ca_system_score_gemma":0.000028980417,"threshold_uncertainty_score":0.7024276},"labels":[],"label_agreement":null},{"id":"W1994506872","doi":"10.1007/s13311-011-0027-3","title":"Emerging Approaches to the Surgical Management of Acute Traumatic Spinal Cord Injury","year":2011,"lang":"en","type":"review","venue":"Neurotherapeutics","topic":"Spinal Cord Injury Research","field":"Medicine","cited_by":56,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Western Hospital; University of Toronto","funders":"","keywords":"Medicine; Neurosurgery; Spinal cord injury; Surgical decompression; Spinal cord; Neurology; Clinical trial; Decompression; Physical medicine and rehabilitation; Surgery","score_opus":0.44388021587353216,"score_gpt":0.46990982775185697,"score_spread":0.02602961187832481,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1994506872","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00017184058,0.9873494,0.00017791122,0.0003850485,0.00029218462,0.004288915,0.000039228184,0.00006312761,0.007232375],"genre_scores_gemma":[0.00016306416,0.99617934,0.0010251123,0.00023921495,0.00019234247,0.00035507756,0.000015124311,0.00014974235,0.0016809959],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9971089,0.00028561827,0.0008573621,0.000528448,0.0007045607,0.00051510986],"domain_scores_gemma":[0.9982174,0.00006324779,0.00026354525,0.0011995035,0.00006331924,0.00019300365],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0005054764,0.00049364654,0.0015643036,0.00033838215,0.000081827326,0.000027032622,0.0007829919,0.00019268347,0.00019430842],"category_scores_gemma":[0.000006101428,0.0003055484,0.0006339147,0.0009209719,0.0001464604,0.00002942161,0.00019566179,0.00088588515,0.00019678842],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00176083,0.00016575691,0.0000033195633,0.015882643,0.0011829546,0.00014507656,0.000029611985,4.1539792e-8,5.7457544e-7,0.0014110721,0.00016333307,0.9792548],"study_design_scores_gemma":[0.00025988705,0.006884958,0.00004157266,0.006803006,0.0037704585,0.0003288985,0.00003750353,0.000009731053,0.000007866879,0.000020619409,0.9815969,0.00023864038],"about_ca_topic_score_codex":0.0000050952185,"about_ca_topic_score_gemma":5.766678e-7,"teacher_disagreement_score":0.9814335,"about_ca_system_score_codex":0.00008202371,"about_ca_system_score_gemma":0.0001445664,"threshold_uncertainty_score":0.9999397},"labels":[],"label_agreement":null},{"id":"W2001248086","doi":"10.1016/j.nurt.2008.10.009","title":"Poster 8: A Comparison of Two Brief Cognitive Instruments in Huntington Disease (HD)","year":2008,"lang":"en","type":"article","venue":"Neurotherapeutics","topic":"Genetic Neurodegenerative Diseases","field":"Neuroscience","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Montreal Cognitive Assessment; Huntington's disease; Cognition; Psychology; Stroop effect; Verbal fluency test; Audiology; Cognitive impairment; Internal medicine; Physical therapy; Medicine; Psychiatry; Neuropsychology; Disease","score_opus":0.08373017974533162,"score_gpt":0.34179281257955463,"score_spread":0.25806263283422304,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2001248086","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99783397,0.00004232378,0.00004619451,0.0001313676,0.00017715449,0.00053740287,0.00006493457,0.0000436314,0.0011230215],"genre_scores_gemma":[0.99552536,0.00004642782,0.0000349419,0.0041562207,0.000034888835,0.000029923916,0.0000038214025,0.000048263064,0.00012014541],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9978291,0.0003487832,0.00044978163,0.0005371994,0.00048467855,0.00035045852],"domain_scores_gemma":[0.99905,0.00023784804,0.0001859683,0.00030059338,0.000069511174,0.00015607297],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0000431839,0.00023653638,0.0002974117,0.00016639162,0.00010473102,0.000022296763,0.00026833636,0.000033318465,0.000057262812],"category_scores_gemma":[0.0002515087,0.0002448835,0.00009039678,0.0004033945,0.00032892398,0.00011512949,0.00006959937,0.00019760692,0.000030996704],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00026594326,0.00091071014,0.6413419,0.000024558683,0.000005161085,0.000028999657,0.0007458096,0.000100075886,0.35336468,0.0001848331,0.000017040842,0.0030102886],"study_design_scores_gemma":[0.0016143118,0.00017913214,0.24066274,0.000032572207,0.000021305748,0.0000042343854,0.00002381449,0.0007030798,0.75630116,0.000099448975,0.00018152036,0.00017666948],"about_ca_topic_score_codex":0.000015507056,"about_ca_topic_score_gemma":0.000011957663,"teacher_disagreement_score":0.4029365,"about_ca_system_score_codex":0.000017785096,"about_ca_system_score_gemma":0.00011100942,"threshold_uncertainty_score":0.9986059},"labels":[],"label_agreement":null},{"id":"W2002951499","doi":"10.1007/s13311-013-0238-x","title":"Treatment of Cognitive, Psychiatric, and Affective Disorders Associated with Parkinson's Disease","year":2013,"lang":"en","type":"review","venue":"Neurotherapeutics","topic":"Parkinson's Disease Mechanisms and Treatments","field":"Medicine","cited_by":79,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; McMaster University; Toronto Western Hospital; Hamilton Health Sciences","funders":"","keywords":"Psychiatry; Dementia; Anxiety; Psychosis; Disease; Neurology; Parkinson's disease; Medicine; Depression (economics); Mood disorders; Cognition; Psychology; Clinical psychology; Pathology","score_opus":0.0377683137413533,"score_gpt":0.31723300508366564,"score_spread":0.27946469134231233,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2002951499","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0031551814,0.99169034,0.00003257766,0.00003455162,0.00009386761,0.004036465,0.0005057385,0.00006696246,0.00038433913],"genre_scores_gemma":[0.008496025,0.98989934,0.000069943046,0.00007740367,0.000048963804,0.0006930936,0.00025308668,0.00015385984,0.00030829536],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9982058,0.0002060183,0.00032435107,0.00062850513,0.00030745444,0.00032787886],"domain_scores_gemma":[0.9984473,0.0003567065,0.0004076868,0.0003304,0.000083514824,0.00037440853],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.000026293124,0.0006823316,0.0016638535,0.00022491602,0.000079891426,0.000024462428,0.000062309526,0.00018963577,0.000048081976],"category_scores_gemma":[0.00002914804,0.00043736916,0.0004189834,0.00031493383,0.00013997768,0.000043349213,0.000013361459,0.00014521665,0.000015293012],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022764865,0.0025318654,0.004879846,0.0020674292,0.0024139963,0.000090077076,0.000042834108,5.9432775e-8,1.949454e-7,0.000028800076,0.000010012553,0.98770726],"study_design_scores_gemma":[0.0062612747,0.005103745,0.012138195,0.0049718427,0.022490317,0.00003121181,0.000019970292,0.000023188752,0.000002159922,0.00006201276,0.9484068,0.0004892502],"about_ca_topic_score_codex":0.000019044666,"about_ca_topic_score_gemma":0.000011916115,"teacher_disagreement_score":0.98721796,"about_ca_system_score_codex":0.0001263401,"about_ca_system_score_gemma":0.0003529129,"threshold_uncertainty_score":0.99980783},"labels":[],"label_agreement":null},{"id":"W2004127863","doi":"10.1016/j.nurt.2007.01.004","title":"Challenges in the Design and Conduct of Therapeutic Trials in Channel Disorders","year":2007,"lang":"en","type":"review","venue":"Neurotherapeutics","topic":"Ion channel regulation and function","field":"Biochemistry, Genetics and Molecular Biology","cited_by":9,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"National Center for Research Resources; National Institute of Neurological Disorders and Stroke; National Institutes of Health; Deutsches Krebsforschungszentrum","keywords":"Medicine; Weakness; Clinical trial; Ataxia; Paroxysmal dyskinesia; Neuroscience; Neurology; Pediatrics; Physical medicine and rehabilitation; Psychiatry; Psychology; Pathology; Surgery; Dyskinesia","score_opus":0.45156108505491266,"score_gpt":0.42549346248598147,"score_spread":0.026067622568931192,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2004127863","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00002512004,0.9965557,0.0014990052,0.00015068699,0.00024957256,0.0012367986,0.000004532567,0.0000040943955,0.0002745316],"genre_scores_gemma":[0.0020759418,0.9973175,0.000038596278,0.00024853591,0.00015031465,0.00007683836,0.000022373544,0.000039483104,0.00003043759],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9970101,0.0016581145,0.0006762344,0.0003284662,0.00013932644,0.00018777192],"domain_scores_gemma":[0.9988801,0.0004802593,0.00030111364,0.00029507853,0.000022675975,0.000020783027],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0027812088,0.0002622441,0.0008551334,0.00021213647,0.00002134254,0.000012394116,0.00018983771,0.00037329877,0.0000035752355],"category_scores_gemma":[0.00009324277,0.00017309155,0.00019480677,0.0001938735,0.0000848234,0.0000027048147,0.000017998784,0.0002130266,9.3982464e-7],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000051336152,0.00008059796,0.0000027060232,0.0008487762,0.000054340784,9.723103e-7,0.00019429252,0.000037160946,0.00007337893,0.00019492928,0.000015610007,0.9984459],"study_design_scores_gemma":[0.0005121872,0.00030788835,0.000039802926,0.00037678174,0.000108560904,0.000018197217,0.00013419858,0.00007169275,0.00007905448,0.00025189322,0.99790627,0.00019348205],"about_ca_topic_score_codex":0.0000026425694,"about_ca_topic_score_gemma":0.000026834947,"teacher_disagreement_score":0.9982524,"about_ca_system_score_codex":0.0000089800715,"about_ca_system_score_gemma":0.00006585396,"threshold_uncertainty_score":0.7058469},"labels":[],"label_agreement":null},{"id":"W2005397880","doi":"10.1016/j.nurt.2008.08.007","title":"Spinal Muscular Atrophy","year":2008,"lang":"en","type":"review","venue":"Neurotherapeutics","topic":"Neurogenetic and Muscular Disorders Research","field":"Medicine","cited_by":69,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Montreal Neurological Institute and Hospital","funders":"National Center for Research Resources; National Institutes of Health; Georgia Clinical and Translational Science Alliance; Spinal Muscular Atrophy Foundation","keywords":"SMA*; Spinal muscular atrophy; SMN1; Clinical trial; Medicine; Disease; Bioinformatics; Neuroscience; Preclinical testing; Pathology; Biology","score_opus":0.1412575311618893,"score_gpt":0.426179409533586,"score_spread":0.2849218783716967,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2005397880","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000012420566,0.9951763,0.000108569315,0.00007154092,0.00020103794,0.0017531348,0.000008988588,0.000097493525,0.002570475],"genre_scores_gemma":[0.0000037377722,0.9966846,0.00025025173,0.0009141304,0.0003395933,0.00011796676,0.00003331985,0.00024036289,0.0014160458],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99745595,0.00020779892,0.0004896443,0.0006235963,0.0006977822,0.0005252274],"domain_scores_gemma":[0.9985192,0.00004299191,0.00012571256,0.00096601446,0.00008770464,0.00025837292],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.000053229796,0.00052912073,0.0015899008,0.00030482837,0.00010841711,0.00002573308,0.0002985936,0.00035703025,0.0001556692],"category_scores_gemma":[0.00002676368,0.00041937982,0.0013711399,0.00049279386,0.00019433469,0.0000176868,0.00005878589,0.0009510601,0.00051703426],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00002356101,0.00014718268,0.000004824065,0.006800308,0.00028291994,0.0006302776,0.000008429458,1.05594175e-7,0.000005728552,0.000033004242,0.00042490097,0.9916388],"study_design_scores_gemma":[0.00052207016,0.00069212844,0.000014866619,0.0018901605,0.00083146576,0.002441309,0.0000019616207,0.000004599329,0.0000035183975,0.0000064629185,0.9933038,0.00028771028],"about_ca_topic_score_codex":0.0000031996674,"about_ca_topic_score_gemma":3.2150024e-7,"teacher_disagreement_score":0.99287885,"about_ca_system_score_codex":0.00005624094,"about_ca_system_score_gemma":0.0006945376,"threshold_uncertainty_score":0.9998258},"labels":[],"label_agreement":null},{"id":"W2016127680","doi":"10.1016/j.nurt.2007.07.005","title":"Targeting MMPs in Acute and Chronic Neurological Conditions","year":2007,"lang":"en","type":"review","venue":"Neurotherapeutics","topic":"Protease and Inhibitor Mechanisms","field":"Biochemistry, Genetics and Molecular Biology","cited_by":63,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Matrix metalloproteinase; Medicine; Downregulation and upregulation; Central nervous system; Multiple sclerosis; Neurology; Neuroscience; Neurosurgery; Bioinformatics; Immunology; Internal medicine; Biology; Surgery","score_opus":0.04209401027709576,"score_gpt":0.3458042616081801,"score_spread":0.30371025133108437,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2016127680","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00042320383,0.9982509,0.00020411417,0.000020948553,0.00019920738,0.0006498576,0.000055912238,0.00001955183,0.00017631947],"genre_scores_gemma":[0.00028445543,0.99788827,0.00011920009,0.0008362284,0.00041417353,0.00007624571,0.00020298982,0.00006635683,0.00011209788],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9985102,0.00015406868,0.0003751793,0.0005091971,0.00010157276,0.00034982688],"domain_scores_gemma":[0.9994651,0.00002947122,0.00013019372,0.00027842988,0.000019645924,0.00007716229],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00015062187,0.0003269184,0.00051310257,0.000099774166,0.0000622462,0.000026944832,0.00018932398,0.00052298355,0.000019875037],"category_scores_gemma":[0.000018143477,0.00028628812,0.0001552837,0.00012690171,0.000078024554,0.0000027254778,0.000089424306,0.0004383252,0.000012840673],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000041823914,0.00019103929,0.000023376848,0.0025046542,0.00026522594,0.00028392725,0.000015218314,0.0000049716978,0.050666023,0.00062710495,0.00070128875,0.9446753],"study_design_scores_gemma":[0.00021671355,0.00047885557,0.0000018639568,0.00026358268,0.00014026673,0.00010888573,8.7228017e-7,0.000021402275,0.0013526456,0.00005635466,0.99708825,0.00027031242],"about_ca_topic_score_codex":7.7082564e-7,"about_ca_topic_score_gemma":0.0000030634808,"teacher_disagreement_score":0.99638695,"about_ca_system_score_codex":0.000015676427,"about_ca_system_score_gemma":0.0001257143,"threshold_uncertainty_score":0.99995893},"labels":[],"label_agreement":null},{"id":"W2017747930","doi":"10.1016/j.nurt.2008.10.013","title":"Poster 12: A Metabolic Network Associated with the Progression of Preclinical Huntington's Disease: Application of the Ordinal Trends Analysis to a Longitudinal PET Study","year":2008,"lang":"en","type":"article","venue":"Neurotherapeutics","topic":"Genetic Neurodegenerative Diseases","field":"Neuroscience","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Putamen; Voxel; Internal medicine; Longitudinal study; Oncology; Pathology; Radiology","score_opus":0.05903184801074006,"score_gpt":0.33713642379514014,"score_spread":0.27810457578440007,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2017747930","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9975057,0.000041769395,0.0003133161,0.0008898753,0.000056180674,0.00104378,0.000044540186,0.00003091458,0.00007390063],"genre_scores_gemma":[0.9986312,0.000008974177,0.00003894436,0.0009063276,0.000054472035,0.00016400949,0.0000026529724,0.000034214427,0.00015919919],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9967844,0.0010267748,0.00042750116,0.0005797455,0.00088358554,0.0002979754],"domain_scores_gemma":[0.9979239,0.00044068872,0.00046971088,0.0008886479,0.00016468253,0.00011236085],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023277079,0.0002357042,0.00039512664,0.00012079369,0.0003001811,0.000025554044,0.0006573225,0.000025809546,0.000016708558],"category_scores_gemma":[0.00024129404,0.00012835342,0.00024642854,0.0026055195,0.00035068122,0.00004507698,0.00013274654,0.00018781531,0.000001437472],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00045344155,0.0013270502,0.9767334,0.0000046212463,0.00021728566,0.0000055118435,0.00035281354,0.0057217483,0.01363928,0.000063663225,0.00003925755,0.0014419162],"study_design_scores_gemma":[0.0005085504,0.00057292974,0.9754315,0.0000100830885,0.001282209,0.0000027061617,0.000015613345,0.0011394314,0.020598875,0.000005557326,0.00030594066,0.00012661217],"about_ca_topic_score_codex":0.000007556253,"about_ca_topic_score_gemma":0.00008935758,"teacher_disagreement_score":0.0069595957,"about_ca_system_score_codex":0.0000081054695,"about_ca_system_score_gemma":0.00008843132,"threshold_uncertainty_score":0.5234101},"labels":[],"label_agreement":null},{"id":"W2023282360","doi":"10.1007/s13311-012-0123-z","title":"Preventive Interventions for ADHD: A Neurodevelopmental Perspective","year":2012,"lang":"en","type":"review","venue":"Neurotherapeutics","topic":"Attention Deficit Hyperactivity Disorder","field":"Medicine","cited_by":146,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Institute of Mental Health; Canadian Institutes of Health Research; National Institutes of Health","keywords":"Psychological intervention; Attention deficit hyperactivity disorder; Intervention (counseling); Psychology; Perspective (graphical); Neurodevelopmental disorder; Neurology; Developmental psychology; Brain Structure and Function; Persistence (discontinuity); Cognition; Psychiatry; Clinical psychology; Autism","score_opus":0.33126197148077996,"score_gpt":0.48400093170851893,"score_spread":0.15273896022773897,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2023282360","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000017628372,0.9911416,0.001692588,0.00019382585,0.0007094249,0.004627581,0.00016930398,0.00013921352,0.0013088008],"genre_scores_gemma":[0.00008665017,0.9890913,0.0010437712,0.00033701325,0.00043261965,0.00095744844,0.00017311095,0.00026919995,0.007608893],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9978078,0.00019888248,0.000659524,0.0005919092,0.00028046482,0.00046140148],"domain_scores_gemma":[0.9984459,0.00027304114,0.00042183185,0.0004697576,0.00023384512,0.00015559388],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00016620372,0.0005468518,0.0015823796,0.00034311166,0.00012445147,0.00004171113,0.00018212452,0.000303775,0.00036564472],"category_scores_gemma":[0.00009381828,0.00048983964,0.0020811567,0.00034205857,0.00008728806,0.00012522298,0.000060329163,0.00064927916,0.00022885323],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00004345182,0.0013363127,0.000022394735,0.022261482,0.0011543331,0.000010478949,0.00045429068,1.09686155e-7,0.000003663753,0.0006782384,0.00026425664,0.973771],"study_design_scores_gemma":[0.00071358547,0.0002862074,0.000050604634,0.0058434363,0.00619671,0.00031777323,0.00049363467,0.0000046688874,7.40936e-7,0.000044220036,0.9856731,0.0003753111],"about_ca_topic_score_codex":0.0000033441338,"about_ca_topic_score_gemma":0.000003070279,"teacher_disagreement_score":0.98540884,"about_ca_system_score_codex":0.00030770854,"about_ca_system_score_gemma":0.00035313942,"threshold_uncertainty_score":0.9997553},"labels":[],"label_agreement":null},{"id":"W2025962668","doi":"10.1007/s13311-014-0290-1","title":"Nonpharmacological Therapies for Neurologic Devices","year":2014,"lang":"en","type":"editorial","venue":"Neurotherapeutics","topic":"Neurological disorders and treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Western Hospital; University of Toronto","funders":"","keywords":"Deep brain stimulation; Essential tremor; Medicine; Movement disorders; Neurology; Neuromodulation; Disease; Adverse effect; Therapeutic window; Neurosurgery; Neuroscience; Intensive care medicine; Physical medicine and rehabilitation; Parkinson's disease; Psychology; Psychiatry; Central nervous system","score_opus":0.037442670022104996,"score_gpt":0.3454040231817963,"score_spread":0.3079613531596913,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2025962668","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0067173233,0.0028155071,0.0004731467,0.0062616984,0.9759625,0.004027506,0.0003312278,0.00063211884,0.0027789655],"genre_scores_gemma":[0.031043503,0.0022535757,0.0008532996,0.072352804,0.88823736,0.00096089067,0.00055413396,0.00036233457,0.0033820758],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9973243,0.00017396886,0.00043715004,0.0008894262,0.0005779147,0.0005972264],"domain_scores_gemma":[0.99707764,0.0017887781,0.00024590825,0.00046866297,0.0002386633,0.000180359],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00015886991,0.0006249301,0.000962711,0.00010837259,0.00016411168,0.00006780933,0.00032507314,0.0011188966,0.00018726358],"category_scores_gemma":[0.00025439204,0.0004275846,0.00046856274,0.00012835348,0.0001799003,0.000030915246,0.00004487183,0.0010154862,0.000077032346],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017892177,0.0008725811,0.00079429056,0.0003935873,0.00034053545,0.00011467341,0.00002175884,0.0000032595783,0.0005217307,0.00006607745,0.9856064,0.00947593],"study_design_scores_gemma":[0.003916344,0.0067136213,0.0006626306,0.000017536986,0.00083986734,0.000004763991,0.0000025182826,0.00014072892,0.000063150124,0.0013947015,0.9859222,0.000321936],"about_ca_topic_score_codex":0.000002903947,"about_ca_topic_score_gemma":0.000003315637,"teacher_disagreement_score":0.087725125,"about_ca_system_score_codex":0.000027340862,"about_ca_system_score_gemma":0.00012055985,"threshold_uncertainty_score":0.9998176},"labels":[],"label_agreement":null},{"id":"W2037123984","doi":"10.1016/j.nurt.2009.09.006","title":"Poster 5: Usefulness of Two Brief Cognitive Screening Measures in Huntington's Disease","year":2010,"lang":"en","type":"article","venue":"Neurotherapeutics","topic":"Genetic Neurodegenerative Diseases","field":"Neuroscience","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Montreal Cognitive Assessment; Huntington's disease; Cognition; Psychology; Medicine; Cognitive impairment; Demography; Internal medicine; Gerontology; Audiology; Disease; Psychiatry","score_opus":0.06855199675514623,"score_gpt":0.3102078649173114,"score_spread":0.24165586816216517,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2037123984","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9975456,0.000017742792,0.00049860857,0.00024184375,0.00034050402,0.0004987135,0.0000880188,0.00005981099,0.00070916745],"genre_scores_gemma":[0.99525887,0.0000093615645,0.00010897067,0.0043437984,0.00008379889,0.0000409122,0.0000023274592,0.0000691839,0.000082750084],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.997773,0.00035336622,0.00035390013,0.00061106856,0.0005167386,0.00039193736],"domain_scores_gemma":[0.9986141,0.0005006039,0.00015864066,0.00040644113,0.00013494826,0.0001852927],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0001358947,0.00025970215,0.00024206402,0.00019186601,0.0000952995,0.00006755089,0.00036756787,0.00004815998,0.00008802123],"category_scores_gemma":[0.0008519639,0.00026039843,0.000106292435,0.00041093468,0.00034318177,0.00014768985,0.000076190954,0.00039652246,0.000013260428],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018209142,0.00025615827,0.10317335,0.000019624913,0.000004445852,0.000024115174,0.00020551772,0.000083120314,0.8885124,0.0006790931,0.000004587435,0.0068555167],"study_design_scores_gemma":[0.0011602713,0.00006535729,0.15755668,0.0000308226,0.000032034,0.0000034618167,0.000017819382,0.00028336598,0.84004426,0.00022289496,0.00037089307,0.0002121116],"about_ca_topic_score_codex":0.000017669916,"about_ca_topic_score_gemma":0.00006712736,"teacher_disagreement_score":0.054383323,"about_ca_system_score_codex":0.0000051452707,"about_ca_system_score_gemma":0.00009966838,"threshold_uncertainty_score":0.9999848},"labels":[],"label_agreement":null},{"id":"W2037170404","doi":"10.1016/j.nurt.2008.09.009","title":"Platform Presentation—Loss of Striatal Dopaminergic Function and Thalamic Compensatory Mechanism During Phenocoversion of Preclinical Huntington's Disease","year":2008,"lang":"en","type":"article","venue":"Neurotherapeutics","topic":"Genetic Neurodegenerative Diseases","field":"Neuroscience","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Putamen; Dopaminergic; Striatum; Medicine; Asymptomatic; Internal medicine; Basal ganglia; Raclopride; Huntington's disease; Caudate nucleus; Neurology; Thalamus; Endocrinology; Psychology; Disease; Gastroenterology; Neuroscience; Dopamine; Central nervous system; Psychiatry","score_opus":0.0567189148239805,"score_gpt":0.2862379495870754,"score_spread":0.22951903476309488,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2037170404","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99883294,0.00004669949,0.00022129166,0.000037983962,0.00023430903,0.0004256503,0.00007278352,0.00004003783,0.00008828248],"genre_scores_gemma":[0.9993038,0.00022593344,0.00006522329,0.000209003,0.00005322765,0.000011103944,0.000004654182,0.000032958338,0.00009408809],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99838156,0.00015507598,0.00039482932,0.00043248202,0.00044054515,0.00019548732],"domain_scores_gemma":[0.9989216,0.0003036482,0.0002759687,0.0003136111,0.00006572809,0.000119495104],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00005527883,0.00018231194,0.00022944105,0.00010449357,0.00014645421,0.000011497441,0.0001709645,0.00004599691,0.000029427789],"category_scores_gemma":[0.0001518552,0.000180332,0.00009235662,0.0001743384,0.00031320745,0.00016578162,0.00008132921,0.00012632264,0.0000030318436],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005354909,0.00026978535,0.04717367,0.00010683797,0.000010726716,0.000007777125,0.00011268833,0.00045123196,0.94943863,0.0017587699,0.0000047656226,0.00012963702],"study_design_scores_gemma":[0.0013348471,0.00022617858,0.23278725,0.00001647961,0.000052586296,0.0000064183964,0.000026369731,0.000806534,0.76390934,0.0006928734,0.00001947849,0.00012163375],"about_ca_topic_score_codex":0.0000031940835,"about_ca_topic_score_gemma":5.837172e-7,"teacher_disagreement_score":0.18561357,"about_ca_system_score_codex":0.000011146262,"about_ca_system_score_gemma":0.000081310194,"threshold_uncertainty_score":0.73537254},"labels":[],"label_agreement":null},{"id":"W2042668292","doi":"10.1007/s13311-013-0243-0","title":"Effects of Marketed Antiepileptic Drugs and Placebo in the Human Photosensitivity Screening Protocol","year":2013,"lang":"en","type":"article","venue":"Neurotherapeutics","topic":"Epilepsy research and treatment","field":"Medicine","cited_by":30,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Epilepsiatutkimussäätiö; University of Calgary; GlaxoSmithKline","keywords":"Placebo; Medicine; Photosensitivity; Levetiracetam; Carbamazepine; Epilepsy; Clinical trial; Anesthesia; Pharmacology; Internal medicine; Psychiatry","score_opus":0.020140904610729083,"score_gpt":0.31687252503528573,"score_spread":0.29673162042455664,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2042668292","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.937844,0.000015776852,0.000014467246,0.00038960477,0.000006783839,0.060231857,0.0000013675105,0.00001835479,0.00147782],"genre_scores_gemma":[0.98199445,0.000009598613,0.0001880153,0.0007151653,0.000021585334,0.016986372,0.000001501331,0.000019560464,0.00006375506],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988276,0.00031281743,0.00017321197,0.0001730424,0.0002767638,0.00023661566],"domain_scores_gemma":[0.999114,0.00049442734,0.000051430085,0.0002244526,0.000047050617,0.00006865933],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023769776,0.00012682201,0.00021651662,0.00008903218,0.000056885776,0.000023599048,0.000062528576,0.000048931965,0.000030738396],"category_scores_gemma":[0.000037316633,0.00008051438,0.000043806882,0.00016113452,0.00012584768,0.000046422556,0.000019518779,0.00023418896,0.00001263371],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009902752,0.0014484032,0.6096255,0.0013653097,0.00020328391,0.00024438577,0.0015419999,8.498278e-7,0.33365753,0.0000864892,0.00027593478,0.050559994],"study_design_scores_gemma":[0.0068068383,0.0012630363,0.94115365,0.0001741801,0.000046610614,0.0000310881,0.00011632175,0.0005808961,0.04907984,0.000100029094,0.0005631036,0.000084426036],"about_ca_topic_score_codex":0.0000942965,"about_ca_topic_score_gemma":0.0000071720497,"teacher_disagreement_score":0.3315281,"about_ca_system_score_codex":0.000011643999,"about_ca_system_score_gemma":0.000023325367,"threshold_uncertainty_score":0.3283281},"labels":[],"label_agreement":null},{"id":"W2048198700","doi":"10.1007/s13311-014-0320-z","title":"Promoting Autophagic Clearance: Viable Therapeutic Targets in Alzheimer's Disease","year":2014,"lang":"en","type":"review","venue":"Neurotherapeutics","topic":"Autophagy in Disease and Therapy","field":"Medicine","cited_by":84,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Institute of Neurological Disorders and Stroke; Weston Brain Institute; BrightFocus Foundation; National Institutes of Health; Alzheimer's Association","keywords":"Autophagy; PI3K/AKT/mTOR pathway; Cell biology; Autophagosome; Lysosome; Intracellular; Biology; Protein degradation; Neuroscience; Chemistry; Signal transduction; Biochemistry; Enzyme; Apoptosis","score_opus":0.05998631047213323,"score_gpt":0.36327875780372554,"score_spread":0.30329244733159233,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2048198700","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00004404822,0.9950089,0.00005176487,0.000158554,0.00050085713,0.0031338322,0.000031563824,0.00029656023,0.0007739457],"genre_scores_gemma":[0.0014777984,0.9922573,0.00007210741,0.0042943284,0.00058587175,0.00039629414,0.00011077045,0.00042338372,0.0003821319],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9957675,0.00051644264,0.0011516818,0.0010395977,0.0006074413,0.0009173825],"domain_scores_gemma":[0.9974267,0.00022085475,0.0004826439,0.0012858959,0.00007662473,0.000507271],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0003761862,0.0009914844,0.002786151,0.00043333945,0.00012989911,0.00007816869,0.00049194164,0.0004869453,0.000427066],"category_scores_gemma":[0.000034194578,0.0008198544,0.0009438976,0.0007184883,0.00016337559,0.000101063706,0.000053297663,0.0012329711,0.00041256566],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013901808,0.00057001156,0.000057294314,0.008066045,0.000627255,0.00040122773,0.0001591392,0.0000026930616,0.0000042430283,0.0002543597,0.000056023997,0.9896627],"study_design_scores_gemma":[0.0012526946,0.0002785663,0.0002406235,0.007190019,0.003351206,0.00007192401,0.000003976373,0.0007854794,0.00001617557,0.00045475582,0.9856859,0.00066869176],"about_ca_topic_score_codex":0.0000044776834,"about_ca_topic_score_gemma":0.0000010467887,"teacher_disagreement_score":0.988994,"about_ca_system_score_codex":0.00013329746,"about_ca_system_score_gemma":0.0007920666,"threshold_uncertainty_score":0.99942523},"labels":[],"label_agreement":null},{"id":"W2051991099","doi":"10.1007/s13311-014-0275-0","title":"Deep Brain Stimulation for Disorders of Memory and Cognition","year":2014,"lang":"en","type":"review","venue":"Neurotherapeutics","topic":"Neurological disorders and treatments","field":"Medicine","cited_by":40,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Western Hospital; Health Sciences Centre; University of Alberta","funders":"Boston Scientific Corporation; Dana Foundation","keywords":"Deep brain stimulation; Neuroscience; Neurology; Cognition; Essential tremor; Psychology; Brain stimulation; Anxiety; Disease; Nucleus basalis; Medicine; Parkinson's disease; Psychiatry; Stimulation; Cholinergic neuron; Internal medicine","score_opus":0.06448202819604432,"score_gpt":0.36452398359697297,"score_spread":0.30004195540092865,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2051991099","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000072240844,0.9944514,0.0021676184,0.00020863344,0.000081625105,0.0024320902,0.000024625424,0.000031729185,0.0005300064],"genre_scores_gemma":[0.00069054734,0.99707454,0.00020763591,0.0015943416,0.000042284642,0.00010937385,0.00012230246,0.000057138528,0.00010184005],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99911594,0.00007762025,0.00030769198,0.0002606576,0.000107276595,0.0001307944],"domain_scores_gemma":[0.9990712,0.00049355946,0.00018973877,0.00016468641,0.000030652922,0.000050198058],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000056806122,0.00022175162,0.0008589996,0.00008363302,0.00003412228,0.0000066786474,0.000038717335,0.00018364299,0.000015587424],"category_scores_gemma":[0.00005965837,0.00016359487,0.00023337772,0.000081390615,0.00006511401,0.000014948945,0.000009212786,0.00012087925,0.0000029810842],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00005320107,0.00015639038,0.000026769834,0.0074906447,0.00011818812,0.0000010653799,0.000011712627,0.0000010539347,0.0000029302585,0.000068140114,0.000030055598,0.99203986],"study_design_scores_gemma":[0.0028608993,0.0023785383,0.0001672912,0.001266475,0.003447935,0.000010931819,0.0000040364325,0.00075600983,0.0000030389401,0.003118142,0.9857686,0.00021810539],"about_ca_topic_score_codex":8.96447e-7,"about_ca_topic_score_gemma":0.0000028359725,"teacher_disagreement_score":0.99182177,"about_ca_system_score_codex":0.00000672252,"about_ca_system_score_gemma":0.000024893867,"threshold_uncertainty_score":0.6671205},"labels":[],"label_agreement":null},{"id":"W2052644993","doi":"10.1007/s13311-012-0162-5","title":"Hematopoietic Stem Cell Therapy for Multiple Sclerosis: Top 10 Lessons Learned","year":2012,"lang":"en","type":"review","venue":"Neurotherapeutics","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":78,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa; Ottawa Hospital","funders":"","keywords":"Medicine; Multiple sclerosis; Stem cell; Haematopoiesis; Hematopoietic stem cell transplantation; Hematopoietic stem cell; Neurology; Immune system; Oncology; Chemotherapy; Disease; Neurosurgery; Internal medicine; Surgery; Immunology; Biology; Psychiatry","score_opus":0.48540495711779513,"score_gpt":0.432709704511701,"score_spread":0.052695252606094145,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2052644993","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000032862656,0.9907514,0.00014298348,0.0006629053,0.00041673463,0.006747262,0.0002396087,0.00024689478,0.00075934426],"genre_scores_gemma":[0.0003661033,0.988349,0.00046082522,0.00063917326,0.00077487883,0.0023172584,0.000091170186,0.00047705165,0.0065245233],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9954828,0.00040695185,0.0010025896,0.0009902458,0.000808571,0.0013088404],"domain_scores_gemma":[0.99576825,0.0015841632,0.00047096936,0.0014351065,0.00030415007,0.00043736584],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00056492246,0.0010197049,0.0029852479,0.00035168417,0.00032329262,0.000108688386,0.00057950534,0.0006297532,0.00027321075],"category_scores_gemma":[0.00007068334,0.0007702259,0.0014137247,0.0004985182,0.0002326552,0.00008656721,0.0001335782,0.0009895203,0.00037478842],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015320268,0.0006504191,0.000025622467,0.017641325,0.0004992389,0.0000036215222,0.0003132184,3.362332e-7,0.00029975805,0.000022220971,0.0011157172,0.97927535],"study_design_scores_gemma":[0.0028929524,0.00061051594,0.000040884985,0.00399079,0.001180943,0.00001822362,0.00007485274,0.000035404133,0.0003838543,0.0000057759953,0.9901729,0.00059288234],"about_ca_topic_score_codex":0.000006172907,"about_ca_topic_score_gemma":0.0000037591026,"teacher_disagreement_score":0.9890572,"about_ca_system_score_codex":0.00020004774,"about_ca_system_score_gemma":0.00045711838,"threshold_uncertainty_score":0.9994749},"labels":[],"label_agreement":null},{"id":"W2052967774","doi":"10.1007/s13311-013-0218-1","title":"Pathogenesis-Targeted, Disease-Modifying Therapies in Parkinson Disease","year":2013,"lang":"en","type":"review","venue":"Neurotherapeutics","topic":"Parkinson's Disease Mechanisms and Treatments","field":"Medicine","cited_by":153,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Western Hospital; University Health Network","funders":"Canadian Institutes of Health Research; National Institute of Neurological Disorders and Stroke; University of Toronto","keywords":"Disease; Parkinson's disease; Medicine; Neuroscience; Neurology; Neuroprotection; Dopaminergic; Clinical trial; Pathogenesis; Bioinformatics; Psychology; Dopamine; Pathology; Biology","score_opus":0.08742858773090376,"score_gpt":0.3413525419736459,"score_spread":0.25392395424274217,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2052967774","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0007272288,0.9945532,0.000035366378,0.00012482693,0.00040011664,0.003473485,0.00033605343,0.00019153327,0.0001581736],"genre_scores_gemma":[0.001670784,0.9938901,0.00029241992,0.0010765117,0.0002783301,0.0014685222,0.00032239076,0.0003545776,0.0006463323],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9962985,0.00038536446,0.0007992692,0.0011265947,0.00061966234,0.0007706448],"domain_scores_gemma":[0.99731815,0.00013736324,0.0003379114,0.001170535,0.000069639995,0.000966378],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00012455459,0.0010521014,0.0019813764,0.00051495584,0.0001239665,0.00010478224,0.00032148068,0.00029322773,0.00030964188],"category_scores_gemma":[0.000038850198,0.0008177533,0.0009882003,0.0005125357,0.0000830356,0.000113301685,0.000059565562,0.00051526417,0.0003804382],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015985373,0.0009246227,0.0025905408,0.009884095,0.00043215437,0.0016340975,0.000043730066,0.0000012908893,0.000008051245,0.00009764907,0.00006265225,0.98416126],"study_design_scores_gemma":[0.0012201595,0.000110472276,0.0068790563,0.0055594426,0.0030353789,0.000023040802,0.00000950904,0.00008234555,0.0000016931507,0.00018938594,0.98226863,0.000620886],"about_ca_topic_score_codex":0.000014262089,"about_ca_topic_score_gemma":0.0000029448934,"teacher_disagreement_score":0.98354036,"about_ca_system_score_codex":0.0002517305,"about_ca_system_score_gemma":0.0007702529,"threshold_uncertainty_score":0.9994273},"labels":[],"label_agreement":null},{"id":"W2054233677","doi":"10.1007/s13311-013-0228-z","title":"Epigenetics of Neural Repair Following Spinal Cord Injury","year":2013,"lang":"en","type":"review","venue":"Neurotherapeutics","topic":"Histone Deacetylase Inhibitors Research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":37,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"International Collaboration On Repair Discoveries; University of British Columbia","funders":"","keywords":"Neuroscience; Spinal cord injury; Spinal cord; Central nervous system; Medicine; Biology","score_opus":0.07782792623367334,"score_gpt":0.4078148844610375,"score_spread":0.3299869582273641,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2054233677","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0038081775,0.9938544,0.00005210735,0.000010484683,0.0006542882,0.001105362,0.00006563479,0.00004169487,0.00040784138],"genre_scores_gemma":[0.00044529876,0.99642056,0.0006151206,0.00013340732,0.00046708857,0.00012498292,0.00009985032,0.0002189792,0.0014746864],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9970833,0.00039370064,0.00085635367,0.0007003087,0.00044835455,0.0005179911],"domain_scores_gemma":[0.9981215,0.00003865925,0.00036758775,0.0011812329,0.00013417697,0.00015686442],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0002150312,0.0005492319,0.0011335223,0.00018905393,0.0000803247,0.000029830693,0.00063383393,0.0006265163,0.00003770836],"category_scores_gemma":[0.00008941392,0.000509617,0.001329779,0.00029623898,0.00019152813,0.0000035662936,0.00019627226,0.0005429076,0.00006334404],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008302241,0.000099336045,0.000007913818,0.0032460783,0.0003064072,0.000019812556,0.0000053994804,0.000001098913,0.008502899,0.000009223881,0.0018052944,0.9859135],"study_design_scores_gemma":[0.00014815005,0.0023766228,0.0000020419354,0.0007715494,0.00028680387,0.00003451074,0.0000033949318,0.000014416649,0.004755203,0.000002833634,0.99119586,0.00040859188],"about_ca_topic_score_codex":0.000011999014,"about_ca_topic_score_gemma":0.0000033643134,"teacher_disagreement_score":0.9893906,"about_ca_system_score_codex":0.00004244296,"about_ca_system_score_gemma":0.00039994883,"threshold_uncertainty_score":0.99973553},"labels":[],"label_agreement":null},{"id":"W2058388133","doi":"10.1007/s13311-013-0221-6","title":"Designing Clinical Trials for Dystonia","year":2013,"lang":"en","type":"review","venue":"Neurotherapeutics","topic":"Statistical Methods in Clinical Trials","field":"Mathematics","cited_by":17,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dystonia Medical Research Foundation Canada; Toronto Western Hospital","funders":"National Center for Advancing Translational Sciences; National Institute of Neurological Disorders and Stroke; National Institutes of Health; Dystonia Coalition; Dystonia Medical Research Foundation","keywords":"Clinical trial; Dystonia; Tolerability; Clinical study design; Medicine; Medical physics; Psychology; Intensive care medicine; Alternative medicine; Psychiatry; Pathology","score_opus":0.9729653065478591,"score_gpt":0.7536013271799333,"score_spread":0.21936397936792573,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2058388133","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":"methods","model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[4.683994e-8,0.6305251,0.3576579,0.00004766417,0.0030617237,0.007889723,0.000255301,0.00020064489,0.00036188684],"genre_scores_gemma":[5.6579252e-9,0.5235724,0.47241175,0.00035200105,0.0016791114,0.0010796337,0.0000044192197,0.00026547967,0.0006351961],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9676426,0.021343349,0.008585908,0.0011652015,0.0005172116,0.0007457162],"domain_scores_gemma":[0.48167005,0.51294965,0.003491664,0.0013166497,0.0002497818,0.00032223095],"candidate_categories":["metaresearch","metaepi_narrow","research_integrity"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.03889813,0.00097293686,0.011452583,0.00018084318,0.0001418108,0.0001961813,0.0010828301,0.001766312,0.0004908408],"category_scores_gemma":[0.33608496,0.00068238244,0.0039596935,0.00030705176,0.0002960934,0.00005168282,0.00010048765,0.0015505183,0.00029160787],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000027637765,0.00018045817,3.2618377e-7,0.010643199,0.0006706064,0.0000049028504,0.0000070481838,2.3947669e-8,0.0000010400867,0.020057937,0.0069291783,0.96147764],"study_design_scores_gemma":[0.0007330034,0.00033334453,5.94455e-8,0.0028801851,0.004637791,0.00001019785,0.0000020461932,0.000023223369,0.0000042687043,0.28158453,0.70932424,0.00046713994],"about_ca_topic_score_codex":7.3477355e-7,"about_ca_topic_score_gemma":2.8230704e-7,"teacher_disagreement_score":0.9610105,"about_ca_system_score_codex":0.00007554866,"about_ca_system_score_gemma":0.00048000077,"threshold_uncertainty_score":0.99956274},"labels":[{"model":"gemma","categories":[],"domain":null,"study_design":"not_applicable","genre":"methods","about_ca_system":false,"about_ca_topic":false,"confidence":"low"},{"model":"gpt","categories":["metaresearch"],"domain":"methods","study_design":"theoretical_or_conceptual","genre":"methods","about_ca_system":false,"about_ca_topic":false,"confidence":"low"}],"label_agreement":"split"},{"id":"W2059062495","doi":"10.1007/s13311-012-0130-0","title":"ADHD Treatments, Sleep, and Sleep Problems: Complex Associations","year":2012,"lang":"en","type":"review","venue":"Neurotherapeutics","topic":"Attention Deficit Hyperactivity Disorder","field":"Medicine","cited_by":165,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Stimulant; Sleep (system call); Methylphenidate; Pharmacotherapy; Neurology; Psychiatry; Medicine; Psychology; Dosing; Attention deficit hyperactivity disorder; Clinical psychology; Internal medicine","score_opus":0.29674656080825956,"score_gpt":0.4156485027002638,"score_spread":0.11890194189200426,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2059062495","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00006416685,0.9948193,0.00008239319,0.0003183534,0.0002152851,0.0021510085,0.00016791966,0.00015119826,0.0020303635],"genre_scores_gemma":[0.00027793107,0.9956411,0.00030829213,0.00066884875,0.0003022321,0.00019712784,0.0004462054,0.00019330654,0.0019649542],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99796563,0.00023909828,0.0005586822,0.00044979938,0.00036003953,0.00042674804],"domain_scores_gemma":[0.9985408,0.0002360032,0.00042599792,0.00052042975,0.000090171714,0.0001865673],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00012275463,0.0005276529,0.0015573996,0.00020404786,0.0001461464,0.000054352156,0.00010726844,0.0003887887,0.00039524882],"category_scores_gemma":[0.00003010813,0.00044295273,0.00040080957,0.0003125097,0.00007946332,0.00010400736,0.000042506064,0.00056470506,0.00029109372],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000003861813,0.0006359041,0.00068624865,0.003686365,0.0011766779,0.000007813589,0.00013932656,3.6506628e-7,0.0000061545725,0.00009853438,0.00010327126,0.99345547],"study_design_scores_gemma":[0.0007136729,0.00013854788,0.00091537816,0.00063853746,0.008661678,0.00018621709,0.000028286779,0.00004360336,1.251322e-7,0.0000114229415,0.9883513,0.0003112619],"about_ca_topic_score_codex":0.000010242006,"about_ca_topic_score_gemma":0.000005042957,"teacher_disagreement_score":0.9931442,"about_ca_system_score_codex":0.0001665116,"about_ca_system_score_gemma":0.00009409829,"threshold_uncertainty_score":0.99980223},"labels":[],"label_agreement":null},{"id":"W2062556960","doi":"10.1016/j.nurt.2007.10.020","title":"Longitudinal Decline in Negative Emotion Recognition Prior to Diagnosis in Huntington’s Disease","year":2008,"lang":"en","type":"article","venue":"Neurotherapeutics","topic":"Genetic Neurodegenerative Diseases","field":"Neuroscience","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University","funders":"","keywords":"Huntington's disease; Neurology; Psychology; Neurosurgery; Disease; Medicine; Neuroscience; Audiology; Psychiatry; Pathology","score_opus":0.09908785438174297,"score_gpt":0.31250104029162123,"score_spread":0.21341318590987826,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2062556960","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9963894,0.000019652962,0.00015342083,0.0020763252,0.00021396737,0.0009064657,0.00005016012,0.00006328693,0.00012731667],"genre_scores_gemma":[0.9896119,0.00026502853,0.00035513396,0.0093099065,0.000079240905,0.0002674421,0.000004041267,0.00004937957,0.00005788071],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99766856,0.00040816786,0.0003898106,0.00073903997,0.00039053708,0.00040385628],"domain_scores_gemma":[0.9989178,0.00042206983,0.00008988264,0.00029659344,0.0000626171,0.0002110146],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.000092419,0.0002428438,0.00021114835,0.0003486768,0.00012353974,0.000040679777,0.00024042836,0.00004517373,0.00008313699],"category_scores_gemma":[0.0012190138,0.00026297756,0.00006881694,0.00090555724,0.00010592709,0.00016497869,0.00007236019,0.00021564247,0.00013620118],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004978041,0.0014163655,0.86714506,0.00003148889,0.000002895523,0.00026566605,0.0011928105,0.0028185,0.109616585,0.000051811792,0.000097170036,0.016863866],"study_design_scores_gemma":[0.00075892155,0.00014656098,0.6526289,0.000036301113,0.000007841777,0.0000041410844,0.000015226252,0.00054955436,0.3449553,0.00040123917,0.0002904087,0.00020564196],"about_ca_topic_score_codex":0.00004159326,"about_ca_topic_score_gemma":0.0001882803,"teacher_disagreement_score":0.2353387,"about_ca_system_score_codex":0.000074009586,"about_ca_system_score_gemma":0.000094280935,"threshold_uncertainty_score":0.99998224},"labels":[],"label_agreement":null},{"id":"W2066326028","doi":"10.1016/j.nurt.2007.11.003","title":"The History and Future of Deep Brain Stimulation","year":2008,"lang":"en","type":"review","venue":"Neurotherapeutics","topic":"Neurological disorders and treatments","field":"Medicine","cited_by":142,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Deep brain stimulation; Stimulation; Neuroscience; Neurology; Neurosurgery; Medicine; Psychology; Surgery; Pathology","score_opus":0.0625146234994241,"score_gpt":0.3259086727037641,"score_spread":0.26339404920434,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2066326028","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000017485481,0.99787694,0.000006105155,0.00040309966,0.00026316344,0.00063187804,0.0000035224557,0.000018840576,0.00077897846],"genre_scores_gemma":[0.000013210786,0.9975726,0.000026860407,0.0017608772,0.00011751418,0.000018745934,0.000010531073,0.00003584573,0.00044378746],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99919266,0.0001021192,0.0002540427,0.00018980348,0.00014396053,0.000117425094],"domain_scores_gemma":[0.9992319,0.00028330952,0.00016035214,0.00025701802,0.000022504799,0.000044955705],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000025736055,0.0001972449,0.0005891515,0.000040030773,0.000055641038,0.0000033382078,0.00006241363,0.00016471591,0.000022565366],"category_scores_gemma":[0.000012383499,0.00010590803,0.00018497962,0.00006764667,0.0001273937,0.000010041467,0.000012264608,0.00023658386,0.0000041056514],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000020621392,0.00006999855,0.000029509249,0.00071313116,0.00007922661,0.00002313669,0.000027341359,7.0023084e-8,4.8453825e-7,0.00012447416,0.0005988449,0.9983132],"study_design_scores_gemma":[0.0003576355,0.0003677767,0.00019325544,0.00012011269,0.00033098008,0.00005725354,0.0000019041449,0.000016147926,8.558183e-8,0.00008009178,0.99840856,0.00006621383],"about_ca_topic_score_codex":9.406654e-7,"about_ca_topic_score_gemma":0.0000011357714,"teacher_disagreement_score":0.99824697,"about_ca_system_score_codex":0.00003361153,"about_ca_system_score_gemma":0.00006224884,"threshold_uncertainty_score":0.4318804},"labels":[],"label_agreement":null},{"id":"W2080423736","doi":"10.1016/j.nurt.2007.05.004","title":"Magnetic Resonance Imaging of Myelin","year":2007,"lang":"en","type":"review","venue":"Neurotherapeutics","topic":"Advanced Neuroimaging Techniques and Applications","field":"Medicine","cited_by":324,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; University of British Columbia Hospital","funders":"Multiple Sclerosis Society; Multiple Sclerosis Society of Canada","keywords":"Myelin; Diffusion imaging; Magnetic resonance imaging; Diffusion MRI; Magnetization transfer; Neuroscience; Nuclear magnetic resonance; Neurology; T2 relaxation; In vivo magnetic resonance spectroscopy; Relaxation (psychology); Medicine; Psychology; Physics; Radiology; Central nervous system","score_opus":0.19439852431245547,"score_gpt":0.44790907994188484,"score_spread":0.25351055562942937,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2080423736","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[5.5864984e-7,0.99370444,0.0025007133,0.00009907181,0.000058725313,0.0010208458,0.000030457477,0.000175301,0.0024099003],"genre_scores_gemma":[0.0000038681524,0.9884536,0.009505244,0.0009799469,0.000119540746,0.0000619887,0.0000153919,0.0001359371,0.00072443264],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.998506,0.000035871417,0.00060735067,0.00038188702,0.00021711612,0.00025177829],"domain_scores_gemma":[0.9986582,0.00014746434,0.00024308416,0.0007974692,0.00008030973,0.00007349658],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00009864184,0.00030203845,0.0009830812,0.0002066453,0.000033435146,0.0000073666015,0.0002159792,0.00011358624,0.00003903388],"category_scores_gemma":[0.000020428186,0.00026258003,0.00031972775,0.00045221826,0.00014204485,0.000019184155,0.00003618919,0.0005144925,0.000020783347],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000053330114,0.000061079445,0.000032775242,0.002417972,0.0000043098235,0.00002533057,0.0000047583317,3.1594535e-8,0.00001636425,0.0004498415,0.00016953798,0.99681264],"study_design_scores_gemma":[0.00014671397,0.00008738734,0.00003298902,0.003570285,0.0004021156,0.00026511698,0.0000011014428,0.000022598912,0.000038820133,0.00013711919,0.99512905,0.000166702],"about_ca_topic_score_codex":0.0000015700546,"about_ca_topic_score_gemma":1.433815e-7,"teacher_disagreement_score":0.996646,"about_ca_system_score_codex":0.000035436267,"about_ca_system_score_gemma":0.000119907316,"threshold_uncertainty_score":0.99998266},"labels":[],"label_agreement":null},{"id":"W2082094370","doi":"10.1007/s13311-011-0047-z","title":"Vascular Cognitive Impairment: Disease Mechanisms and Therapeutic Implications","year":2011,"lang":"en","type":"review","venue":"Neurotherapeutics","topic":"Cerebrovascular and Carotid Artery Diseases","field":"Medicine","cited_by":128,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Institute of Neurological Disorders and Stroke; National Institute on Aging; National Institutes of Health; Canadian Stroke Network","keywords":"Medicine; Dementia; Vascular dementia; Intensive care medicine; Cognitive decline; Disease; Memantine; Population; Systematic review; Cochrane Library; Adverse effect; Psychiatry; MEDLINE; Internal medicine; Meta-analysis","score_opus":0.057077001892077914,"score_gpt":0.319842858130274,"score_spread":0.2627658562381961,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2082094370","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000016872349,0.9950177,0.00060392154,0.00004773285,0.00011328259,0.0030319123,0.00021009332,0.00016363386,0.0007948644],"genre_scores_gemma":[0.0003735282,0.99628097,0.00006131456,0.001975653,0.00012694816,0.0005849665,0.0001942352,0.00019776766,0.00020461551],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9979739,0.00021276929,0.00045474627,0.00071471673,0.00024796018,0.00039589676],"domain_scores_gemma":[0.998277,0.00011186773,0.00017440629,0.0007880453,0.000103742,0.0005449125],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00009823251,0.0006163147,0.0012557624,0.00021509692,0.00014804765,0.000055462086,0.00016502147,0.00019946646,0.0002861205],"category_scores_gemma":[0.000015591831,0.0004944763,0.0011176398,0.00025408823,0.00015524258,0.00004192513,0.00005732586,0.00037747258,0.00011209542],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00002415225,0.00046377283,0.0001552174,0.006901999,0.0012880929,0.00001065808,0.0000651869,2.2667212e-8,9.13076e-7,0.0028809467,0.000014802691,0.9881942],"study_design_scores_gemma":[0.0010374924,0.00034474742,0.0035497856,0.0040123304,0.019587575,0.00020033804,0.000028801105,0.000005950334,0.000001339869,0.001040435,0.9696262,0.0005649913],"about_ca_topic_score_codex":0.0000029296646,"about_ca_topic_score_gemma":7.4982955e-7,"teacher_disagreement_score":0.98762923,"about_ca_system_score_codex":0.000046678193,"about_ca_system_score_gemma":0.0003851557,"threshold_uncertainty_score":0.9997507},"labels":[],"label_agreement":null},{"id":"W2083124467","doi":"10.1007/s13311-011-0076-7","title":"Cellular Treatments for Spinal Cord Injury: The Time is Right for Clinical Trials","year":2011,"lang":"en","type":"review","venue":"Neurotherapeutics","topic":"Nerve injury and regeneration","field":"Neuroscience","cited_by":97,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Western Hospital; University Health Network","funders":"","keywords":"Spinal cord injury; Clinical trial; Medicine; Neuroscience; Neurology; Neurosurgery; Physical medicine and rehabilitation; Medical physics; Intensive care medicine; Spinal cord; Psychology; Pathology; Surgery","score_opus":0.590352132972703,"score_gpt":0.5443732218893329,"score_spread":0.045978911083370044,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2083124467","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000029487705,0.97964364,0.0017517023,0.00034185557,0.0038222051,0.012252184,0.0017050189,0.00011293244,0.00034094558],"genre_scores_gemma":[0.000005963319,0.9839127,0.00025394987,0.0033649905,0.0017364873,0.0012656942,0.000050042123,0.00016343304,0.009246717],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9942865,0.0023469597,0.0017590616,0.00093659083,0.00022986371,0.00044105903],"domain_scores_gemma":[0.9947558,0.002946403,0.0012512426,0.0008644582,0.00007244731,0.00010964097],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0019892685,0.00060160185,0.002031122,0.00010161522,0.00044871715,0.00013199073,0.0008220066,0.0005420909,0.00015777948],"category_scores_gemma":[0.0005203268,0.00032843315,0.0020933067,0.00021319174,0.00022984373,0.00007892302,0.000039977906,0.00039305416,0.00021029761],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007271221,0.00023632542,1.4342922e-7,0.0006769765,0.000159505,0.0000023357443,0.00000852328,1.8530523e-8,0.0008864941,0.0018742994,0.0054243985,0.9900039],"study_design_scores_gemma":[0.0006283758,0.0041677975,1.2514039e-7,0.0003654185,0.0026434194,0.000011516544,3.453704e-7,0.000043582262,0.011612063,0.00074892037,0.97944516,0.00033330455],"about_ca_topic_score_codex":7.4908655e-7,"about_ca_topic_score_gemma":2.8368666e-7,"teacher_disagreement_score":0.9896706,"about_ca_system_score_codex":0.000038518883,"about_ca_system_score_gemma":0.0002404733,"threshold_uncertainty_score":0.9999168},"labels":[],"label_agreement":null},{"id":"W2083980936","doi":"10.1016/j.nurt.2007.11.001","title":"Surgical Experimental Neurotherapeutics","year":2008,"lang":"en","type":"article","venue":"Neurotherapeutics","topic":"Neurological disorders and treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Western Hospital","funders":"","keywords":"Neurosurgery; Neurology; Medicine; Psychology; Neuroscience; Surgery","score_opus":0.06899671905621081,"score_gpt":0.3175163913343332,"score_spread":0.24851967227812238,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2083980936","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98029673,0.0009530811,0.0000415999,0.0016389973,0.00020154944,0.0005123918,0.000003613094,0.00023073233,0.016121311],"genre_scores_gemma":[0.9796819,0.00053110824,0.00019534101,0.017583232,0.00011434713,0.00003100379,0.0000057776074,0.000063999396,0.0017932937],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.9986226,0.00006357576,0.00023815746,0.00037790064,0.00033736666,0.00036041427],"domain_scores_gemma":[0.99930435,0.00006169258,0.000045949022,0.00035880154,0.000037708287,0.00019146697],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00002482705,0.00024901767,0.00030585728,0.00006494443,0.00016479615,0.000012527618,0.00010181345,0.000110523346,0.00044950287],"category_scores_gemma":[0.00000549334,0.00019651285,0.00018451585,0.00018784053,0.00020610412,0.000045700835,0.000022395921,0.00025992582,0.00017978756],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008057514,0.02665331,0.6894714,0.00011898712,0.0010661521,0.044509135,0.0019740367,0.00007440127,0.17690505,0.00787161,0.0059908535,0.037307505],"study_design_scores_gemma":[0.029294971,0.015435061,0.16227782,0.000034810873,0.0003684882,0.00923384,0.00010139091,0.0016961187,0.10031761,0.0012435827,0.6786616,0.0013347442],"about_ca_topic_score_codex":0.0000037837733,"about_ca_topic_score_gemma":2.5012503e-7,"teacher_disagreement_score":0.6726707,"about_ca_system_score_codex":0.000021154054,"about_ca_system_score_gemma":0.000045060595,"threshold_uncertainty_score":0.80135614},"labels":[],"label_agreement":null},{"id":"W2093280383","doi":"10.1007/s13311-014-0300-3","title":"Triadopathies: An Emerging Class of Skeletal Muscle Diseases","year":2014,"lang":"en","type":"review","venue":"Neurotherapeutics","topic":"Genetic Neurodegenerative Diseases","field":"Neuroscience","cited_by":80,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"National Institute of Arthritis and Musculoskeletal and Skin Diseases; National Institutes of Health; Muscular Dystrophy Association","keywords":"Skeletal muscle; Triad (sociology); Endoplasmic reticulum; Neuroscience; Medicine; Muscle contraction; Biology; Anatomy; Cell biology; Psychology","score_opus":0.11061780900458754,"score_gpt":0.37426462674984273,"score_spread":0.2636468177452552,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2093280383","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0011306945,0.9948684,0.00020726162,0.000030409776,0.0010367878,0.0014713155,0.0006038603,0.00021325565,0.0004380226],"genre_scores_gemma":[0.002876678,0.99506557,0.00004976851,0.00096765725,0.00040386926,0.00014113812,0.000030037454,0.0002736411,0.00019161428],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99445134,0.002014443,0.0010541271,0.0012277497,0.00070399744,0.0005483426],"domain_scores_gemma":[0.9965543,0.0008730259,0.00080059894,0.0013913554,0.000079895144,0.00030079455],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00013583049,0.00078501995,0.0019242367,0.00033646642,0.00016501633,0.00009421429,0.0011352323,0.00020352878,0.00010858666],"category_scores_gemma":[0.0004948364,0.00068201864,0.000857372,0.00062880793,0.00036583643,0.00012351344,0.000114821094,0.0004418322,0.00007308717],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000008939142,0.00043171083,0.0000038385956,0.0059925416,0.000024727029,0.000023335659,0.00005374499,0.000031453084,0.0030139673,0.0010710382,0.00006120325,0.9892835],"study_design_scores_gemma":[0.00032012459,0.00040438332,0.000015300498,0.00085815106,0.0008013101,0.000015642632,0.000007157403,0.0001972402,0.002371727,0.00010978936,0.9943153,0.00058382243],"about_ca_topic_score_codex":0.0000020230716,"about_ca_topic_score_gemma":0.0000013121597,"teacher_disagreement_score":0.9942542,"about_ca_system_score_codex":0.000032370895,"about_ca_system_score_gemma":0.00032303703,"threshold_uncertainty_score":0.9995631},"labels":[],"label_agreement":null},{"id":"W2108835750","doi":"10.1007/s13311-011-0034-4","title":"Plasticity After Spinal Cord Injury: Relevance to Recovery and Approaches to Facilitate It","year":2011,"lang":"en","type":"review","venue":"Neurotherapeutics","topic":"Nerve injury and regeneration","field":"Neuroscience","cited_by":144,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"National Institutes of Health; National Institute of Neurological Disorders and Stroke; Fondation pour la Recherche Médicale; Kentucky Spinal Cord and Head Injury Research Trust","keywords":"Neuroscience; Neuroplasticity; Spinal cord injury; Plasticity; Developmental plasticity; Psychology; Synaptic plasticity; Medicine; Spinal cord","score_opus":0.4780742803442951,"score_gpt":0.3628026759174693,"score_spread":0.11527160442682582,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2108835750","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0033483338,0.9794628,0.005309918,0.0006618059,0.0024985564,0.0053686635,0.0009945679,0.00026564504,0.0020896965],"genre_scores_gemma":[0.00047925487,0.98882335,0.00076497166,0.0052152853,0.00025975148,0.0004454183,0.000003416195,0.00011329064,0.0038952634],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99719685,0.00041137595,0.00057184626,0.0011079682,0.00025990483,0.0004520337],"domain_scores_gemma":[0.9988077,0.00025199167,0.00017706199,0.00048051018,0.000025408166,0.00025731127],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00014753814,0.00056737533,0.000868754,0.00024304209,0.00014514895,0.0001284313,0.00040519246,0.0002544341,0.000040350944],"category_scores_gemma":[0.0002004526,0.00046709395,0.00019546619,0.0004669143,0.00012159737,0.00014962969,0.00013979881,0.00049611495,0.00037651317],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00092166255,0.00005655014,6.4500693e-7,0.0016062172,0.000012640541,0.000014674499,0.00006599747,0.00000271278,0.0005081158,0.00039058705,0.00027982134,0.99614036],"study_design_scores_gemma":[0.000062592124,0.0028312413,0.000005133193,0.0011689224,0.00012612646,0.00004215339,0.0000018883959,0.000007230934,0.0015256685,0.000100625904,0.9936308,0.00049761956],"about_ca_topic_score_codex":0.0000044555936,"about_ca_topic_score_gemma":0.000012950269,"teacher_disagreement_score":0.9956428,"about_ca_system_score_codex":0.000052551488,"about_ca_system_score_gemma":0.00009448264,"threshold_uncertainty_score":0.9997781},"labels":[],"label_agreement":null},{"id":"W2116581820","doi":"10.1007/s13311-010-0007-z","title":"Neuroimaging in Parkinson's Disease","year":2011,"lang":"en","type":"review","venue":"Neurotherapeutics","topic":"Parkinson's Disease Mechanisms and Treatments","field":"Medicine","cited_by":68,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Vancouver Coastal Health","funders":"Canadian Institutes of Health Research; Fondation pour la Recherche sur Alzheimer; Canada Research Chairs; Michael Smith Health Research BC","keywords":"Neurochemical; Positron emission tomography; Parkinson's disease; Neuroscience; Neuroimaging; Disease; Neurology; Magnetic resonance imaging; Medicine; Dopaminergic; Neurochemistry; Functional imaging; Dopamine; Psychology; Pathology; Radiology","score_opus":0.09976104997814313,"score_gpt":0.34806157233303436,"score_spread":0.24830052235489125,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2116581820","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000041388263,0.99585766,0.00001884692,0.00004229535,0.00035018608,0.0014796716,0.000072858405,0.00012612995,0.0020109653],"genre_scores_gemma":[0.0002442558,0.99713194,0.00016075184,0.001172424,0.00014197233,0.0002441794,0.00007086805,0.00023020834,0.0006034167],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99774563,0.00018411862,0.00051457644,0.0007869032,0.00025929278,0.00050946133],"domain_scores_gemma":[0.9984139,0.0000622793,0.00020665073,0.00082697376,0.000030336214,0.00045981666],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.000081980514,0.00064344803,0.0014736322,0.00043286002,0.00004953752,0.00003488905,0.00022235361,0.00017554966,0.00017985978],"category_scores_gemma":[0.000022583106,0.0005319331,0.00061256276,0.00040471714,0.000054982796,0.000057231286,0.000048955113,0.00055268116,0.0002698084],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000065673164,0.00055994524,0.0009060636,0.005293444,0.00013718344,0.0021732308,0.000020484224,7.638858e-8,3.1846875e-7,0.00019214967,0.000048566708,0.99060285],"study_design_scores_gemma":[0.0007927806,0.000102109865,0.0016127368,0.0043485565,0.0021252339,0.00009163711,0.0000014999205,0.000019887293,6.2794646e-7,0.00011693809,0.9904452,0.00034280727],"about_ca_topic_score_codex":0.000009875235,"about_ca_topic_score_gemma":0.0000022809454,"teacher_disagreement_score":0.9903966,"about_ca_system_score_codex":0.00012270905,"about_ca_system_score_gemma":0.0004767441,"threshold_uncertainty_score":0.99971324},"labels":[],"label_agreement":null},{"id":"W2132190410","doi":"10.1007/s13311-011-0050-4","title":"Blood Biomarkers of Ischemic Stroke","year":2011,"lang":"sl","type":"review","venue":"Neurotherapeutics","topic":"Acute Ischemic Stroke Management","field":"Medicine","cited_by":221,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Canadian Institutes of Health Research; University of California, Davis; National Institutes of Health; National Center for Research Resources; National Institute of Neurological Disorders and Stroke; American Heart Association","keywords":"Medicine; Ischemic stroke; Stroke (engine); Neurology; Etiology; Biomarker; Internal medicine; Ischemia; Brain ischemia; Bioinformatics; Thrombosis; Intensive care medicine","score_opus":0.05772344354556225,"score_gpt":0.306877384021052,"score_spread":0.24915394047548978,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2132190410","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00065115193,0.82415015,0.00013703569,0.00008712139,0.0012273529,0.0027145345,0.00032233517,0.000111742665,0.17059861],"genre_scores_gemma":[0.000547717,0.97903657,0.0013211278,0.0011276102,0.00057748967,0.000108825065,0.00009545211,0.0004197623,0.016765468],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9946129,0.00027610848,0.00206534,0.0011873362,0.00084349216,0.0010148406],"domain_scores_gemma":[0.99511576,0.00032976083,0.0016345159,0.0023462195,0.00023400196,0.0003397258],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.00044879282,0.0013374856,0.0032213002,0.00062320504,0.00007006488,0.00002650108,0.0012015859,0.0008935405,0.0018339902],"category_scores_gemma":[0.000101765516,0.0012107522,0.0014261456,0.00071457203,0.0005473847,0.000070226466,0.00030488375,0.0012745808,0.00040621578],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022986514,0.001399048,0.0008470095,0.03926217,0.016053429,0.00021717878,0.00034083627,1.5073671e-7,0.008433566,0.0001366351,0.039297033,0.8937831],"study_design_scores_gemma":[0.002131641,0.00084404164,0.000049049966,0.006862175,0.02270116,0.00018378475,0.00013208689,0.00001201402,0.005296659,0.0000012345392,0.9610692,0.0007169],"about_ca_topic_score_codex":0.000034243643,"about_ca_topic_score_gemma":0.000001257341,"teacher_disagreement_score":0.92177224,"about_ca_system_score_codex":0.000118710595,"about_ca_system_score_gemma":0.0005112536,"threshold_uncertainty_score":0.99993765},"labels":[],"label_agreement":null},{"id":"W2136610170","doi":"10.1007/s13311-014-0281-2","title":"Intracranial Applications of Magnetic Resonance-guided Focused Ultrasound","year":2014,"lang":"en","type":"review","venue":"Neurotherapeutics","topic":"Ultrasound and Hyperthermia Applications","field":"Engineering","cited_by":72,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre; University of Toronto; University Health Network","funders":"","keywords":"Medicine; Focused ultrasound; Essential tremor; Radiology; Magnetic resonance imaging; Neurosurgery; Neurology; Medical physics; Ultrasound; Physical medicine and rehabilitation","score_opus":0.03200873387970173,"score_gpt":0.28480985770802136,"score_spread":0.25280112382831965,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2136610170","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000004414086,0.9879793,0.0061054737,0.0000061847504,0.00014092606,0.0013013884,0.00016194179,0.0003049909,0.0039953687],"genre_scores_gemma":[0.000048209582,0.99689955,0.001346867,0.00005753283,0.00036384966,0.0007874854,0.00005358839,0.0002178124,0.0002251104],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9983531,0.00006734119,0.00076256937,0.00031733574,0.00020275939,0.00029686667],"domain_scores_gemma":[0.9983901,0.0004978679,0.00013918773,0.00083330186,0.000056551784,0.00008299794],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00008654467,0.0004336593,0.0010973623,0.00016113184,0.0000669205,0.000038339676,0.0005448606,0.00033599808,0.00013852172],"category_scores_gemma":[0.000011390325,0.00040974014,0.0003324164,0.0005196894,0.00011235023,0.000029514948,0.000011453459,0.0004231525,0.00015635318],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[5.885246e-7,0.000037893285,0.00000259751,0.0032638276,0.00003906881,3.367852e-7,0.000027619551,0.000012414802,0.00008129764,0.00080216205,0.00019920878,0.995533],"study_design_scores_gemma":[0.00015375242,0.000035821973,0.0000072077373,0.00043165262,0.00044053388,0.000052514897,0.0000015339328,0.00010020117,0.000011673764,0.00019997705,0.9982282,0.00033695347],"about_ca_topic_score_codex":0.0000030314595,"about_ca_topic_score_gemma":0.000006627445,"teacher_disagreement_score":0.998029,"about_ca_system_score_codex":0.000042544834,"about_ca_system_score_gemma":0.00006923372,"threshold_uncertainty_score":0.99983543},"labels":[],"label_agreement":null},{"id":"W2142923836","doi":"10.1007/s13311-012-0115-z","title":"Nonhuman Primate Models of Stroke for Translational Neuroprotection Research","year":2012,"lang":"en","type":"review","venue":"Neurotherapeutics","topic":"Neuroinflammation and Neurodegeneration Mechanisms","field":"Neuroscience","cited_by":130,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Toronto Western Hospital; University Health Network","funders":"","keywords":"Neuroprotection; Stroke (engine); Clinical trial; Medicine; Neurology; Translational research; Preclinical research; Neuroscience; Nonhuman primate; Physical medicine and rehabilitation; Pharmacology; Psychology; Medical physics; Internal medicine; Pathology; Biology; Psychiatry","score_opus":0.5398518973403037,"score_gpt":0.46508112543490193,"score_spread":0.07477077190540177,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2142923836","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00010997992,0.92783356,0.049589135,0.0002679003,0.0029134932,0.0139262555,0.0012919452,0.0005544854,0.0035132596],"genre_scores_gemma":[0.00038517412,0.996074,0.00064126303,0.00028998882,0.00043787324,0.0006135421,0.000029877767,0.00026024607,0.0012680256],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99530816,0.0012768457,0.0010344815,0.0007888264,0.0009974466,0.00059425813],"domain_scores_gemma":[0.99734604,0.0011125883,0.00053008297,0.00065421563,0.00022114231,0.00013591492],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00071830663,0.000460077,0.00090375595,0.0006965689,0.0003814263,0.00009839327,0.00058570056,0.00029866188,0.00007347112],"category_scores_gemma":[0.000106644664,0.00042883656,0.0005177315,0.0006177304,0.00016000077,0.00030619686,0.00004468811,0.0008217255,0.000052638607],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006209001,0.00025996103,8.859221e-8,0.007402547,0.000021653572,0.000003730341,0.00014434414,0.00020844946,0.09186451,0.08222662,0.000047819056,0.8177582],"study_design_scores_gemma":[0.00035335438,0.00026245115,1.2797821e-7,0.0002803626,0.00017997684,0.000049634746,0.0000016261562,0.0027516468,0.07027657,0.0016480263,0.9238796,0.00031661364],"about_ca_topic_score_codex":7.680501e-7,"about_ca_topic_score_gemma":0.0000012190378,"teacher_disagreement_score":0.92383176,"about_ca_system_score_codex":0.00003614358,"about_ca_system_score_gemma":0.00023919663,"threshold_uncertainty_score":0.99981636},"labels":[],"label_agreement":null},{"id":"W2157842784","doi":"10.1016/j.nurt.2009.07.008","title":"Targeting the NMDA Receptor Subunit NR2B for the Treatment of Neuropathic Pain","year":2009,"lang":"en","type":"review","venue":"Neurotherapeutics","topic":"Pain Mechanisms and Treatments","field":"Medicine","cited_by":196,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canada Research Chairs; University of Toronto","funders":"Canadian Institutes of Health Research","keywords":"Neuropathic pain; NMDA receptor; Neuroscience; Medicine; Synaptic plasticity; Ionotropic effect; Chronic pain; Glutamate receptor; Receptor; Psychology; Internal medicine","score_opus":0.10393121207818849,"score_gpt":0.3583018756631737,"score_spread":0.25437066358498517,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2157842784","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000056574077,0.9918911,0.0023181678,0.0004900753,0.0003482079,0.004753367,0.00007653263,0.00005170721,0.00006520006],"genre_scores_gemma":[0.00002421414,0.99585414,0.0004772509,0.0015071543,0.00043338802,0.00048988627,0.000075296855,0.00013680967,0.0010018799],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99705917,0.0012921585,0.0006139889,0.00037799362,0.0002889299,0.00036774128],"domain_scores_gemma":[0.9950185,0.0035650749,0.00044036604,0.0008084392,0.000095292984,0.00007235729],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013081222,0.00053249666,0.0012742501,0.000077247714,0.00023197345,0.000028521774,0.0002818864,0.00020926616,0.00004070179],"category_scores_gemma":[0.00018709646,0.00023582779,0.0008458235,0.0002583072,0.000080023514,0.000014498526,0.000010067892,0.00027427857,0.000018185612],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000036707588,0.00043598042,0.0000048863917,0.0013363659,0.0004484974,0.000006277419,0.0001225918,0.0000013811422,0.000028446773,0.000117214666,0.00017723053,0.9972844],"study_design_scores_gemma":[0.0006699686,0.002570637,0.0000023858315,0.0011429212,0.0025378333,0.00001377601,0.000024755243,0.00030070348,0.00004796778,0.000045065273,0.9924856,0.00015840602],"about_ca_topic_score_codex":0.000008660281,"about_ca_topic_score_gemma":0.0000014782471,"teacher_disagreement_score":0.99712604,"about_ca_system_score_codex":0.000098909564,"about_ca_system_score_gemma":0.00020681521,"threshold_uncertainty_score":0.9616778},"labels":[],"label_agreement":null},{"id":"W2171533346","doi":"10.1007/s13311-011-0062-0","title":"Immune Mechanisms Underlying the Beneficial Effects of Autologous Hematopoietic Stem Cell Transplantation in Multiple Sclerosis","year":2011,"lang":"en","type":"review","venue":"Neurotherapeutics","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"Canadian Institutes of Health Research; Multiple Sclerosis Society; Multiple Sclerosis Society of Canada","keywords":"Multiple sclerosis; Hematopoietic stem cell transplantation; Immune system; Transplantation; Medicine; Stem cell; Immunology; Immunosuppression; Haematopoiesis; Conditioning regimen; Clinical trial; Biology; Internal medicine","score_opus":0.19612253835282925,"score_gpt":0.3418853617533089,"score_spread":0.14576282340047966,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2171533346","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.001185795,0.9932805,0.0007931377,0.00003306073,0.0003150287,0.004131451,0.000033568325,0.00006848035,0.00015898916],"genre_scores_gemma":[0.04619116,0.9529017,0.00023048968,0.0000735163,0.000022933109,0.0003830028,0.000017140157,0.00013297464,0.000047069756],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.9969337,0.0005680124,0.0009943219,0.00048390264,0.0005006048,0.00051945617],"domain_scores_gemma":[0.99705124,0.0016747068,0.00044312867,0.00066714466,0.000085599815,0.00007818976],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00036329235,0.0005340292,0.0019796495,0.0003405955,0.00013902801,0.000021552965,0.00041240142,0.00036734104,0.00001579268],"category_scores_gemma":[0.000039419232,0.00035864068,0.00055270415,0.00052933383,0.00017953006,0.000039942126,0.00006060139,0.000854781,0.000020180263],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010039484,0.00039137757,0.000022466342,0.07325999,0.0002491752,0.000039265014,0.0019798186,0.0000040116383,0.0044437763,0.00017870446,0.0000029728947,0.91932803],"study_design_scores_gemma":[0.044752385,0.0144237345,0.066426255,0.40938336,0.03753859,0.0011110125,0.0028316542,0.0025283978,0.07298858,0.0010985776,0.3387624,0.008155039],"about_ca_topic_score_codex":0.000083882456,"about_ca_topic_score_gemma":0.00004326798,"teacher_disagreement_score":0.911173,"about_ca_system_score_codex":0.00011039394,"about_ca_system_score_gemma":0.000201487,"threshold_uncertainty_score":0.9998866},"labels":[],"label_agreement":null},{"id":"W2232090021","doi":"10.1007/s13311-015-0409-z","title":"Therapeutic Advances and Future Prospects in Progressive Forms of Multiple Sclerosis","year":2016,"lang":"en","type":"review","venue":"Neurotherapeutics","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":84,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Canadian Institutes of Health Research","keywords":"Natalizumab; Medicine; Fingolimod; Pharmacology; Oxcarbazepine; Clinical trial; Multiple sclerosis; Oncology; Internal medicine; Immunology; Carbamazepine","score_opus":0.10947534610332328,"score_gpt":0.37585917805834707,"score_spread":0.2663838319550238,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2232090021","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00013668205,0.9949696,0.0000056291733,0.00026992286,0.00014614173,0.0039638304,0.000085515,0.000052775995,0.00036989967],"genre_scores_gemma":[0.0007200241,0.9977531,0.00020552562,0.00014153431,0.00035440287,0.00059760606,0.000010680214,0.0001367555,0.000080378704],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9971796,0.00017990477,0.00080339995,0.0006586429,0.0005896281,0.00058881077],"domain_scores_gemma":[0.9980946,0.0005321595,0.00046564598,0.0005979201,0.00016233184,0.00014730396],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00021945339,0.0006006519,0.0022624803,0.0004143733,0.00007148539,0.000026606482,0.00024947975,0.00033875796,0.000042123742],"category_scores_gemma":[0.00009961969,0.00034571506,0.00033285515,0.00053113716,0.0004378679,0.0001295698,0.000109080815,0.0006136413,0.000010022085],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009375479,0.00019392816,0.0012385965,0.02130164,0.00023753862,0.000015445543,0.00013864644,2.2158057e-8,0.00006636824,0.00007766135,0.000008017873,0.97662836],"study_design_scores_gemma":[0.0019145551,0.0005391784,0.0023763299,0.020666357,0.0002763879,0.000032862015,0.000047873786,0.0000067458395,0.00008084537,0.000054054137,0.9736844,0.00032043832],"about_ca_topic_score_codex":0.0000020077568,"about_ca_topic_score_gemma":0.0000125795605,"teacher_disagreement_score":0.9763079,"about_ca_system_score_codex":0.0001147292,"about_ca_system_score_gemma":0.00023017783,"threshold_uncertainty_score":0.9998995},"labels":[],"label_agreement":null},{"id":"W2240098740","doi":"10.1007/s13311-015-0415-1","title":"Electrical Stimulation to Enhance Axon Regeneration After Peripheral Nerve Injuries in Animal Models and Humans","year":2016,"lang":"en","type":"review","venue":"Neurotherapeutics","topic":"Nerve injury and regeneration","field":"Neuroscience","cited_by":323,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"Canadian Institutes of Health Research","keywords":"Reinnervation; Regeneration (biology); Axon; Medicine; Peripheral nerve injury; Nerve injury; Stimulation; Epineurial repair; Neuroscience; Denervation; Neurotrophic factors; Neurotrophin; Biology; Anatomy; Sciatic nerve; Anesthesia; Internal medicine; Cell biology","score_opus":0.06916172160027054,"score_gpt":0.3676436610399179,"score_spread":0.2984819394396474,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2240098740","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.026585335,0.9640968,0.005585683,0.00031826348,0.0005017889,0.0024869617,0.00008079518,0.00013749521,0.00020687695],"genre_scores_gemma":[0.047677223,0.9494937,0.00023762515,0.0008625731,0.00050300447,0.0004089779,0.0000113957,0.000116231204,0.00068926613],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9970161,0.0006398442,0.00068294106,0.0009194578,0.00033675178,0.00040491796],"domain_scores_gemma":[0.99910206,0.00018429228,0.00019989548,0.0003691586,0.000040678984,0.00010394037],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00016607132,0.00047631757,0.00072042947,0.00032472468,0.00014671676,0.00018219651,0.0002176209,0.00034336364,0.0000298635],"category_scores_gemma":[0.000048977967,0.00036608684,0.00014444704,0.00044580494,0.00008881199,0.00040775898,0.000052239517,0.00038939985,0.000025214364],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019553343,0.000108596185,0.000014357574,0.00064564124,0.000009432051,0.000026833131,0.00023090505,0.00021659183,0.04107331,0.0037832789,0.000039432554,0.9536561],"study_design_scores_gemma":[0.000684418,0.0018876784,0.00008613163,0.0041627726,0.00025783223,0.000075992284,0.0000031532202,0.010255425,0.07439368,0.0021848674,0.90379864,0.0022094005],"about_ca_topic_score_codex":0.0000033422018,"about_ca_topic_score_gemma":0.000024535006,"teacher_disagreement_score":0.9514467,"about_ca_system_score_codex":0.00014160476,"about_ca_system_score_gemma":0.0001124169,"threshold_uncertainty_score":0.9998791},"labels":[],"label_agreement":null},{"id":"W2259666796","doi":"10.1007/s13311-016-0423-9","title":"Exercise and Environmental Enrichment as Enablers of Task-Specific Neuroplasticity and Stroke Recovery","year":2016,"lang":"en","type":"review","venue":"Neurotherapeutics","topic":"Stroke Rehabilitation and Recovery","field":"Medicine","cited_by":119,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; University of Toronto; Heart and Stroke Foundation; Toronto Rehabilitation Institute; Memorial University of Newfoundland; University of Ottawa","funders":"Canadian Institutes of Health Research; Canada Excellence Research Chairs, Government of Canada; Heart and Stroke Foundation of Canada","keywords":"Stroke (engine); Neuroplasticity; Environmental enrichment; Aerobic exercise; Rehabilitation; Spontaneous recovery; Medicine; Neurology; Physical medicine and rehabilitation; Stroke recovery; Neurochemistry; Cognition; Neuroscience; Physical therapy; Psychology; Internal medicine; Psychiatry; Anesthesia","score_opus":0.02758625102349241,"score_gpt":0.2842626955110607,"score_spread":0.2566764444875683,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2259666796","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0026012755,0.9948047,0.00003724422,0.000033400647,0.0004345042,0.0012147694,0.00023611574,0.000026488884,0.00061152165],"genre_scores_gemma":[0.00039970956,0.9972688,0.00014190354,0.00017911247,0.000104857,0.000037346454,0.000018235041,0.00008162809,0.0017684395],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99822736,0.00013072733,0.000571224,0.0005092638,0.0003156736,0.00024576718],"domain_scores_gemma":[0.9986109,0.0005545949,0.0002709326,0.0003635557,0.000016986998,0.00018302354],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00010113782,0.00040411289,0.0012948946,0.00026000213,0.00004843371,0.000020647722,0.00007781464,0.00024314524,0.00015369525],"category_scores_gemma":[0.000028058033,0.00028271182,0.00029797605,0.0000824976,0.00029020992,0.000052062296,0.000052595413,0.00030045095,0.000030594332],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000107529406,0.00013773053,0.00018352614,0.004674722,0.00013760984,0.00001909588,0.00004843108,1.3489543e-7,0.0004911548,0.00003605332,0.00010819075,0.9940558],"study_design_scores_gemma":[0.0007642498,0.00079313875,0.00033539493,0.0054826722,0.0006236956,0.00016445701,0.000034374705,0.0000025539086,0.00004729467,0.000010406194,0.99151784,0.00022392905],"about_ca_topic_score_codex":0.0000015992297,"about_ca_topic_score_gemma":1.3993508e-7,"teacher_disagreement_score":0.9938319,"about_ca_system_score_codex":0.00007417444,"about_ca_system_score_gemma":0.00009643454,"threshold_uncertainty_score":0.9999625},"labels":[],"label_agreement":null},{"id":"W2296117242","doi":"10.1007/s13311-016-0424-8","title":"A Site-Specific, Sustained-Release Drug Delivery System for Aneurysmal Subarachnoid Hemorrhage","year":2016,"lang":"en","type":"article","venue":"Neurotherapeutics","topic":"Intracranial Aneurysms: Treatment and Complications","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital","funders":"Canadian Institutes of Health Research; Heart and Stroke Foundation of Canada","keywords":"Nimodipine; Medicine; Subarachnoid hemorrhage; Cerebrospinal fluid; Anesthesia; Vasospasm; PLGA; Drug delivery; Subarachnoid space; Cerebral vasospasm; Neurology; Pharmacology; Internal medicine; Calcium; In vitro; Chemistry","score_opus":0.01963740421164223,"score_gpt":0.24385005611211188,"score_spread":0.22421265190046966,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2296117242","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98503894,0.00038531283,0.0038376732,0.006274291,0.00029571127,0.0016715601,0.00014914203,0.0004697562,0.0018776385],"genre_scores_gemma":[0.991564,0.000022513079,0.00096354046,0.001268207,0.00044015885,0.00020257656,0.000029192752,0.00008477405,0.0054250886],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9984857,0.000046000085,0.00031961096,0.00043868553,0.00022940358,0.00048061606],"domain_scores_gemma":[0.99871093,0.00018909294,0.00009633036,0.000563861,0.0002533712,0.00018643639],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000081029495,0.00027246325,0.0002915632,0.00011128227,0.00020442384,0.000035562884,0.00015184686,0.000089191104,0.00008554698],"category_scores_gemma":[0.000012523123,0.00018946256,0.00019941434,0.00015919324,0.00008463756,0.00006967089,0.000019398287,0.000115693954,0.0002294498],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004313304,0.0015901502,0.010140275,0.0014047283,0.00008253188,0.0013661854,0.0004903091,0.000004426884,0.80707425,0.019383805,0.0017999602,0.15235008],"study_design_scores_gemma":[0.05822623,0.008671763,0.027987849,0.00032093344,0.0042953365,0.009148102,0.00227487,0.011858439,0.52218324,0.0019003573,0.34906903,0.0040638484],"about_ca_topic_score_codex":0.000009146812,"about_ca_topic_score_gemma":0.0000068279787,"teacher_disagreement_score":0.34726906,"about_ca_system_score_codex":0.00014207412,"about_ca_system_score_gemma":0.000079828285,"threshold_uncertainty_score":0.7726059},"labels":[],"label_agreement":null},{"id":"W2560539130","doi":"10.1007/s13311-016-0499-2","title":"Withania somnifera Reverses Transactive Response DNA Binding Protein 43 Proteinopathy in a Mouse Model of Amyotrophic Lateral Sclerosis/Frontotemporal Lobar Degeneration","year":2016,"lang":"en","type":"article","venue":"Neurotherapeutics","topic":"Amyotrophic Lateral Sclerosis Research","field":"Medicine","cited_by":54,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval; Institut Universitaire en Santé Mentale de Québec","funders":"Canadian Institutes of Health Research; Valeant Pharmaceuticals International; Fondation Brain Canada","keywords":"Amyotrophic lateral sclerosis; Withania somnifera; Frontotemporal lobar degeneration; Rotarod performance test; Neuroinflammation; Ubiquitin; Neuroscience; Biology; Frontotemporal dementia; Medicine; Pathology; Internal medicine; Biochemistry; Disease; Dementia; Gene","score_opus":0.06901847468915077,"score_gpt":0.280850521161037,"score_spread":0.2118320464718862,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2560539130","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99272776,0.000033602966,0.0020622401,0.0022182332,0.000039635313,0.0027047934,0.00009403113,0.00008864124,0.000031065032],"genre_scores_gemma":[0.9940039,0.00009538413,0.002574225,0.00026512356,0.00006363443,0.00026918043,0.000004813311,0.000116882715,0.002606869],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9966241,0.00059060386,0.0007033955,0.00061824097,0.00081777654,0.0006458952],"domain_scores_gemma":[0.9987102,0.00007193621,0.00020854743,0.0005725418,0.00022448882,0.00021229892],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0005862857,0.0003792825,0.00057485077,0.0003911485,0.0000901776,0.000037516056,0.00024086585,0.0002646752,0.00007768225],"category_scores_gemma":[0.000095468684,0.00027292545,0.00015560139,0.00037128179,0.00024329845,0.00038846137,0.00003495554,0.00040145862,0.000025424502],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009982951,0.00037064237,0.0035211393,0.00009056056,0.000045736262,0.000027327482,0.0006075564,0.00016261762,0.982852,0.0000618084,0.000004973235,0.0022726797],"study_design_scores_gemma":[0.0062535293,0.0020509844,0.01614183,0.0007161065,0.000039780833,0.0000127569365,0.00002700118,0.0053306813,0.9689049,0.00013538249,0.00003358155,0.00035344274],"about_ca_topic_score_codex":0.00006954604,"about_ca_topic_score_gemma":0.000044573146,"teacher_disagreement_score":0.013947085,"about_ca_system_score_codex":0.00040673153,"about_ca_system_score_gemma":0.0004346345,"threshold_uncertainty_score":0.9999723},"labels":[],"label_agreement":null},{"id":"W2590949011","doi":"10.1007/s13311-017-0514-2","title":"Targeting Epigenetic Pathways in the Treatment of Pediatric Diffuse (High Grade) Gliomas","year":2017,"lang":"en","type":"review","venue":"Neurotherapeutics","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":27,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Stollery Children's Hospital; University of Alberta; Research Institute in Oncology and Hematology; University of Manitoba; CancerCare Manitoba","funders":"Kids With Cancer Society; University of Alberta; Alberta Cancer Foundation; St. Baldrick's Foundation; Melanoma Research Alliance","keywords":"Epigenetics; Medicine; Temozolomide; Histone H3; Histone; Cancer research; Receptor tyrosine kinase; Oncology; Bioinformatics; Biology; Internal medicine; Glioma; Gene; Receptor; Genetics","score_opus":0.16759691743011226,"score_gpt":0.3712586353660016,"score_spread":0.20366171793588936,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2590949011","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0055791023,0.99121255,0.0000017027338,0.00009944085,0.00028147342,0.0026219925,0.00006985442,0.000024725297,0.00010914619],"genre_scores_gemma":[0.006022773,0.9925971,0.000078301346,0.00008632418,0.0005064853,0.00049270387,0.000075231015,0.00010920638,0.000031890184],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9976157,0.00029328206,0.0008069342,0.00047960287,0.00040537427,0.00039909227],"domain_scores_gemma":[0.9975476,0.0004787965,0.00063058076,0.0012103986,0.0000441061,0.00008846766],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0001425312,0.00059482415,0.0019091836,0.0003717214,0.00011355266,0.000047998616,0.00035892584,0.00026631556,0.000021153228],"category_scores_gemma":[0.000030580995,0.00032821123,0.0006951316,0.00034464398,0.0000761175,0.000021202723,0.000018386429,0.0002318377,0.000031096206],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000144421465,0.006092855,0.0020843167,0.0035708733,0.0003291729,0.0009353468,0.00048665854,0.0000013249379,0.000006862383,0.000102030455,0.000038571183,0.98633754],"study_design_scores_gemma":[0.0026341386,0.0018332034,0.001282984,0.0009407328,0.0048453254,0.00009163106,0.000017133425,0.000007977327,0.00002733078,0.00004257777,0.98800814,0.0002688472],"about_ca_topic_score_codex":0.00006234225,"about_ca_topic_score_gemma":0.000010614369,"teacher_disagreement_score":0.9879695,"about_ca_system_score_codex":0.00012997103,"about_ca_system_score_gemma":0.00020432004,"threshold_uncertainty_score":0.999917},"labels":[],"label_agreement":null},{"id":"W2725319424","doi":"10.1007/s13311-017-0556-5","title":"Role of DISC1 in Neuronal Trafficking and its Implication in Neuropsychiatric Manifestation and Neurotherapeutics","year":2017,"lang":"en","type":"review","venue":"Neurotherapeutics","topic":"Phosphodiesterase function and regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":27,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Centre for Addiction and Mental Health","funders":"National Center for Research Resources; Institute for Protein Research, Osaka University; Japan Society for the Promotion of Science; Congressionally Directed Medical Research Programs; Johns Hopkins University; Takeda Science Foundation; Naito Foundation; U.S. Department of Defense","keywords":"DISC1; Schizophrenia (object-oriented programming); Neuroscience; DECIPHER; Major depressive disorder; Psychology; Psychiatry; Neurology; Mood disorders; Cognition; Medicine; Biology; Bioinformatics; Genetics; Gene","score_opus":0.048908982774833375,"score_gpt":0.34302040843106907,"score_spread":0.2941114256562357,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2725319424","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.076684505,0.922141,0.000015896861,0.000049500737,0.00016182568,0.000816447,0.000024691519,0.0000095730065,0.000096543816],"genre_scores_gemma":[0.0643448,0.935238,0.000023120221,0.00010179999,0.00007731356,0.000039178485,0.000058956863,0.00006406007,0.00005279335],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99848586,0.0002004649,0.00051764055,0.00048856775,0.000117644486,0.00018983822],"domain_scores_gemma":[0.9991573,0.00004001184,0.00040475788,0.0003213046,0.00003029593,0.000046349905],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00013061623,0.00029779857,0.0004954901,0.00023559663,0.00005686031,0.000042981188,0.00015668423,0.00025583684,0.0000014950509],"category_scores_gemma":[0.000022560587,0.00028447906,0.00008356641,0.00013843364,0.00006421994,0.000012507896,0.000049466526,0.00023708059,7.2163584e-7],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000052562482,0.000106973224,0.0010977563,0.0014989713,0.000026010588,0.0000024852877,0.000093588314,0.000023283264,0.005822902,0.00018041844,0.0000021312692,0.9910929],"study_design_scores_gemma":[0.0012671237,0.00055255706,0.053322405,0.0009337369,0.00022965104,0.00016042747,0.000025561509,0.001074952,0.00044741062,0.00010912924,0.9412332,0.0006438342],"about_ca_topic_score_codex":0.000005600266,"about_ca_topic_score_gemma":0.000047942332,"teacher_disagreement_score":0.9904491,"about_ca_system_score_codex":0.000011783925,"about_ca_system_score_gemma":0.00007558586,"threshold_uncertainty_score":0.9999607},"labels":[],"label_agreement":null},{"id":"W2750301819","doi":"10.1007/s13311-017-0564-5","title":"Five Questions Answered: A Review of Autologous Hematopoietic Stem Cell Transplantation for the Treatment of Multiple Sclerosis","year":2017,"lang":"en","type":"review","venue":"Neurotherapeutics","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital","funders":"","keywords":"Medicine; Multiple sclerosis; Hematopoietic stem cell transplantation; Stem cell; Clinical trial; Quality of life (healthcare); Natural history; Transplantation; Neurology; Oncology; Disease; Randomized controlled trial; Internal medicine; Immunology; Biology","score_opus":0.2703824145849819,"score_gpt":0.41590892641615496,"score_spread":0.14552651183117304,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2750301819","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000014946376,0.9906139,0.00024220788,0.00024778603,0.00014296349,0.0076830722,0.0009313585,0.0000286091,0.000095172174],"genre_scores_gemma":[0.00015886402,0.99722576,0.000331487,0.00008516168,0.00007003244,0.0015491929,0.000073460586,0.00007977768,0.0004262783],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9977384,0.00024595758,0.0009497284,0.00037403812,0.0003967813,0.00029505568],"domain_scores_gemma":[0.9955148,0.0021450215,0.00086862885,0.0010715039,0.00032319064,0.00007686023],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00024813652,0.00042771478,0.002443963,0.0001279641,0.00019294846,0.000013692832,0.00032680194,0.00018144687,0.0000156837],"category_scores_gemma":[0.000080173246,0.00024965114,0.001088875,0.00015619463,0.00030276025,0.000027339584,0.000014688895,0.00018677152,0.0000050720064],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00004773185,0.00040778503,0.00001150926,0.21527691,0.0004856386,0.0000027059034,0.0004054116,7.4562655e-7,0.000033743076,0.000007734393,0.00009497,0.7832251],"study_design_scores_gemma":[0.0014008683,0.0015234018,0.00023754146,0.10567015,0.0070442823,0.000027233304,0.00003382031,0.000071530354,0.00024504322,0.000001787076,0.8835601,0.00018420661],"about_ca_topic_score_codex":0.000045355464,"about_ca_topic_score_gemma":0.000019846497,"teacher_disagreement_score":0.8834652,"about_ca_system_score_codex":0.00010090147,"about_ca_system_score_gemma":0.0003371966,"threshold_uncertainty_score":0.9999956},"labels":[],"label_agreement":null},{"id":"W2758569115","doi":"10.1007/s13311-017-0574-3","title":"The Gut Microbiota and Pediatric Multiple Sclerosis: Recent Findings","year":2017,"lang":"en","type":"review","venue":"Neurotherapeutics","topic":"Gut microbiota and health","field":"Biochemistry, Genetics and Molecular Biology","cited_by":18,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"Canadian Institutes of Health Research; University of California, San Francisco; European Committee for Treatment and Research in Multiple Sclerosis; Multiple Sclerosis Trust; Multiple Sclerosis Society; Multiple Sclerosis Society of Canada; Race to Erase MS; National Institutes of Health; National Multiple Sclerosis Society; U.S. Department of Veterans Affairs; Multiple Sclerosis Scientific Research Foundation; Michael Smith Health Research BC; Biogen","keywords":"Multiple sclerosis; Gut flora; Disease; Neurology; Clinically isolated syndrome; Medicine; Neurochemistry; Immune system; Immunology; Pediatrics; Internal medicine; Psychiatry","score_opus":0.17681994242431948,"score_gpt":0.3603906464749623,"score_spread":0.1835707040506428,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2758569115","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00032480276,0.9979521,0.0000048050797,0.00016885127,0.00054627913,0.00077194086,0.00009287278,0.000014110021,0.00012426221],"genre_scores_gemma":[0.000054094773,0.9976011,0.00006178799,0.00049451616,0.0005386331,0.00004311196,0.000078866164,0.00010097862,0.0010269214],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99833274,0.00015591104,0.00041367486,0.00056176394,0.00008859688,0.0004473254],"domain_scores_gemma":[0.9985162,0.00006781919,0.00031600762,0.00093348755,0.000061357874,0.000105119434],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00023311289,0.000413485,0.00057267305,0.00005409377,0.0006801838,0.0002123497,0.0006108366,0.00047583066,0.000005081778],"category_scores_gemma":[0.000066843844,0.00028961955,0.00022327111,0.00007231201,0.00015125924,0.0000023322032,0.00017962404,0.00038771052,0.000029495379],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000015574677,0.00003970428,0.00009293701,0.0019912622,0.00009623146,0.0000019079712,0.000016874437,4.003951e-8,0.00563927,0.000010654882,0.0048939916,0.9872016],"study_design_scores_gemma":[0.00024951165,0.00011054247,0.00026146337,0.0003144928,0.0002623728,0.000047027053,0.0000026263851,4.1169514e-7,0.000043888816,0.0000022114607,0.9984175,0.0002879492],"about_ca_topic_score_codex":0.000004860878,"about_ca_topic_score_gemma":0.000028576496,"teacher_disagreement_score":0.99352354,"about_ca_system_score_codex":0.000021772641,"about_ca_system_score_gemma":0.00030895302,"threshold_uncertainty_score":0.9999556},"labels":[],"label_agreement":null},{"id":"W2771314136","doi":"10.1007/s13311-017-0590-3","title":"Chronic Fluoxetine Induces Activity Changes in Recovery From Poststroke Anxiety, Depression, and Cognitive Impairment","year":2017,"lang":"en","type":"article","venue":"Neurotherapeutics","topic":"Neuroinflammation and Neurodegeneration Mechanisms","field":"Neuroscience","cited_by":30,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital","funders":"Canadian Institutes of Health Research; University of Ottawa","keywords":"Nucleus accumbens; FOSB; Neuroscience; Prefrontal cortex; Psychology; Hippocampus; Antidepressant; Stroke (engine); Glutamate receptor; Amygdala; Fluoxetine; Basolateral amygdala; Medicine; Internal medicine; Serotonin; Cognition; Central nervous system; Chemistry; Receptor","score_opus":0.042084375332975106,"score_gpt":0.29598823888905473,"score_spread":0.25390386355607963,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2771314136","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9955027,0.00006423336,0.00012345922,0.0027618485,0.0004705862,0.00054511783,0.00007531256,0.0000816155,0.00037511127],"genre_scores_gemma":[0.99575686,0.0010646946,0.0000386432,0.0026031,0.00021589446,0.000047991412,0.0000027409278,0.000040127507,0.0002299653],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99833727,0.00025724285,0.00016812421,0.0006591867,0.00028691857,0.00029127538],"domain_scores_gemma":[0.9989215,0.0002452618,0.00024998895,0.0004488499,0.000030534302,0.000103871396],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011365699,0.00025051285,0.00021590579,0.000114365364,0.00043389518,0.0002943492,0.00028916844,0.00009614994,0.0000992648],"category_scores_gemma":[0.0002168235,0.000226394,0.00004053956,0.00007503062,0.00012101696,0.00036461448,0.00013865966,0.00030368578,0.000023682664],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000116580806,0.000060915416,0.0026982438,0.000007695661,0.0000034242257,0.000027087523,0.00009721101,0.000006426843,0.9365278,0.00004973585,0.0000107158085,0.060394164],"study_design_scores_gemma":[0.0012554516,0.00027997358,0.06761963,0.00003626845,0.000014081591,0.000017427248,0.0000091860275,0.0009553066,0.9286554,0.0001882682,0.00077590917,0.00019312864],"about_ca_topic_score_codex":0.000032349297,"about_ca_topic_score_gemma":0.0002481906,"teacher_disagreement_score":0.06492139,"about_ca_system_score_codex":0.000029179178,"about_ca_system_score_gemma":0.000053783424,"threshold_uncertainty_score":0.9232079},"labels":[],"label_agreement":null},{"id":"W2791817201","doi":"10.1007/s13311-017-0579-y","title":"Abstracts from HSG 2017","year":2017,"lang":"en","type":"article","venue":"Neurotherapeutics","topic":"Genetic Neurodegenerative Diseases","field":"Neuroscience","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; University of Alberta","funders":"CHDI Foundation","keywords":"Neurology; Neurosurgery; Medicine; Biology; Neuroscience; Radiology","score_opus":0.11736034699343137,"score_gpt":0.33741937389121746,"score_spread":0.2200590268977861,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2791817201","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97784895,0.000041177926,0.00008399444,0.0011938005,0.00097172335,0.00023922429,0.000106279585,0.00010364341,0.019411214],"genre_scores_gemma":[0.9916922,0.000110957255,0.0001736453,0.0067176833,0.00025738063,0.000015847298,0.0000017067173,0.000050216393,0.0009803806],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9984166,0.000107305954,0.00021185,0.00059242506,0.000344054,0.00032773503],"domain_scores_gemma":[0.9979335,0.00018736659,0.00023151556,0.0014583173,0.000035224293,0.00015407278],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000042710424,0.0002151599,0.00016189784,0.0000374324,0.00068003236,0.0004393587,0.001025447,0.00005908367,0.00017126583],"category_scores_gemma":[0.00047791525,0.00020561466,0.000086795895,0.000032117292,0.00027153705,0.00019176847,0.00009421285,0.00018617304,0.00063450536],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00002464717,0.00009774919,0.0024138275,0.0000026966256,0.0000042574898,0.00007019532,0.0000622822,0.000065617576,0.99134326,0.00045394216,0.00054450915,0.004917],"study_design_scores_gemma":[0.00037629466,0.000050052822,0.12864046,0.0000052715154,0.000016059972,0.0000051577013,0.0000038811345,0.00021852186,0.8439368,0.0011462274,0.02542223,0.00017903865],"about_ca_topic_score_codex":0.00003672615,"about_ca_topic_score_gemma":0.000014839775,"teacher_disagreement_score":0.14740647,"about_ca_system_score_codex":0.000010321764,"about_ca_system_score_gemma":0.000052463165,"threshold_uncertainty_score":0.83847225},"labels":[],"label_agreement":null},{"id":"W2803331941","doi":"10.1007/s13311-018-0634-3","title":"Chronic Administration of Pimozide Fails to Attenuate Motor and Pathological Deficits in Two Mouse Models of Amyotrophic Lateral Sclerosis","year":2018,"lang":"en","type":"article","venue":"Neurotherapeutics","topic":"Amyotrophic Lateral Sclerosis Research","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval; Bombardier Recreational Products (Canada)","funders":"Institute of Neurosciences, Mental Health and Addiction; U.S. Department of Defense","keywords":"Pimozide; SOD1; Amyotrophic lateral sclerosis; Medicine; Pharmacology; Riluzole; Internal medicine; Disease","score_opus":0.0908572307264077,"score_gpt":0.3443106161489537,"score_spread":0.25345338542254603,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2803331941","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9974872,0.000095307194,0.00036110808,0.0010891816,0.000033945962,0.0007712201,0.000023089367,0.000026567723,0.000112401984],"genre_scores_gemma":[0.9978789,0.0002179495,0.0010462054,0.00056650874,0.00011329222,0.00003223419,0.0000038587077,0.00003726903,0.00010376697],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9982482,0.00013494758,0.00049717457,0.000356069,0.00039775867,0.00036580634],"domain_scores_gemma":[0.9991344,0.000059948245,0.0001048957,0.00034923176,0.00019626885,0.00015523542],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020580221,0.00018399072,0.00041971845,0.00019127787,0.000034727178,0.000021234802,0.00014142574,0.00010285585,0.000051328374],"category_scores_gemma":[0.00004034442,0.00015181226,0.00006304085,0.00030862773,0.0002907065,0.0001241949,0.00006682589,0.00022883674,0.000010678917],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009266767,0.00015979039,0.011535993,0.00008307363,0.00001977203,0.000017544819,0.00032595542,0.00012393332,0.9806557,0.00021158274,0.0000051256443,0.0059348405],"study_design_scores_gemma":[0.0048776213,0.011794298,0.77508557,0.00038713674,0.00006945807,0.000053778567,0.000033976383,0.020137724,0.1865227,0.0006023814,0.00010416817,0.0003312021],"about_ca_topic_score_codex":0.00008757532,"about_ca_topic_score_gemma":0.00009663051,"teacher_disagreement_score":0.794133,"about_ca_system_score_codex":0.00007705929,"about_ca_system_score_gemma":0.00010951221,"threshold_uncertainty_score":0.61907244},"labels":[],"label_agreement":null},{"id":"W2899076600","doi":"10.1007/s13311-018-00685-1","title":"Invasive Neuromodulation for the Treatment of Pediatric Epilepsy","year":2018,"lang":"en","type":"review","venue":"Neurotherapeutics","topic":"Vagus Nerve Stimulation Research","field":"Neuroscience","cited_by":13,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"","keywords":"Neuromodulation; Vagus nerve stimulation; Deep brain stimulation; Neuroscience; Medicine; Neurosurgery; Epilepsy; Neurology; Psychology; Vagus nerve; Stimulation; Disease; Surgery; Pathology","score_opus":0.3600899133636662,"score_gpt":0.4459213806134793,"score_spread":0.08583146724981311,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2899076600","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00012825067,0.9925068,0.000569865,0.00008576439,0.0008234213,0.0054350467,0.00024382224,0.00006247383,0.00014455359],"genre_scores_gemma":[0.00024689492,0.99748623,0.00006631424,0.00015946683,0.00090592465,0.00048474415,0.000012400298,0.00012522277,0.0005127798],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9973935,0.0005074838,0.0006614259,0.00062553637,0.00045373832,0.0003583174],"domain_scores_gemma":[0.9913684,0.007015946,0.00055116543,0.0008633147,0.00013617013,0.000065005974],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00014409772,0.0003967952,0.000794518,0.00026732814,0.00022958497,0.00006158176,0.0006221932,0.00018782791,0.00006228733],"category_scores_gemma":[0.0004514372,0.00024562955,0.0006402869,0.0007494278,0.00017993728,0.000054810407,0.000029941002,0.00016171832,0.000076927136],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000035900215,0.00038044222,0.000031201496,0.003331327,0.000061673956,0.0000053808662,0.00019558771,0.00007463502,0.00011409672,0.00039139148,0.00026818173,0.99511015],"study_design_scores_gemma":[0.0003995485,0.001366129,0.000023058326,0.00010917492,0.0006705557,0.000011021251,0.0000015670802,0.0009401028,0.000601468,0.000101509,0.9955777,0.00019819537],"about_ca_topic_score_codex":0.0000032265957,"about_ca_topic_score_gemma":0.0000032235296,"teacher_disagreement_score":0.9953095,"about_ca_system_score_codex":0.00007885817,"about_ca_system_score_gemma":0.00032271745,"threshold_uncertainty_score":0.9999996},"labels":[],"label_agreement":null},{"id":"W2900366772","doi":"10.1007/s13311-018-00684-2","title":"Myopathies Related to Glycogen Metabolism Disorders","year":2018,"lang":"en","type":"review","venue":"Neurotherapeutics","topic":"Glycogen Storage Diseases and Myoclonus","field":"Medicine","cited_by":80,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Hamilton Health Sciences; Health Sciences Centre; McMaster University Medical Centre","funders":"Canadian Institutes of Health Research","keywords":"Glycogen debranching enzyme; Glycogen phosphorylase; Glycogen; Glycogenolysis; Glycolysis; Internal medicine; Rhabdomyolysis; Glycogen synthase; Phosphofructokinase; Endocrinology; Phosphorylase kinase; Phosphoglycerate mutase; Myoglobinuria; Glycogen branching enzyme; Phosphoglucomutase; Biology; Biochemistry; Medicine; Metabolism; Enzyme","score_opus":0.041658339707797865,"score_gpt":0.360956706706261,"score_spread":0.31929836699846315,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2900366772","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000769837,0.9934289,0.000025338137,0.00020032511,0.0011897063,0.0022508425,0.00015286106,0.00023713196,0.002437915],"genre_scores_gemma":[0.000019517507,0.9926924,0.00024451318,0.0027009905,0.0004295453,0.00018249426,0.00012994137,0.0002984945,0.003302108],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99735785,0.00016694535,0.00072615815,0.00075443974,0.00043656497,0.0005580535],"domain_scores_gemma":[0.9980649,0.00008376163,0.0002329627,0.0010324335,0.00012236604,0.00046359072],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0001318553,0.00069968804,0.0019287923,0.0003671048,0.000117593816,0.000051020827,0.00033762556,0.00044599356,0.00032705677],"category_scores_gemma":[0.000075552416,0.00055130216,0.0010791688,0.0007711606,0.00012233816,0.000039459774,0.00008079555,0.0005147822,0.0013033537],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00005857015,0.00015838692,0.00000304372,0.0044054682,0.0005760016,0.0004275502,0.00013531253,1.6392148e-7,0.0000035605215,0.00023032523,0.0021884954,0.9918131],"study_design_scores_gemma":[0.00045447864,0.00034324743,0.000008692478,0.0023244126,0.004924066,0.00059434003,0.000011952644,0.0000027911456,0.000002597281,0.00008524699,0.9907746,0.00047362508],"about_ca_topic_score_codex":0.000012783554,"about_ca_topic_score_gemma":0.0000043834552,"teacher_disagreement_score":0.9913395,"about_ca_system_score_codex":0.000063505315,"about_ca_system_score_gemma":0.0003585703,"threshold_uncertainty_score":0.9996939},"labels":[],"label_agreement":null},{"id":"W2901464853","doi":"10.1007/s13311-018-00686-0","title":"Dynamin 2 (DNM2) as Cause of, and Modifier for, Human Neuromuscular Disease","year":2018,"lang":"en","type":"review","venue":"Neurotherapeutics","topic":"Cellular transport and secretion","field":"Biochemistry, Genetics and Molecular Biology","cited_by":55,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"Natural Sciences and Engineering Research Council of Canada; Canadian Institutes of Health Research","keywords":"Dynamin; GTPase; Neuroscience; Biology; Genetics; Endocytosis; Cell","score_opus":0.061467354039809075,"score_gpt":0.3488701099412626,"score_spread":0.28740275590145353,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2901464853","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.003199604,0.99283826,0.0025378636,0.00001040771,0.00014840694,0.0009669224,0.00015835336,0.000012882994,0.00012727779],"genre_scores_gemma":[0.00096197776,0.9947337,0.000054218242,0.00014447424,0.00024785168,0.00007203292,0.0029738543,0.00011751178,0.00069438],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99868613,0.000079595404,0.00037596488,0.0005125989,0.00013351778,0.00021219978],"domain_scores_gemma":[0.999046,0.000015739484,0.00018383538,0.00055801315,0.000070314025,0.00012608907],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00009473279,0.00034222397,0.00054081256,0.0000690877,0.0000763205,0.000020407444,0.00020032727,0.00029633957,0.000009712382],"category_scores_gemma":[0.0000135572345,0.00031566469,0.00040783448,0.00006536729,0.00015886694,0.0000021542976,0.000030657156,0.000119270044,0.0000029107769],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00049810787,0.0008660743,0.00037716163,0.06113293,0.002379624,0.0001345295,0.00019186678,0.000008848833,0.053934976,0.004519411,0.00025487508,0.8757016],"study_design_scores_gemma":[0.00026770704,0.00036683158,0.000026780292,0.00035278194,0.0009812284,0.000011961401,0.0000014774458,0.00002568921,0.00017655098,0.00012750196,0.9973686,0.00029291713],"about_ca_topic_score_codex":0.000004066892,"about_ca_topic_score_gemma":0.000008744113,"teacher_disagreement_score":0.9971137,"about_ca_system_score_codex":0.0000061043847,"about_ca_system_score_gemma":0.00010599874,"threshold_uncertainty_score":0.99992955},"labels":[],"label_agreement":null},{"id":"W2914643639","doi":"10.1007/s13311-019-00713-8","title":"A Longitudinal Study of the Neurologic Safety of Acute Baclofen Use After Spinal Cord Injury","year":2019,"lang":"en","type":"article","venue":"Neurotherapeutics","topic":"Spinal Cord Injury Research","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Saskatchewan; International Collaboration On Repair Discoveries; University of British Columbia","funders":"Canadian Institutes of Health Research; University of British Columbia; International Foundation for Research in Paraplegia; Michael Smith Health Research BC; Rick Hansen Institute","keywords":"Medicine; Baclofen; Spinal cord injury; Anesthesia; Concomitant; Hazard ratio; Spasticity; Cohort; Traumatic brain injury; Spinal cord; Surgery; Confidence interval; Internal medicine","score_opus":0.09391365052028106,"score_gpt":0.39693742088775463,"score_spread":0.3030237703674736,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2914643639","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.997023,0.000041465064,0.00001455475,0.00036022102,0.00027848463,0.0018647794,0.000028796452,0.000023702381,0.0003650027],"genre_scores_gemma":[0.9978521,0.000039733346,0.00009057281,0.0012422962,0.00004475604,0.000026436253,8.874395e-7,0.000044670625,0.000658557],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99785423,0.00023932055,0.0004716956,0.00035975926,0.00076094037,0.00031406642],"domain_scores_gemma":[0.9983195,0.00008876868,0.0001824919,0.0010777309,0.00025497438,0.00007653126],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020400413,0.00020781487,0.0004508119,0.00013562583,0.000038244958,0.000014298916,0.000371224,0.000089813286,0.00024025745],"category_scores_gemma":[0.00004225758,0.00013737194,0.00017158249,0.0005382073,0.00017609363,0.0000835215,0.00017851254,0.00055749575,0.000031217947],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.08537048,0.0008739515,0.88052756,0.00008531217,0.00020919675,0.00003656494,0.000050425053,0.0000016755571,0.02986278,0.00003677328,0.000034455716,0.0029108024],"study_design_scores_gemma":[0.0016201524,0.066442326,0.9265483,0.000039018218,0.00031253343,0.000058641537,0.00004275866,0.000062056984,0.0028360626,0.000016276525,0.0019224299,0.00009943875],"about_ca_topic_score_codex":0.000043916356,"about_ca_topic_score_gemma":0.000010022296,"teacher_disagreement_score":0.08375033,"about_ca_system_score_codex":0.000029184217,"about_ca_system_score_gemma":0.00011523171,"threshold_uncertainty_score":0.5601865},"labels":[],"label_agreement":null},{"id":"W2956028033","doi":"10.1007/s13311-019-00755-y","title":"Consequences of Metabolic Disruption in Alzheimer's Disease Pathology","year":2019,"lang":"en","type":"review","venue":"Neurotherapeutics","topic":"Alzheimer's disease research and treatments","field":"Medicine","cited_by":81,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal Neurological Institute and Hospital","funders":"National Institute on Aging","keywords":"Dementia; Neurology; Disease; Atrophy; Cognitive decline; Apolipoprotein E; Medicine; Alzheimer's disease; Risk factor; Psychology; Neuroscience; Pathology; Gerontology","score_opus":0.15951040232895805,"score_gpt":0.42280303003101866,"score_spread":0.26329262770206063,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2956028033","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00024059408,0.9967588,0.000002026104,0.00007220343,0.00014444704,0.002159712,0.00024082334,0.000025707594,0.00035567],"genre_scores_gemma":[0.0031996055,0.99604064,0.000038830556,0.00016901738,0.00006563807,0.00018245346,0.00019448466,0.000078364494,0.000030937234],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9976407,0.000429329,0.0006237421,0.00049389986,0.00040784793,0.0004044373],"domain_scores_gemma":[0.99848795,0.00019351301,0.00028251144,0.00066678406,0.00007511826,0.00029413405],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00012990697,0.00041184484,0.0018660992,0.00040907526,0.000023618572,0.000012427835,0.00018437681,0.00021377177,0.00012615812],"category_scores_gemma":[0.000034555214,0.00030629212,0.0005439946,0.00040511432,0.0003165471,0.000052144587,0.000037780883,0.00039865295,0.00020839248],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023372279,0.0009660679,0.0037948026,0.0070960964,0.0075277183,0.0014155473,0.000031472333,7.0012857e-7,0.0000048870097,0.000892483,0.000014005757,0.9780225],"study_design_scores_gemma":[0.0022058578,0.0006044329,0.003582507,0.006856375,0.032965355,0.00025398252,0.0000127671865,0.0000143310535,0.000031556032,0.000248056,0.9527009,0.00052387844],"about_ca_topic_score_codex":0.000013921063,"about_ca_topic_score_gemma":0.0000020923337,"teacher_disagreement_score":0.9774986,"about_ca_system_score_codex":0.000028986804,"about_ca_system_score_gemma":0.0012026656,"threshold_uncertainty_score":0.9999389},"labels":[],"label_agreement":null},{"id":"W2964013225","doi":"10.1007/s13311-019-00765-w","title":"The Novel Small Molecule TRVA242 Stabilizes Neuromuscular Junction Defects in Multiple Animal Models of Amyotrophic Lateral Sclerosis","year":2019,"lang":"en","type":"article","venue":"Neurotherapeutics","topic":"Amyotrophic Lateral Sclerosis Research","field":"Medicine","cited_by":34,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Treventis (Canada); Montreal Neurological Institute and Hospital; University of Toronto; Fonds de Recherche du Québec - Santé; St. Michael's Hospital; Université de Montréal; McGill University; Centre Hospitalier de l’Université de Montréal","funders":"Mitacs; ALS Society of Canada","keywords":"Amyotrophic lateral sclerosis; Zebrafish; SOD1; Neuroscience; C9orf72; Neuromuscular junction; Biology; Caenorhabditis elegans; Neurology; Medicine; Trinucleotide repeat expansion; Genetics; Disease; Gene; Pathology","score_opus":0.08397349794007626,"score_gpt":0.26820376997395773,"score_spread":0.18423027203388148,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2964013225","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99697906,0.00023012378,0.00021312702,0.0007453457,0.00017287672,0.0013436242,0.000007479412,0.000058919413,0.0002494711],"genre_scores_gemma":[0.998249,0.00047124832,0.00023632724,0.00066238764,0.000053732743,0.00005366748,0.0000058089136,0.00009446612,0.00017338143],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9975718,0.00020028948,0.00051401416,0.00048576633,0.0006304041,0.0005976999],"domain_scores_gemma":[0.9985776,0.00025721977,0.00012904173,0.0007218885,0.00018387423,0.00013038042],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00029757494,0.00027623816,0.00042944532,0.000159173,0.00009777248,0.00005139163,0.00028878657,0.00016271333,0.000042679338],"category_scores_gemma":[0.0000705542,0.00019820374,0.00021138955,0.00049287855,0.00018505803,0.00013375941,0.00009029296,0.0005601374,0.000028236609],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001116457,0.0003464364,0.04311433,0.00009819664,0.000051253017,0.000008125927,0.00019192106,0.0020578047,0.9515526,0.0002496132,0.0000057474194,0.0012074565],"study_design_scores_gemma":[0.0063070883,0.0022288759,0.8085797,0.00016375302,0.0000711114,0.000020694737,0.000043721033,0.14341359,0.038123004,0.00015685547,0.0005973154,0.00029431324],"about_ca_topic_score_codex":0.00021416026,"about_ca_topic_score_gemma":0.00008613555,"teacher_disagreement_score":0.9134297,"about_ca_system_score_codex":0.00010013375,"about_ca_system_score_gemma":0.00011014451,"threshold_uncertainty_score":0.8082514},"labels":[],"label_agreement":null},{"id":"W2966113050","doi":"10.1007/s13311-019-00768-7","title":"DNA Damage Repair in Huntington's Disease and Other Neurodegenerative Diseases","year":2019,"lang":"en","type":"review","venue":"Neurotherapeutics","topic":"Genetic Neurodegenerative Diseases","field":"Neuroscience","cited_by":96,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"Krembil Foundation; Huntington's Disease Society of America","keywords":"Huntington's disease; Neurology; DNA repair; Disease; DNA damage; Medicine; Neurodegeneration; Neuroscience; Neurosurgery; Biology; Genetics; DNA; Pathology; Psychiatry","score_opus":0.10169970750839041,"score_gpt":0.34852371060019005,"score_spread":0.24682400309179964,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2966113050","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.009744785,0.9826693,0.000009123312,0.00009496612,0.0008025836,0.0036190927,0.0022149205,0.00038428712,0.00046094472],"genre_scores_gemma":[0.0007711413,0.98988986,0.000039256152,0.0070699817,0.00028147202,0.00037806926,0.000023999963,0.00044944155,0.0010968013],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99325186,0.0019957346,0.0009381399,0.002346202,0.0006377035,0.0008303431],"domain_scores_gemma":[0.9964297,0.0010562878,0.00048283467,0.0015017528,0.000046142344,0.00048330196],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.000116717245,0.0012021549,0.0018056438,0.0005336406,0.0001783402,0.00019076625,0.00077573286,0.00021370288,0.000099024706],"category_scores_gemma":[0.0006165699,0.0010683568,0.0006879118,0.0008359016,0.00041644016,0.00017818635,0.00029341955,0.00072054006,0.00018400658],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006541953,0.0054587503,0.007882933,0.08301125,0.00051010516,0.0017744522,0.0010050063,0.0005933118,0.011168612,0.014862054,0.004018498,0.8690608],"study_design_scores_gemma":[0.0005514021,0.0001556977,0.0004658279,0.0015968033,0.0010078768,0.0000105410745,0.0000066882435,0.00031242476,0.0010616379,0.00008755812,0.9936546,0.0010889351],"about_ca_topic_score_codex":0.000004717225,"about_ca_topic_score_gemma":0.000007094162,"teacher_disagreement_score":0.9896361,"about_ca_system_score_codex":0.00007008246,"about_ca_system_score_gemma":0.0005236061,"threshold_uncertainty_score":0.9991767},"labels":[],"label_agreement":null},{"id":"W2990175007","doi":"10.1007/s13311-019-00808-2","title":"Gender-Specific Beneficial Effects of Docosahexaenoic Acid Dietary Supplementation in G93A-SOD1 Amyotrophic Lateral Sclerosis Mice","year":2019,"lang":"en","type":"article","venue":"Neurotherapeutics","topic":"Amyotrophic Lateral Sclerosis Research","field":"Medicine","cited_by":28,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canada's Michael Smith Genome Sciences Centre; University of British Columbia","funders":"Instituto de Salud Carlos III; Generalitat de Catalunya; Fundación Española para el Fomento de la Investigación de la Esclerosis Lateral Amiotrófica","keywords":"Docosahexaenoic acid; SOD1; Excitotoxicity; Endocrinology; Internal medicine; Amyotrophic lateral sclerosis; Neuroprotection; Oxidative stress; Motor neuron; Spinal cord; Medicine; Biology; Polyunsaturated fatty acid; Fatty acid; Glutamate receptor; Biochemistry; Neuroscience; Superoxide dismutase","score_opus":0.0547665981668043,"score_gpt":0.2980842104110267,"score_spread":0.24331761224422238,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2990175007","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99605024,0.0006342281,0.000034260698,0.00069973234,0.00038135593,0.0017756633,0.000019027895,0.000056239245,0.00034924207],"genre_scores_gemma":[0.9964376,0.00149174,0.00049419055,0.0010487059,0.00018030389,0.00006246791,0.00005328058,0.00009139255,0.00014028673],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9972504,0.00021527354,0.0006006489,0.0005349693,0.0007752632,0.00062344404],"domain_scores_gemma":[0.9989268,0.0001526107,0.00014031128,0.0005212576,0.00011541055,0.0001436095],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00017842295,0.00030969403,0.0005522225,0.00032942274,0.0000515604,0.000035364246,0.00025132237,0.00018398366,0.0005870448],"category_scores_gemma":[0.000014943838,0.0002826628,0.00016856272,0.00055834005,0.000099429446,0.0001700678,0.000071697155,0.00051347195,0.00014450925],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00081164105,0.00039024663,0.087701745,0.00046672116,0.000070393806,0.000033294775,0.0006034538,0.00006935972,0.90073085,0.00010430098,0.00006782212,0.008950175],"study_design_scores_gemma":[0.0056038457,0.0015135421,0.88552684,0.00022618102,0.000059144764,0.000013395611,0.000030707604,0.00067328423,0.104856156,0.00014597729,0.0010900883,0.00026086761],"about_ca_topic_score_codex":0.00009799683,"about_ca_topic_score_gemma":0.000022835111,"teacher_disagreement_score":0.79782504,"about_ca_system_score_codex":0.00016916501,"about_ca_system_score_gemma":0.000087422246,"threshold_uncertainty_score":0.99996257},"labels":[],"label_agreement":null},{"id":"W2994970239","doi":"10.1007/s13311-019-00818-0","title":"One-Day Acceptance and Commitment Therapy Compared to Support for Depressed Migraine Patients: a Randomized Clinical Trial","year":2019,"lang":"en","type":"article","venue":"Neurotherapeutics","topic":"Migraine and Headache Studies","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto General Hospital; University Health Network","funders":"National Institute of Mental Health; Center for Innovations in Quality, Effectiveness and Safety; National Institutes of Health; U.S. Department of Veterans Affairs","keywords":"Migraine; Depression (economics); Psychological intervention; Randomized controlled trial; Anxiety; Medicine; Acceptance and commitment therapy; Quality of life (healthcare); Psychiatry; Clinical trial; Physical therapy; Psychology; Clinical psychology; Intervention (counseling); Internal medicine","score_opus":0.12495940660804473,"score_gpt":0.4016295600450261,"score_spread":0.27667015343698137,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2994970239","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9804536,0.00042271227,0.00090295787,0.0036987478,0.00028349843,0.012879979,0.0000368744,0.000077374534,0.0012442406],"genre_scores_gemma":[0.9679726,0.001032171,0.0018552347,0.025380576,0.0003963564,0.0006121961,0.00004322302,0.00006446437,0.0026432176],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9979552,0.0002913355,0.0007294817,0.00042480894,0.00028328726,0.0003158957],"domain_scores_gemma":[0.9975873,0.0014729924,0.00015476954,0.00042165496,0.0001952268,0.0001680562],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009462566,0.00023641692,0.001236403,0.00007475862,0.00007474865,0.000027032193,0.00011515978,0.000100128425,0.00012896075],"category_scores_gemma":[0.00031285992,0.00018604254,0.00035945387,0.00010264451,0.00011188593,0.000036114812,0.000033318363,0.0001870599,0.000024148816],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.90283686,0.0021951005,0.053127166,0.000104970684,0.00089678465,0.0000017005473,0.0017152339,0.0000013376248,0.0006043625,0.00020647049,0.013256881,0.025053158],"study_design_scores_gemma":[0.7432654,0.0057193222,0.023008388,0.0000333267,0.00021762766,8.1870644e-7,0.00005339077,0.00026119765,0.00023549754,0.00007397985,0.22693764,0.00019341787],"about_ca_topic_score_codex":0.000007960986,"about_ca_topic_score_gemma":0.000020148917,"teacher_disagreement_score":0.21368076,"about_ca_system_score_codex":0.000017895922,"about_ca_system_score_gemma":0.000059831695,"threshold_uncertainty_score":0.7586595},"labels":[],"label_agreement":null},{"id":"W2996258182","doi":"10.1007/s13311-019-00809-1","title":"Poly-Arginine Peptide-18 (R18) Reduces Brain Injury and Improves Functional Outcomes in a Nonhuman Primate Stroke Model","year":2019,"lang":"en","type":"article","venue":"Neurotherapeutics","topic":"S100 Proteins and Annexins","field":"Biochemistry, Genetics and Molecular Biology","cited_by":24,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Kingston Health Sciences Centre; Dalhousie University; Queen's University","funders":"Multiple Sclerosis Society of Western Australia; Multiple Sclerosis Society","keywords":"Medicine; Stroke (engine); Neuroprotection; Magnetic resonance imaging; Lesion; Neurology; Anesthesia; Internal medicine; Pathology; Radiology","score_opus":0.020479596865438144,"score_gpt":0.2830031343784438,"score_spread":0.26252353751300567,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2996258182","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9970517,0.0004515302,0.00019854945,0.0007117903,0.00011956757,0.0003140324,0.000048684502,0.000019696556,0.0010844596],"genre_scores_gemma":[0.988573,0.00010502463,0.0006291336,0.0032503537,0.00008950451,0.000027862445,0.000024017278,0.000043942215,0.0072571617],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99897176,0.000035628924,0.00021035367,0.00038823235,0.00013163639,0.0002623672],"domain_scores_gemma":[0.9995529,0.000015271926,0.000069507885,0.0002717047,0.000033304143,0.000057306683],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000102351776,0.00019951194,0.0001899012,0.00007512006,0.000047240752,0.00004119078,0.00012461268,0.00012867094,0.0000399324],"category_scores_gemma":[0.000014775788,0.00018112015,0.00006849864,0.000052816893,0.00006496691,0.000009833544,0.000071446004,0.00014880698,0.000008342383],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013815884,0.000078048724,0.012564617,0.000015429892,0.00003234462,0.0000010920534,0.00004803582,0.00004523795,0.98014575,0.00016286707,0.00019137088,0.0065770303],"study_design_scores_gemma":[0.0055112704,0.0027284797,0.12271514,0.000052114086,0.000048797596,0.00003248574,0.00023002297,0.011821857,0.8108874,0.00096853706,0.043681826,0.0013220713],"about_ca_topic_score_codex":0.000010961179,"about_ca_topic_score_gemma":0.000019064944,"teacher_disagreement_score":0.16925837,"about_ca_system_score_codex":0.000008980666,"about_ca_system_score_gemma":0.0000651361,"threshold_uncertainty_score":0.73858654},"labels":[],"label_agreement":null},{"id":"W2997230488","doi":"10.1007/s13311-019-00824-2","title":"Considering Drug-Associated Contexts in Substance Use Disorders and Treatment Development","year":2020,"lang":"en","type":"review","venue":"Neurotherapeutics","topic":"Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes","field":"Psychology","cited_by":40,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Concordia University","funders":"Institute of Neurosciences, Mental Health and Addiction; National Institute on Alcohol Abuse and Alcoholism; Fonds de Recherche du Québec - Santé; Natural Sciences and Engineering Research Council of Canada; National Institutes of Health; Concordia University","keywords":"Drug; Psychology; Psychological intervention; Cognition; Mindfulness; Substance use; Medicine; Clinical psychology; Psychiatry","score_opus":0.1440162050965548,"score_gpt":0.38006050455570145,"score_spread":0.23604429945914665,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2997230488","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0010435412,0.99516886,0.00006632186,0.00007431522,0.00085013174,0.0019211028,0.00009152749,0.00015842357,0.00062577485],"genre_scores_gemma":[0.0018514013,0.99546236,0.00018307791,0.00037675526,0.00008998727,0.0006936171,0.00006745017,0.00022193108,0.0010534177],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99648774,0.0005610947,0.00085825595,0.0012065214,0.00026457294,0.00062181253],"domain_scores_gemma":[0.9975017,0.0012878752,0.00054334535,0.00040063052,0.000076646065,0.00018981377],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00012514852,0.00091932295,0.0017042143,0.00049940136,0.00013615828,0.00011796423,0.0002486279,0.00036969496,0.00008675051],"category_scores_gemma":[0.00011829522,0.00080541114,0.00021118399,0.001086477,0.00015312513,0.00011415256,0.000042523978,0.00048934727,0.00011005378],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00003663117,0.00057400856,0.009510867,0.00041819297,0.00070769514,0.00007754785,0.0029073758,1.4341657e-7,2.0063666e-7,0.00003773291,0.00011557712,0.985614],"study_design_scores_gemma":[0.0017338414,0.00014208164,0.0027890014,0.0015769332,0.00041132994,0.000016748794,0.00012512635,0.0000012034386,0.0000025431596,0.000049587,0.99252844,0.0006231897],"about_ca_topic_score_codex":0.00006909499,"about_ca_topic_score_gemma":0.0009892466,"teacher_disagreement_score":0.99241287,"about_ca_system_score_codex":0.0004062012,"about_ca_system_score_gemma":0.0002461306,"threshold_uncertainty_score":0.99943966},"labels":[],"label_agreement":null},{"id":"W3000029919","doi":"10.1007/s13311-019-00828-y","title":"GPCR and Alcohol-Related Behaviors in Genetically Modified Mice","year":2020,"lang":"en","type":"review","venue":"Neurotherapeutics","topic":"Receptor Mechanisms and Signaling","field":"Biochemistry, Genetics and Molecular Biology","cited_by":14,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Douglas Mental Health University Institute","funders":"","keywords":"G protein-coupled receptor; Neuroscience; Computational biology; Biology; Drug discovery; Neuropharmacology; Crosstalk; Bioinformatics; Medicine; Receptor; Genetics","score_opus":0.0462636363418782,"score_gpt":0.32082997115157064,"score_spread":0.27456633480969245,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3000029919","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.001365617,0.9973009,0.00020113886,0.000032406184,0.00019871931,0.0006178263,0.000026671223,0.000018457264,0.00023823726],"genre_scores_gemma":[0.0007482708,0.9979913,0.0003617527,0.0003601591,0.00010833405,0.00005035268,0.00008337175,0.00012284493,0.00017358536],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9981995,0.00018640995,0.00053205696,0.00064911885,0.00013867024,0.00029419368],"domain_scores_gemma":[0.9993814,0.00002462171,0.00015406874,0.00028964898,0.000025673653,0.00012458146],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00011184082,0.0004117204,0.0007612698,0.00008046582,0.000039474682,0.000045657016,0.000268874,0.0006060098,0.00003512575],"category_scores_gemma":[0.000017903807,0.0003827006,0.00022206477,0.00016838562,0.000059810412,0.0000017308769,0.00008942772,0.00040383975,0.0000118582675],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000015191307,0.000054260476,0.000006196154,0.00073442934,0.000102351885,0.00003894425,0.000037665177,0.000009016272,0.030957302,0.00014502277,0.000028447515,0.9678712],"study_design_scores_gemma":[0.0003613539,0.00024656832,0.0000034834547,0.0004093539,0.0002807373,0.00006153637,0.000005091355,0.000077561715,0.0014808604,0.00003993605,0.99660736,0.00042617973],"about_ca_topic_score_codex":0.000004833434,"about_ca_topic_score_gemma":0.0000038829157,"teacher_disagreement_score":0.9965789,"about_ca_system_score_codex":0.000014241948,"about_ca_system_score_gemma":0.00012475769,"threshold_uncertainty_score":0.9998625},"labels":[],"label_agreement":null},{"id":"W3031288384","doi":"10.1007/s13311-020-00871-0","title":"Treating Post-traumatic Stress Disorder with Neuromodulation Therapies: Transcranial Magnetic Stimulation, Transcranial Direct Current Stimulation, and Deep Brain Stimulation","year":2020,"lang":"en","type":"review","venue":"Neurotherapeutics","topic":"Transcranial Magnetic Stimulation Studies","field":"Neuroscience","cited_by":40,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Hospital; University of Toronto; Sunnybrook Health Science Centre","funders":"Dana Foundation; U.S. Department of Veterans Affairs","keywords":"Transcranial direct-current stimulation; Neuromodulation; Transcranial magnetic stimulation; Deep brain stimulation; Medicine; Anxiety; Randomized controlled trial; Stimulation; Brain stimulation; Depression (economics); Population; Neurology; Psychology; Psychiatry; Clinical psychology; Internal medicine; Disease; Parkinson's disease","score_opus":0.0554612223034106,"score_gpt":0.3214503414784585,"score_spread":0.2659891191750479,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3031288384","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.008816516,0.9600134,0.018439323,0.00075712526,0.000793909,0.00919707,0.00073591765,0.0009869334,0.000259811],"genre_scores_gemma":[0.18224338,0.8142236,0.00082799204,0.000695667,0.0006295128,0.00041737888,0.000226829,0.00067754317,0.000058090118],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9919035,0.0015896432,0.0020279235,0.0021610653,0.0014280295,0.0008898806],"domain_scores_gemma":[0.994002,0.0037782213,0.0008469287,0.00077202905,0.00026251574,0.0003383338],"candidate_categories":["metaepi_narrow"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.00022170912,0.0017871755,0.0025853035,0.0006099389,0.00082163076,0.00047244644,0.00059223175,0.00044533054,0.00022745082],"category_scores_gemma":[0.00035303048,0.0015373151,0.00054310734,0.0017233284,0.0004757998,0.0005376848,0.000043114036,0.0010310987,0.000034094945],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00038265812,0.0004927716,0.00026194172,0.004755658,0.00010937688,0.000029294186,0.007628262,0.010451102,0.0007177967,0.00020786829,0.0000032769217,0.97495997],"study_design_scores_gemma":[0.018766314,0.009861455,0.023326805,0.00840289,0.008822993,0.00025538943,0.0004695262,0.18892552,0.00003122735,0.00033453738,0.73465276,0.006150606],"about_ca_topic_score_codex":0.000051719926,"about_ca_topic_score_gemma":0.00020780346,"teacher_disagreement_score":0.96880937,"about_ca_system_score_codex":0.00011588638,"about_ca_system_score_gemma":0.00024574366,"threshold_uncertainty_score":0.99948734},"labels":[],"label_agreement":null},{"id":"W3043245611","doi":"10.1007/s13311-020-00885-8","title":"Inhibition of the BMP Signaling Pathway Ameliorated Established Clinical Symptoms of Experimental Autoimmune Encephalomyelitis","year":2020,"lang":"en","type":"article","venue":"Neurotherapeutics","topic":"TGF-β signaling in diseases","field":"Biochemistry, Genetics and Molecular Biology","cited_by":12,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; St. Michael's Hospital","funders":"European Regional Development Fund; Instituto de Salud Carlos III; European Commission","keywords":"Experimental autoimmune encephalomyelitis; Bone morphogenetic protein; Noggin; Immunology; Immune system; Myelin oligodendrocyte glycoprotein; Autoimmune disease; Multiple sclerosis; Encephalomyelitis; Medicine; Biology; Antibody","score_opus":0.03084317578943844,"score_gpt":0.2884182761563314,"score_spread":0.25757510036689296,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3043245611","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99789304,0.0010798615,0.00034920368,0.00009261841,0.0001696753,0.00024345308,0.000043638058,0.000021935119,0.000106600965],"genre_scores_gemma":[0.99841034,0.000017748815,0.00019430269,0.0011335013,0.00015237274,0.00001074344,0.000029554822,0.000034892702,0.000016532169],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9985538,0.00022617627,0.00055270264,0.00029119768,0.00021891242,0.00015720497],"domain_scores_gemma":[0.99913937,0.000041000378,0.00028364564,0.00034648235,0.00012148006,0.000068026195],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011214841,0.00015221375,0.00021807259,0.0000191879,0.000049325907,0.000014516409,0.00026183436,0.00013334767,0.000043147495],"category_scores_gemma":[0.000111495705,0.00012821163,0.00018646684,0.00019078195,0.000255588,0.00000578464,0.00009212448,0.00012894861,0.000002163618],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014418011,0.0001710983,0.004621514,0.000023405773,0.00004892901,0.0000016278581,0.00022479215,0.00018454737,0.9926098,0.000029117642,0.000032127144,0.0019088787],"study_design_scores_gemma":[0.00071663625,0.00063357776,0.0054676062,0.000037076734,0.000025320585,0.0000017534388,0.00010752184,0.00019520914,0.9896342,0.000009957492,0.003048545,0.00012259786],"about_ca_topic_score_codex":0.000004400506,"about_ca_topic_score_gemma":5.407434e-7,"teacher_disagreement_score":0.0030164178,"about_ca_system_score_codex":0.0000056139565,"about_ca_system_score_gemma":0.00015260554,"threshold_uncertainty_score":0.52283186},"labels":[],"label_agreement":null},{"id":"W3045443729","doi":"10.1007/s13311-020-00891-w","title":"Therapeutic Update on Huntington's Disease: Symptomatic Treatments and Emerging Disease-Modifying Therapies","year":2020,"lang":"en","type":"review","venue":"Neurotherapeutics","topic":"Genetic Neurodegenerative Diseases","field":"Neuroscience","cited_by":68,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"","keywords":"Huntington's disease; Disease; Apathy; Medicine; Huntingtin; Clinical trial; Bioinformatics; Cognitive decline; Biology; Dementia; Internal medicine","score_opus":0.08318257101095569,"score_gpt":0.34745517760256833,"score_spread":0.26427260659161267,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3045443729","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0024694437,0.99222535,0.000052717794,0.0009008579,0.00056102633,0.0027537255,0.00042946025,0.00047462113,0.00013280827],"genre_scores_gemma":[0.007453116,0.9836748,0.00004307648,0.00726316,0.0002750429,0.00051844737,0.00003877691,0.00048820552,0.00024536139],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9937122,0.0014427284,0.0008770423,0.0021432503,0.0009434627,0.00088134996],"domain_scores_gemma":[0.9963659,0.0008972007,0.0006127136,0.001235932,0.00004213544,0.00084610423],"candidate_categories":["metaepi_narrow"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.00009067109,0.0015397037,0.0017591297,0.00036739424,0.0005743695,0.00049051974,0.0009006652,0.00015084885,0.000090354566],"category_scores_gemma":[0.00022491388,0.0012599329,0.0007109015,0.000697235,0.00034220496,0.00016554147,0.00018912608,0.00063832547,0.00028803767],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008522241,0.00034245857,0.000072482355,0.0049986746,0.0002391047,0.00016174262,0.00017479713,0.000019879879,0.0003769235,0.0013372094,0.00003810152,0.9921534],"study_design_scores_gemma":[0.0006931948,0.00021082784,0.00027272006,0.0029806471,0.0029926922,0.000012388934,0.000014768715,0.0005006268,0.00056042185,0.0005930146,0.9898408,0.0013279134],"about_ca_topic_score_codex":8.065683e-7,"about_ca_topic_score_gemma":2.6973487e-7,"teacher_disagreement_score":0.9908255,"about_ca_system_score_codex":0.00010258331,"about_ca_system_score_gemma":0.00036965634,"threshold_uncertainty_score":0.9997352},"labels":[],"label_agreement":null},{"id":"W3047091630","doi":"10.1007/s13311-020-00894-7","title":"Therapy of Parkinson's Disease Subtypes","year":2020,"lang":"en","type":"review","venue":"Neurotherapeutics","topic":"Parkinson's Disease Mechanisms and Treatments","field":"Medicine","cited_by":97,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa; Toronto Western Hospital; University of Toronto","funders":"","keywords":"Subtyping; Disease; Clinical trial; Parkinson's disease; Neurology; Personalized medicine; Medicine; Bioinformatics; Psychology; Biology; Pathology; Psychiatry; Computer science","score_opus":0.08539846610945344,"score_gpt":0.3460819313506753,"score_spread":0.2606834652412218,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3047091630","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000046596306,0.9972385,0.000025729301,0.0001255718,0.00021874665,0.001493518,0.000253243,0.00010315907,0.00049489],"genre_scores_gemma":[0.00038338633,0.99762493,0.00017666843,0.0009494972,0.00021188457,0.00012999652,0.00011049074,0.00018657316,0.00022655087],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99805725,0.0001477991,0.0005016191,0.00058286457,0.000419134,0.00029132084],"domain_scores_gemma":[0.9983636,0.0000891093,0.0003453379,0.0006714201,0.00006302205,0.00046748057],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.000049242582,0.0005709175,0.0018806037,0.00015846516,0.000043988148,0.000019160705,0.00021876067,0.0001902927,0.00018969901],"category_scores_gemma":[0.000021551446,0.00042116002,0.00095219497,0.00035341652,0.00007339575,0.00002922014,0.00002985095,0.0003065536,0.00011934527],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021005106,0.0004758111,0.00018078143,0.004871121,0.0007645346,0.00047937,0.000018701936,6.212141e-8,0.0000039192296,0.00014898536,0.00010729198,0.9927394],"study_design_scores_gemma":[0.00093981734,0.00040613106,0.0003063881,0.0022170227,0.0020489648,0.00002837572,0.0000017891545,0.0000092515875,0.000020415151,0.00006488934,0.9936964,0.00026058903],"about_ca_topic_score_codex":0.0000025121083,"about_ca_topic_score_gemma":2.3934712e-7,"teacher_disagreement_score":0.9935891,"about_ca_system_score_codex":0.000054705004,"about_ca_system_score_gemma":0.0006862962,"threshold_uncertainty_score":0.99982405},"labels":[],"label_agreement":null},{"id":"W3084702012","doi":"10.1007/s13311-020-00927-1","title":"Neuronal Adenylyl Cyclase Targeting Central Plasticity for the Treatment of Chronic Pain","year":2020,"lang":"en","type":"review","venue":"Neurotherapeutics","topic":"Pain Mechanisms and Treatments","field":"Medicine","cited_by":40,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canada Research Chairs; University of Toronto","funders":"","keywords":"Chronic pain; Medicine; Neuropathic pain; Neuroscience; Long-term potentiation; Excitatory postsynaptic potential; Neurotransmission; Gabapentin; Sensitization; Adenylyl cyclase; Pharmacology; Psychology; Inhibitory postsynaptic potential; Psychiatry; Internal medicine; Stimulation","score_opus":0.07720443948746254,"score_gpt":0.34482775591102105,"score_spread":0.2676233164235585,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3084702012","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000014883204,0.99067533,0.0048743477,0.00025901833,0.0003544364,0.0034764723,0.00027321573,0.00005343782,0.00001886749],"genre_scores_gemma":[0.00010712522,0.99724764,0.0004796074,0.0005050901,0.0009211506,0.00036008577,0.00010791248,0.00013612662,0.00013525676],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9980002,0.00025566694,0.00056978327,0.00044608122,0.00026819593,0.00046009704],"domain_scores_gemma":[0.99763393,0.001529751,0.00033145212,0.0002980612,0.000042679218,0.00016413223],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00011136709,0.0005301006,0.0014586861,0.000057803947,0.00012025095,0.00001902805,0.00016913886,0.00018850848,0.00005573196],"category_scores_gemma":[0.00008342731,0.00030685728,0.00091411476,0.0001542223,0.00006872803,0.000014903207,0.000013492483,0.0002297159,0.0000100540055],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008091804,0.0006666359,0.000009244502,0.0046552466,0.0009560335,0.000047913472,0.00006582054,0.000008566375,0.00003272463,0.00008832203,0.00014322011,0.99324536],"study_design_scores_gemma":[0.0014253538,0.004736137,0.000013441141,0.001016125,0.004533649,0.00002496437,0.000006708742,0.0022508758,0.00010342321,0.000012061376,0.98570144,0.00017580896],"about_ca_topic_score_codex":0.000006260959,"about_ca_topic_score_gemma":0.0000027636072,"teacher_disagreement_score":0.9930695,"about_ca_system_score_codex":0.00029467806,"about_ca_system_score_gemma":0.0005407522,"threshold_uncertainty_score":0.99993837},"labels":[],"label_agreement":null},{"id":"W3092058469","doi":"10.1007/s13311-020-00942-2","title":"Modulation of the Microbiome in Parkinson's Disease: Diet, Drug, Stool Transplant, and Beyond","year":2020,"lang":"en","type":"review","venue":"Neurotherapeutics","topic":"Parkinson's Disease Mechanisms and Treatments","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre for Movement Disorders","funders":"","keywords":"Microbiome; Disease; Dysbiosis; Prebiotic; Parkinson's disease; Medicine; Probiotic; Gut microbiome; Gut flora; Bioinformatics; Biology; Neuroscience; Intensive care medicine; Immunology; Internal medicine; Genetics; Bacteria","score_opus":0.032168850326131836,"score_gpt":0.29228882224536995,"score_spread":0.26011997191923814,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3092058469","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0014432562,0.99569076,0.000018086072,0.0002735688,0.00015468642,0.0017023757,0.00059985317,0.000025563864,0.000091848735],"genre_scores_gemma":[0.019016216,0.9800217,0.00007584538,0.00046279363,0.00005300505,0.00007656101,0.00008514761,0.000082508224,0.00012623274],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99852437,0.00017221444,0.00041500526,0.00044210692,0.00023827539,0.00020800308],"domain_scores_gemma":[0.9991356,0.000063882966,0.00021833193,0.0003961363,0.00002083977,0.00016517143],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.000054950997,0.00038077333,0.0010170625,0.0001310945,0.00004418604,0.000014705126,0.00014498846,0.00012496351,0.000017280376],"category_scores_gemma":[0.0000069081752,0.00025583076,0.00034661058,0.0003514081,0.000076708835,0.0000311048,0.000028487555,0.0002748844,0.000005429986],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003153051,0.00046443442,0.0024668921,0.013818577,0.0004069863,0.00023174552,0.00020792964,0.0000010141201,0.000087389584,0.0001284303,0.000046111272,0.9818252],"study_design_scores_gemma":[0.00093859754,0.00009991211,0.0065817907,0.003105391,0.0020135522,0.000026177568,0.0000034438897,0.00009000196,0.000013186931,0.00006123767,0.9868852,0.0001815222],"about_ca_topic_score_codex":0.00000537236,"about_ca_topic_score_gemma":0.000005789389,"teacher_disagreement_score":0.98683906,"about_ca_system_score_codex":0.00006017791,"about_ca_system_score_gemma":0.00025218364,"threshold_uncertainty_score":0.9999894},"labels":[],"label_agreement":null},{"id":"W3092692652","doi":"10.1007/s13311-020-00952-0","title":"Withaferin-A Treatment Alleviates TAR DNA-Binding Protein-43 Pathology and Improves Cognitive Function in a Mouse Model of FTLD","year":2020,"lang":"en","type":"article","venue":"Neurotherapeutics","topic":"Autophagy in Disease and Therapy","field":"Medicine","cited_by":32,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"Canadian Institutes of Health Research; Canada Research Chairs; Fondation Brain Canada; ALS Society of Canada","keywords":"Withaferin A; Withania somnifera; Frontotemporal lobar degeneration; Autophagy; Biology; Neuroinflammation; Neuroscience; Frontotemporal dementia; Cell biology; Pathology; Dementia; Medicine; Biochemistry; Immunology; Inflammation","score_opus":0.043840850680287896,"score_gpt":0.2771291745486622,"score_spread":0.2332883238683743,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3092692652","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9976151,0.00034467425,0.00036704415,0.0005282359,0.00001667746,0.0009315557,0.000036003705,0.000047534308,0.00011317494],"genre_scores_gemma":[0.9970641,0.00033859373,0.00018113025,0.0019826535,0.00003724968,0.000085528525,0.0000108424065,0.000038785856,0.0002610857],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99919194,0.00004778963,0.00021653168,0.00026401234,0.00010897106,0.00017077486],"domain_scores_gemma":[0.99963516,0.00003355341,0.00008315394,0.000112695685,0.000038425547,0.00009700001],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00003496906,0.00017302363,0.00030455782,0.00006610399,0.00002785337,0.000006844337,0.000034011493,0.00008270858,0.000017737799],"category_scores_gemma":[0.000014718035,0.00014448329,0.00005542043,0.000091034795,0.00008025047,0.000049174294,0.000012644586,0.00011500173,0.0000040244645],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0020147972,0.00033066538,0.0022487463,0.000088103516,0.00014064767,0.00005237381,0.0017477989,0.000020147132,0.983977,0.00011830208,9.812911e-7,0.009260391],"study_design_scores_gemma":[0.0091383075,0.0075190472,0.0036656084,0.00009078867,0.00034993066,0.000019539491,0.00048372702,0.018850286,0.95907533,0.0003697573,0.00018593822,0.0002517482],"about_ca_topic_score_codex":0.0000063061593,"about_ca_topic_score_gemma":0.000003945374,"teacher_disagreement_score":0.024901723,"about_ca_system_score_codex":0.000022526572,"about_ca_system_score_gemma":0.00006634485,"threshold_uncertainty_score":0.5891858},"labels":[],"label_agreement":null},{"id":"W3098728977","doi":"10.1007/s13311-020-00968-6","title":"Overlapping Molecular Pathways Leading to Autism Spectrum Disorders, Fragile X Syndrome, and Targeted Treatments","year":2020,"lang":"en","type":"review","venue":"Neurotherapeutics","topic":"Genetics and Neurodevelopmental Disorders","field":"Biochemistry, Genetics and Molecular Biology","cited_by":30,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Institute of Child Health and Human Development; Eunice Kennedy Shriver National Institute of Child Health and Human Development; Azrieli Foundation; Intellectual and Developmental Disabilities Research Center; MIND Institute, University of California, Davis","keywords":"Fragile X syndrome; Autism; Autism spectrum disorder; Etiology; FMR1; Neuroscience; Neurology; Bioinformatics; Wnt signaling pathway; Genetics; Medicine; Fragile x; Psychology; Gene; Biology; Psychiatry","score_opus":0.02191842075551259,"score_gpt":0.2696872094728059,"score_spread":0.2477687887172933,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3098728977","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.003119347,0.9937227,0.0004698278,0.0003498089,0.00029053906,0.0013802063,0.00013687067,0.000047556638,0.00048316174],"genre_scores_gemma":[0.0072035235,0.99007463,0.00045823277,0.0014831629,0.000021742797,0.00011743437,0.00020733656,0.00022500037,0.00020893122],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99767745,0.00012706965,0.0004423433,0.0010309651,0.00021651678,0.0005056891],"domain_scores_gemma":[0.99909985,0.000016970549,0.0001613475,0.00045334912,0.000007270631,0.0002612181],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.000045157685,0.0006964491,0.0008984432,0.00013215537,0.00012875829,0.00007865554,0.00034489538,0.000323389,0.000016841434],"category_scores_gemma":[0.000014659327,0.00070007273,0.00028864975,0.00029361495,0.00005589677,0.0000033889191,0.0002377755,0.00027075873,0.000055297744],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000031228847,0.00023407387,0.000039711584,0.002674972,0.0011545246,0.00030081428,0.0001738361,0.00003772856,0.029595723,0.00042289426,0.00038309954,0.9649514],"study_design_scores_gemma":[0.00030699617,0.000670237,0.00011787929,0.00039476284,0.00027436815,0.00010192908,0.000006892423,0.000010107154,0.00033839978,0.000114860646,0.9969814,0.0006822138],"about_ca_topic_score_codex":0.000003925928,"about_ca_topic_score_gemma":0.0000060789753,"teacher_disagreement_score":0.99659824,"about_ca_system_score_codex":0.00003355157,"about_ca_system_score_gemma":0.00015044029,"threshold_uncertainty_score":0.99954504},"labels":[],"label_agreement":null},{"id":"W3104112957","doi":"10.1007/s13311-020-00965-9","title":"BDNF rs6265 Variant Alters Outcomes with Levodopa in Early-Stage Parkinson's Disease","year":2020,"lang":"en","type":"article","venue":"Neurotherapeutics","topic":"Nerve injury and regeneration","field":"Neuroscience","cited_by":19,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Institute of Neurological Disorders and Stroke; Genentech; Boston Scientific Corporation; Vanderbilt University Medical Center; Saint Mary's Foundation; Allergan; National Institutes of Health; Ipsen; H. Lundbeck A/S; Weston Brain Institute; Vanderbilt University; American Parkinson Disease Association; U.S. Department of Defense","keywords":"rs6265; Levodopa; Internal medicine; Oncology; Parkinson's disease; Single-nucleotide polymorphism; Medicine; Selegiline; Disease; Genotype; Psychology; Brain-derived neurotrophic factor; Genetics; Neurotrophic factors; Biology; Gene","score_opus":0.06420135401948456,"score_gpt":0.277333290486667,"score_spread":0.21313193646718243,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3104112957","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98759,0.000026584417,0.0016212654,0.00938193,0.00023544069,0.0004716077,0.000043999367,0.00013326456,0.0004958982],"genre_scores_gemma":[0.97417057,0.000045280707,0.00014856188,0.024937324,0.00009210088,0.000026391379,0.0000019022126,0.000048432878,0.00052943],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9983819,0.0002196263,0.00022935362,0.00052411784,0.0003331714,0.0003118024],"domain_scores_gemma":[0.9992705,0.00011810258,0.00008578473,0.00029022616,0.000015070382,0.00022031141],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00006188778,0.00021869766,0.00019624853,0.00006601326,0.000107354324,0.00010020477,0.0002691724,0.000043420765,0.00004802163],"category_scores_gemma":[0.00006472596,0.00016728361,0.0000628049,0.0003552576,0.00010619601,0.00020961798,0.000029282995,0.00025406035,0.000051197705],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0023889646,0.00082226214,0.37427494,0.00017375789,0.000040004208,0.0042414386,0.0031718146,0.010033175,0.57752746,0.02023234,0.00027561045,0.006818208],"study_design_scores_gemma":[0.0051495964,0.0017591263,0.23231448,0.000060413964,0.00009869333,0.00003179339,0.000084546286,0.030383468,0.48670384,0.00039195875,0.24156399,0.0014580861],"about_ca_topic_score_codex":0.000012346836,"about_ca_topic_score_gemma":0.000013733354,"teacher_disagreement_score":0.24128838,"about_ca_system_score_codex":0.000018303946,"about_ca_system_score_gemma":0.000062713,"threshold_uncertainty_score":0.68216276},"labels":[],"label_agreement":null},{"id":"W3118601063","doi":"10.1007/s13311-020-01002-5","title":"Combination of Hydroxychloroquine and Indapamide Attenuates Neurodegeneration in Models Relevant to Multiple Sclerosis","year":2021,"lang":"en","type":"article","venue":"Neurotherapeutics","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"Canadian Institutes of Health Research","keywords":"Medicine; Indapamide; Microglia; Multiple sclerosis; Pharmacology; Hydroxychloroquine; Experimental autoimmune encephalomyelitis; Neuroprotection; Internal medicine; Immunology; Disease; Inflammation","score_opus":0.11542012675119949,"score_gpt":0.30710650164393877,"score_spread":0.19168637489273926,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3118601063","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9934071,0.0003723148,0.0006332182,0.004720722,0.00006283308,0.00056125305,0.000014846413,0.00002726397,0.00020048743],"genre_scores_gemma":[0.9950187,0.0018326887,0.0015567571,0.0013718419,0.0000300844,0.000044359585,0.000013967906,0.00003286533,0.00009870201],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9985984,0.000115218936,0.00034975025,0.00033302032,0.0003736382,0.00022996923],"domain_scores_gemma":[0.99907327,0.00021301504,0.000057474343,0.0002788654,0.0002781494,0.00009920669],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017923309,0.00014114959,0.00031364438,0.00019332473,0.000050746614,0.000021004638,0.000057293524,0.00005982252,0.000009176481],"category_scores_gemma":[0.00038177427,0.00013752603,0.00004137212,0.0004415756,0.000069125104,0.0000982583,0.00007122184,0.00017894588,0.000003094233],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017742302,0.00034811185,0.047133174,0.000100895966,0.000029337756,0.000011224427,0.0008026358,0.0015901834,0.93003815,0.0001859888,0.00004919059,0.019533696],"study_design_scores_gemma":[0.0036994657,0.0005830772,0.46212566,0.00021250708,0.000032912973,0.000011361139,0.00013818426,0.13674393,0.3956002,0.0002076565,0.00048227157,0.00016277439],"about_ca_topic_score_codex":0.000052595067,"about_ca_topic_score_gemma":0.00019217288,"teacher_disagreement_score":0.53443795,"about_ca_system_score_codex":0.000042054144,"about_ca_system_score_gemma":0.000057638434,"threshold_uncertainty_score":0.5608149},"labels":[],"label_agreement":null},{"id":"W3123816984","doi":"10.1007/s13311-020-00998-0","title":"Selective Immunomodulatory and Neuroprotective Effects of a NOD2 Receptor Agonist on Mouse Models of Multiple Sclerosis","year":2021,"lang":"en","type":"article","venue":"Neurotherapeutics","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"Fonds de Recherche du Québec - Santé; Canadian Institutes of Health Research","keywords":"Experimental autoimmune encephalomyelitis; Multiple sclerosis; Muramyl dipeptide; Medicine; Immunology; NOD2; Neuroprotection; Microglia; Agonist; Encephalomyelitis; Pharmacology; Receptor; Immune system; Inflammation; Innate immune system; Internal medicine","score_opus":0.062271191530146826,"score_gpt":0.2809934773647,"score_spread":0.21872228583455317,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3123816984","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99668944,0.0009822687,0.00034041924,0.00022849852,0.00009065641,0.0011647119,0.000050841376,0.00004579432,0.0004073595],"genre_scores_gemma":[0.99595106,0.002383488,0.00090451393,0.0004207752,0.000038865724,0.00008289642,0.000003975993,0.00006899846,0.00014541476],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9981542,0.0002720222,0.0003396277,0.00044346583,0.0004921463,0.00029850542],"domain_scores_gemma":[0.9979685,0.00072468276,0.00015424371,0.0004877288,0.00055634574,0.000108523695],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012024208,0.0002422957,0.0005802743,0.00014457518,0.00010189991,0.0000135367445,0.00009587634,0.0001010002,0.00000945938],"category_scores_gemma":[0.00060415664,0.00022210214,0.00014226338,0.00036366127,0.00032990158,0.00006694144,0.00008850843,0.0004043483,0.000003076245],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00084035535,0.00065017346,0.002910232,0.00056901533,0.00032239515,0.0000068560716,0.001001555,0.00011758122,0.98309666,0.000068632195,0.000036052134,0.010380514],"study_design_scores_gemma":[0.0031889428,0.0016139465,0.08550968,0.00029547454,0.00006647287,0.0000042136307,0.00009890839,0.003202638,0.9056835,0.000037257123,0.00015911061,0.0001398143],"about_ca_topic_score_codex":0.00004387039,"about_ca_topic_score_gemma":0.0000098486535,"teacher_disagreement_score":0.082599446,"about_ca_system_score_codex":0.00006493867,"about_ca_system_score_gemma":0.00013707064,"threshold_uncertainty_score":0.9057062},"labels":[],"label_agreement":null},{"id":"W3129254157","doi":"10.1007/s13311-020-01004-3","title":"Reldesemtiv in Patients with Spinal Muscular Atrophy: a Phase 2 Hypothesis-Generating Study","year":2021,"lang":"en","type":"article","venue":"Neurotherapeutics","topic":"Neurogenetic and Muscular Disorders Research","field":"Medicine","cited_by":44,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; London Health Sciences Centre; Western University; Alberta Children's Hospital; University of Calgary; Montreal Neurological Institute and Hospital","funders":"Astellas Foundation for Research on Metabolic Disorders; Astellas Pharma; Cytokinetics","keywords":"Placebo; Medicine; Spinal muscular atrophy; Cmax; Pharmacokinetics; SMA*; Internal medicine; Cohort; Quartile; Dosing; Pharmacodynamics; Urology; Anesthesia; Gastroenterology; Confidence interval; Pathology","score_opus":0.03717962061417412,"score_gpt":0.32431852271177997,"score_spread":0.28713890209760584,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3129254157","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99779665,0.00030155157,0.0001841305,0.00030915884,0.000043603362,0.0010710075,0.0000026522105,0.000031392097,0.00025985902],"genre_scores_gemma":[0.99710995,0.000043680924,0.0011287278,0.0013115578,0.00005149034,0.00005232071,0.000006794071,0.00007128723,0.00022420257],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981003,0.00021964958,0.0002501872,0.0004546825,0.0006220058,0.0003532175],"domain_scores_gemma":[0.9991122,0.000033031734,0.00004197754,0.000508181,0.00018331104,0.0001213271],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000104138,0.00019322854,0.00029848455,0.00012213302,0.000074966614,0.000036472888,0.00009347007,0.000051809933,0.00008650271],"category_scores_gemma":[0.000065190885,0.00016116063,0.00008274241,0.00047410975,0.000053062668,0.00003546106,0.000033347984,0.00032606904,0.000014383366],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0026342534,0.014709623,0.80011886,0.0001331372,0.00033744142,0.0020759138,0.0006037523,0.00010051396,0.033368524,0.0000214233,0.000033087363,0.14586349],"study_design_scores_gemma":[0.047815178,0.018206095,0.9159746,0.00013189379,0.00033207447,0.00006286287,0.0008361594,0.0008310472,0.009019684,0.000028425677,0.006245903,0.0005160419],"about_ca_topic_score_codex":0.000009539901,"about_ca_topic_score_gemma":0.000025442385,"teacher_disagreement_score":0.14534745,"about_ca_system_score_codex":0.000033997952,"about_ca_system_score_gemma":0.00019692017,"threshold_uncertainty_score":0.65719396},"labels":[],"label_agreement":null},{"id":"W3134947311","doi":"10.1007/s13311-021-01017-6","title":"Pharmacological Inhibition of Brain EGFR Activation By a BBB-penetrating Inhibitor, AZD3759, Attenuates α-synuclein Pathology in a Mouse Model of α-Synuclein Propagation","year":2021,"lang":"en","type":"article","venue":"Neurotherapeutics","topic":"Parkinson's Disease Mechanisms and Treatments","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Simon Fraser University; Montreal Neurological Institute and Hospital","funders":"Canada First Research Excellence Fund; Simon Fraser University; W. Garfield Weston Foundation; Consortium canadien en neurodégénérescence associée au vieillissement; Weston Brain Institute; McGill University","keywords":"Substantia nigra; Alpha-synuclein; Neuroscience; Dopamine; Striatum; Parkinson's disease; Neurology; Neuron; Pathology; Amyloid (mycology); Chemistry; Biology; Dopaminergic; Medicine; Disease","score_opus":0.0389611923069449,"score_gpt":0.29553942550691314,"score_spread":0.25657823319996825,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3134947311","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99648035,0.000094492905,0.0014921206,0.0010740915,0.000034844743,0.00055067835,0.00008012348,0.000037144182,0.00015614404],"genre_scores_gemma":[0.99655104,0.00008244423,0.0014275832,0.0015881656,0.000025833919,0.000056360106,0.00009320369,0.000037807855,0.00013753863],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9984644,0.00019748334,0.0004814468,0.0003521022,0.00028757204,0.00021699486],"domain_scores_gemma":[0.9992723,0.0000924056,0.0002382453,0.00017801061,0.00014602205,0.00007301064],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015783674,0.0001859041,0.00035689733,0.00012719988,0.000037444177,0.0000097158645,0.00004524842,0.00015416999,0.00005290761],"category_scores_gemma":[0.00008859554,0.00017709567,0.00009140925,0.0002698034,0.000066800465,0.00011123252,0.00002640309,0.00019556131,0.0000030115925],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003110766,0.0014404332,0.003170649,0.00009506951,0.00005277324,0.000050824314,0.00023717477,0.00022942343,0.9905688,0.00021146782,0.00006336158,0.0035689357],"study_design_scores_gemma":[0.003379058,0.0005174366,0.0018740717,0.00008842156,0.00009488033,0.000012849674,0.000080094105,0.022675382,0.9707248,0.00034413632,0.00009142846,0.00011742998],"about_ca_topic_score_codex":0.0000106442285,"about_ca_topic_score_gemma":0.000006221716,"teacher_disagreement_score":0.02244596,"about_ca_system_score_codex":0.00008282317,"about_ca_system_score_gemma":0.00013882628,"threshold_uncertainty_score":0.72217524},"labels":[],"label_agreement":null},{"id":"W3137093758","doi":"10.1007/s13311-021-01018-5","title":"Neuroprotection of Exendin-4 by Enhanced Autophagy in a Parkinsonian Rat Model of α-Synucleinopathy","year":2021,"lang":"en","type":"article","venue":"Neurotherapeutics","topic":"Parkinson's Disease Mechanisms and Treatments","field":"Medicine","cited_by":50,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Western Hospital; University Health Network","funders":"Postdoctoral Research Foundation of China; Science and Technology Commission of Shanghai Municipality; Chinese Academy of Sciences; China Postdoctoral Science Foundation; Ministry of Science and Technology of the People's Republic of China; National Natural Science Foundation of China","keywords":"Substantia nigra; Neuroprotection; Dopaminergic; Pars compacta; Tyrosine hydroxylase; Autophagy; Parkinson's disease; Internal medicine; Endocrinology; Wortmannin; Oxidopamine; Ventral tegmental area; Neuroscience; Dopamine; Medicine; Pharmacology; Chemistry; PI3K/AKT/mTOR pathway; Biology; Cell biology; Disease; Biochemistry; Signal transduction","score_opus":0.023730996229593935,"score_gpt":0.26572786690078903,"score_spread":0.2419968706711951,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3137093758","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.995462,0.0005330208,0.002650281,0.00011506048,0.000117378375,0.0003540211,0.00004082288,0.000031092797,0.00069635134],"genre_scores_gemma":[0.9978061,0.00036217872,0.00088707334,0.00051112083,0.00001181653,0.000031206935,0.000009850086,0.000041956533,0.00033872126],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99882096,0.0000787399,0.0003308057,0.00030659838,0.00026223203,0.00020065714],"domain_scores_gemma":[0.99933183,0.000022615424,0.00013228226,0.0003361909,0.00009214155,0.00008493143],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00005478545,0.00016297775,0.00036194653,0.00010585012,0.000022899094,0.0000059780064,0.00006187521,0.00008347222,0.000056218894],"category_scores_gemma":[0.000021633981,0.0001608824,0.00011157455,0.0002951279,0.000039842747,0.00004370967,0.00001818436,0.00014015027,0.0000037953553],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002215067,0.0009319341,0.0012610103,0.00009234453,0.000039399132,0.00006981385,0.00018242901,0.00017729224,0.98191357,0.00013741422,0.000010321011,0.014962984],"study_design_scores_gemma":[0.0025515568,0.00043965937,0.0046856673,0.000072083974,0.000100649915,0.000014507674,0.000028095552,0.010958471,0.97948,0.0002699595,0.0012997505,0.000099542645],"about_ca_topic_score_codex":0.000014544357,"about_ca_topic_score_gemma":0.0000073393176,"teacher_disagreement_score":0.014863442,"about_ca_system_score_codex":0.00003850301,"about_ca_system_score_gemma":0.00013936046,"threshold_uncertainty_score":0.6560594},"labels":[],"label_agreement":null},{"id":"W3140190497","doi":"10.1007/s13311-021-01034-5","title":"Noninvasive Neuroprosthesis Promotes Cardiovascular Recovery After Spinal Cord Injury","year":2021,"lang":"en","type":"article","venue":"Neurotherapeutics","topic":"Spinal Cord Injury Research","field":"Medicine","cited_by":57,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"GF Strong Rehabilitation Centre; International Collaboration On Repair Discoveries; University of British Columbia","funders":"International Collaboration on Repair Discoveries; Michael Smith Health Research BC; Rick Hansen Foundation; Canadian Institutes of Health Research; Faculty of Medicine, University of British Columbia; Craig H. Neilsen Foundation","keywords":"Autonomic dysreflexia; Medicine; Spinal cord injury; Tetraplegia; Neurology; Anesthesia; Autonomic nervous system; Spinal cord; Physical medicine and rehabilitation; Blood pressure; Internal medicine; Heart rate","score_opus":0.05520698885955726,"score_gpt":0.3473373651081553,"score_spread":0.29213037624859806,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3140190497","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9901592,0.004275207,0.00031779255,0.0014651716,0.00041757734,0.00085129443,0.000025608864,0.00015095597,0.0023371717],"genre_scores_gemma":[0.9819133,0.0015373428,0.0021381122,0.009834632,0.0005834296,0.00017699333,0.000012308976,0.00019756303,0.0036063087],"study_design_codex":"design_other","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99732727,0.00025111198,0.0003276878,0.0006696431,0.0008818951,0.0005423656],"domain_scores_gemma":[0.9980008,0.00006517792,0.00005296345,0.0011498086,0.0005058989,0.00022533536],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00016240389,0.00029418865,0.0005205264,0.00015992885,0.00008940705,0.00009032126,0.00017150077,0.00014581799,0.0004087483],"category_scores_gemma":[0.00023481708,0.00028013845,0.0005728148,0.00062315096,0.00014022435,0.00011169668,0.00009368628,0.00062568346,0.00027663528],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.05517498,0.0006088371,0.014821946,0.0006683579,0.00157949,0.015622531,0.000038310118,0.0000030186372,0.28229448,0.00006456945,0.0008177311,0.62830573],"study_design_scores_gemma":[0.0019123483,0.047641315,0.058362853,0.00035087924,0.0010001331,0.00464279,0.00009479256,0.000067895824,0.53645045,0.00027753896,0.34846014,0.000738876],"about_ca_topic_score_codex":0.00000954956,"about_ca_topic_score_gemma":0.0000034042378,"teacher_disagreement_score":0.6275669,"about_ca_system_score_codex":0.0000821545,"about_ca_system_score_gemma":0.00043104475,"threshold_uncertainty_score":0.9999651},"labels":[],"label_agreement":null},{"id":"W3144225459","doi":"10.1007/s13311-021-01015-8","title":"Targeting TDP-43 Pathology Alleviates Cognitive and Motor Deficits Caused by Chronic Cerebral Hypoperfusion","year":2021,"lang":"en","type":"article","venue":"Neurotherapeutics","topic":"Neurological Disease Mechanisms and Treatments","field":"Neuroscience","cited_by":18,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre hospitalier universitaire de Québec; Université Laval","funders":"Consortium canadien en neurodégénérescence associée au vieillissement; Canada Research Chairs; Alzheimer Society; Fondation Brain Canada; ALS Society of Canada","keywords":"Dementia; Neuroscience; Medicine; Cognitive decline; Vascular dementia; Neurodegeneration; Neurology; Microglia; Pathology; Psychology; Disease; Inflammation; Internal medicine","score_opus":0.03331781996170371,"score_gpt":0.2660926824139115,"score_spread":0.23277486245220777,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3144225459","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99664474,0.0014528048,0.00024582894,0.0004757492,0.00021216983,0.0003853587,0.00017937957,0.00011620582,0.00028778208],"genre_scores_gemma":[0.98919356,0.0011577246,0.00004939103,0.009103988,0.000049298545,0.00004016737,0.000018413079,0.000047941787,0.0003395463],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99801147,0.00037140452,0.000213632,0.00075381144,0.00021556915,0.0004341422],"domain_scores_gemma":[0.9992058,0.00035069682,0.00008098816,0.0001701275,0.000047360092,0.00014501365],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000045284713,0.00025751846,0.00023411364,0.000035677625,0.00026015742,0.00008161643,0.000113581744,0.000109237466,0.00023705522],"category_scores_gemma":[0.00020372667,0.00022105,0.00006504858,0.00015697746,0.00011495775,0.00008710304,0.0001063868,0.00022009638,0.00006121143],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000051111554,0.00026240555,0.0009041466,0.000015282665,0.000009132081,0.00072050287,0.00005028011,0.0000036145645,0.9925528,0.00039998218,0.00003728195,0.004993425],"study_design_scores_gemma":[0.0030836544,0.0015706816,0.005220669,0.000027403585,0.000117871,0.00014611127,0.00004506519,0.002232729,0.9816343,0.0013411966,0.0041258927,0.00045440838],"about_ca_topic_score_codex":0.0000023881594,"about_ca_topic_score_gemma":0.0000023454038,"teacher_disagreement_score":0.010918517,"about_ca_system_score_codex":0.000021177708,"about_ca_system_score_gemma":0.000049693735,"threshold_uncertainty_score":0.9014157},"labels":[],"label_agreement":null},{"id":"W3148740062","doi":"10.1007/s13311-020-00993-5","title":"Small Molecule Rescue of ATXN3 Toxicity in C. elegans via TFEB/HLH-30","year":2021,"lang":"en","type":"article","venue":"Neurotherapeutics","topic":"Genetic Neurodegenerative Diseases","field":"Neuroscience","cited_by":10,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Centre Hospitalier de l’Université de Montréal","funders":"Fonds de Recherche du Québec - Santé; Canadian Institutes of Health Research; Montreal Neurological Institute and Hospital; National Institutes of Health; McGill University; Natural Sciences and Engineering Research Council of Canada; Johns Hopkins University","keywords":"Neurodegeneration; Spinocerebellar ataxia; Biology; Neuroprotection; Caenorhabditis elegans; Genetics; Phenotypic screening; Trinucleotide repeat expansion; Neuroscience; Phenotype; Gene; Disease; Medicine; Internal medicine","score_opus":0.06285964121399257,"score_gpt":0.28387014680888284,"score_spread":0.22101050559489027,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3148740062","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99600405,0.00013903227,0.0010390703,0.0005719224,0.00022599769,0.0002998077,0.000042954427,0.000053080326,0.0016241116],"genre_scores_gemma":[0.99212855,0.00013863738,0.00028662392,0.006952416,0.00004478402,0.000022358481,0.0000022360962,0.00006133726,0.0003630842],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99750185,0.00058560626,0.00042685756,0.00069321884,0.00037430125,0.000418178],"domain_scores_gemma":[0.9987752,0.00022463183,0.00009546461,0.0006796608,0.00010664091,0.000118418466],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00008363385,0.00024766373,0.00029724045,0.00012738486,0.00007186053,0.000040068335,0.00038962072,0.00008169995,0.00019710416],"category_scores_gemma":[0.00031546503,0.00026546328,0.00012346065,0.00071330235,0.00016106939,0.00005546192,0.00009280359,0.00025762792,0.000041321717],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000031279185,0.00042164832,0.0021738291,0.000030067273,0.0000042142647,0.00014708372,0.00014374833,0.00065718434,0.9944884,0.00073551264,0.000025113977,0.0011418997],"study_design_scores_gemma":[0.00056668394,0.00014837821,0.00780594,0.000014935782,0.00001584472,0.000021808592,0.000019080742,0.001613812,0.9880944,0.0003223789,0.001167564,0.00020919426],"about_ca_topic_score_codex":0.000018148605,"about_ca_topic_score_gemma":0.00010328065,"teacher_disagreement_score":0.0063940403,"about_ca_system_score_codex":0.000026957085,"about_ca_system_score_gemma":0.00017787747,"threshold_uncertainty_score":0.99997973},"labels":[],"label_agreement":null},{"id":"W3152217306","doi":"10.1007/s13311-021-01022-9","title":"The Sigma-1 Receptor Mediates Pridopidine Rescue of Mitochondrial Function in Huntington Disease Models","year":2021,"lang":"en","type":"article","venue":"Neurotherapeutics","topic":"Pharmacological Receptor Mechanisms and Effects","field":"Biochemistry, Genetics and Molecular Biology","cited_by":61,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Children's Hospital; University of British Columbia","funders":"Fundação Luso-Americana para o Desenvolvimento; Universidade de Coimbra; Fundação para a Ciência e a Tecnologia; Karolinska Institutet; Fundo Regional para a Ciência e Tecnologia","keywords":"Sigma-1 receptor; Mitochondrion; Neuroprotection; Cell biology; Biology; Inositol trisphosphate receptor; Endoplasmic reticulum; Pharmacology; Chemistry; Receptor; Inositol; Agonist; Biochemistry","score_opus":0.01848191230699497,"score_gpt":0.263666797278065,"score_spread":0.24518488497107005,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3152217306","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9921138,0.0016597713,0.0035749897,0.0007117378,0.0013576405,0.00033608297,0.0000178784,0.000015122464,0.00021294368],"genre_scores_gemma":[0.9958453,0.0021563957,0.0002513102,0.00094420125,0.00041037123,0.00004398978,0.00004081913,0.000025157105,0.00028242168],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9989952,0.00017613574,0.00020591251,0.00026019852,0.00015215363,0.00021040654],"domain_scores_gemma":[0.9994763,0.00007675708,0.00005830513,0.00023117554,0.00008218253,0.00007525019],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001315675,0.00011803215,0.00011768019,0.000017636143,0.00006390161,0.000018519528,0.0001367882,0.000092979804,0.000033397788],"category_scores_gemma":[0.00015705076,0.00008821816,0.00008487253,0.00011936996,0.000050963972,0.000004606761,0.00005604211,0.00012013862,0.0000021385304],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005563291,0.00009903122,0.00015195095,0.000015633366,0.00002125831,0.0000014372613,0.000012911287,0.0015129396,0.992878,0.00040242675,0.000318192,0.004029854],"study_design_scores_gemma":[0.0008259719,0.00030920297,0.00041414276,0.000013723645,0.000025334093,4.6948165e-7,0.000019727298,0.0021404256,0.9417491,0.0011022392,0.053276848,0.00012284232],"about_ca_topic_score_codex":0.0000029488365,"about_ca_topic_score_gemma":0.000019265717,"teacher_disagreement_score":0.052958656,"about_ca_system_score_codex":0.000008723625,"about_ca_system_score_gemma":0.00008502427,"threshold_uncertainty_score":0.35974324},"labels":[],"label_agreement":null},{"id":"W3158518340","doi":"10.1007/s13311-021-01035-4","title":"Correction to: Selective Immunomodulatory and Neuroprotective Effects of a NOD2 Receptor Agonist on Mouse Models of Multiple Sclerosis","year":2021,"lang":"en","type":"erratum","venue":"Neurotherapeutics","topic":"Nitric Oxide and Endothelin Effects","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"","keywords":"Neuroprotection; Agonist; Multiple sclerosis; Neuroscience; Neurology; NOD2; Receptor; Pharmacology; Medicine; Psychology; Internal medicine; Immunology","score_opus":0.026546725029944124,"score_gpt":0.24599620480933093,"score_spread":0.2194494797793868,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3158518340","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8995716,0.010403354,0.0036101176,0.00043704335,0.05976954,0.013177329,0.00046711336,0.00047393603,0.012089946],"genre_scores_gemma":[0.9480171,0.0056980713,0.0008750096,0.0029050251,0.0011312682,0.00036647104,0.000114067516,0.00058070815,0.040312268],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9975758,0.0003387812,0.00049931044,0.00070931506,0.0005303847,0.0003463842],"domain_scores_gemma":[0.9974396,0.00086738775,0.0003901201,0.0006731179,0.00046892106,0.00016081108],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00013940963,0.00051853445,0.0011472964,0.0004093285,0.00008603834,0.000020778405,0.00014023688,0.00043210931,0.000009308225],"category_scores_gemma":[0.0005835298,0.00050486537,0.00027426894,0.0005721265,0.00013895065,0.000055390923,0.00006227589,0.0013656911,0.000007059923],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0026185634,0.001028447,0.0002256334,0.0024480615,0.0007316312,0.00003005132,0.0011723035,0.0003647034,0.9311976,0.000014949111,0.03945559,0.020712504],"study_design_scores_gemma":[0.004445393,0.00953137,0.0055070627,0.00422991,0.00078092865,0.000043243046,0.00008642561,0.0063336836,0.9575545,0.00003729705,0.010788373,0.0006618009],"about_ca_topic_score_codex":0.00017426466,"about_ca_topic_score_gemma":0.00001887583,"teacher_disagreement_score":0.058638275,"about_ca_system_score_codex":0.0001498799,"about_ca_system_score_gemma":0.00033755042,"threshold_uncertainty_score":0.9997403},"labels":[],"label_agreement":null},{"id":"W3165668208","doi":"10.1007/s13311-021-01065-y","title":"Correction to: Neuronal Adenylyl Cyclase Targeting Central Plasticity for the Treatment of Chronic Pain","year":2021,"lang":"en","type":"erratum","venue":"Neurotherapeutics","topic":"Pain Mechanisms and Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Adenylyl cyclase; Neurosurgery; Neurology; Neuroscience; Medicine; Neuroplasticity; Neuropathic pain; Chronic pain; Psychology; Psychiatry","score_opus":0.02741888038121848,"score_gpt":0.2907424252189415,"score_spread":0.263323544837723,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3165668208","genre_codex":"editorial","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.025574975,0.062441684,0.32312953,0.016409272,0.5249225,0.037770756,0.0033770036,0.0010402038,0.005334081],"genre_scores_gemma":[0.14655733,0.049534246,0.007382761,0.029409736,0.055654604,0.004225998,0.0060823746,0.0020638816,0.69908905],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99802125,0.0001858274,0.00040215533,0.00050025404,0.00037480012,0.00051572657],"domain_scores_gemma":[0.9981469,0.0009805529,0.00021013663,0.00035359556,0.00014468706,0.00016412197],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00012764806,0.00043386617,0.0006107266,0.00008594928,0.00017706216,0.000031199936,0.000118915916,0.00023563986,0.0001130883],"category_scores_gemma":[0.00020991308,0.0003033734,0.0004202443,0.00016839399,0.000046574194,0.000016947186,0.000014424843,0.000370862,0.0000050079057],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014070475,0.0051684584,0.0007069963,0.00088182336,0.0024974137,0.00018802145,0.00096254284,0.0012891027,0.0138029475,0.00007456423,0.7722331,0.20078796],"study_design_scores_gemma":[0.0022771435,0.009120831,0.0022449275,0.00034266175,0.0013289799,0.000026425392,0.00006180041,0.033253647,0.006792399,0.000012831301,0.94429004,0.00024833262],"about_ca_topic_score_codex":0.000056045283,"about_ca_topic_score_gemma":0.00009751365,"teacher_disagreement_score":0.693755,"about_ca_system_score_codex":0.00050060294,"about_ca_system_score_gemma":0.00065109576,"threshold_uncertainty_score":0.9999418},"labels":[],"label_agreement":null},{"id":"W3180369792","doi":"10.1007/s13311-021-01088-5","title":"Therapeutic Potential of a Novel Glucagon-like Peptide-1 Receptor Agonist, NLY01, in Experimental Autoimmune Encephalomyelitis","year":2021,"lang":"en","type":"article","venue":"Neurotherapeutics","topic":"Adenosine and Purinergic Signaling","field":"Biochemistry, Genetics and Molecular Biology","cited_by":36,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Institute of Neurological Disorders and Stroke; Fonds de Recherche du Québec - Santé; National Institute of General Medical Sciences; U.S. Department of Defense","keywords":"Experimental autoimmune encephalomyelitis; Neuroprotection; Neurodegeneration; Multiple sclerosis; Medicine; Agonist; Myelin oligodendrocyte glycoprotein; Encephalomyelitis; Inflammation; Immunology; Neuroscience; Receptor; Pharmacology; Biology; Internal medicine; Disease","score_opus":0.019096081774839718,"score_gpt":0.2677871437255566,"score_spread":0.2486910619507169,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3180369792","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98036355,0.015055672,0.0028604139,0.00024097529,0.0005111584,0.00020213472,0.00002790577,0.000019707311,0.00071845896],"genre_scores_gemma":[0.99550617,0.00056092406,0.0012864872,0.0012338079,0.00021565595,0.000023292134,0.0000822148,0.000052699943,0.0010387548],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9985794,0.000093661714,0.0003895598,0.00041805406,0.00020587945,0.00031346353],"domain_scores_gemma":[0.99930423,0.000018202358,0.00011485053,0.00041374675,0.000094949544,0.000053990032],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000088648296,0.00022343796,0.0002440566,0.000055328233,0.000057912202,0.000027112892,0.00022451693,0.00016573915,0.00016894021],"category_scores_gemma":[0.000011891945,0.00023880052,0.00015352636,0.00019983492,0.00011123149,0.0000071450804,0.00008374061,0.00015609396,0.000005447393],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001120338,0.00042939401,0.0005137417,0.000016693004,0.00006245264,0.000020710762,0.00017279317,0.00031271623,0.99675107,0.00015739244,0.00026710972,0.0011838917],"study_design_scores_gemma":[0.0019679847,0.00039269778,0.0029863107,0.000033351764,0.000027744049,0.00009642319,0.00040056894,0.0004437877,0.929491,0.000021934375,0.063822165,0.00031604804],"about_ca_topic_score_codex":0.000034596775,"about_ca_topic_score_gemma":0.000004749512,"teacher_disagreement_score":0.06726009,"about_ca_system_score_codex":0.000017759345,"about_ca_system_score_gemma":0.0001824269,"threshold_uncertainty_score":0.97380024},"labels":[],"label_agreement":null},{"id":"W3210974106","doi":"10.1007/s13311-021-01120-8","title":"Correction to: Reldesemtiv in Patients with Spinal Muscular Atrophy: a Phase 2 Hypothesis-Generating Study","year":2021,"lang":"en","type":"erratum","venue":"Neurotherapeutics","topic":"Neurogenetic and Muscular Disorders Research","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; London Health Sciences Centre; Western University; Alberta Children's Hospital; University of Calgary; Montreal Neurological Institute and Hospital","funders":"","keywords":"Spinal muscular atrophy; Neurology; Neurosurgery; Medicine; Physical medicine and rehabilitation; Neuroscience; Psychology; Pathology; Surgery; Disease","score_opus":0.03227463863019181,"score_gpt":0.32556369222236364,"score_spread":0.29328905359217183,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3210974106","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97902834,0.0013164587,0.00037135428,0.00044751505,0.009653743,0.006444903,0.000020388594,0.00010746537,0.0026098317],"genre_scores_gemma":[0.7972442,0.0012572204,0.0027979927,0.011863765,0.0038388104,0.0014768332,0.0007125307,0.0016779181,0.17913072],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99626315,0.00039183884,0.00048250266,0.000989621,0.0012840705,0.000588836],"domain_scores_gemma":[0.99821573,0.000055084107,0.00012859174,0.0008982726,0.00045791292,0.0002444044],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00016916462,0.00051591673,0.0007854618,0.0004648749,0.00012318675,0.00008902372,0.00021479439,0.00023086887,0.000103739265],"category_scores_gemma":[0.0002511384,0.00045369682,0.0001737181,0.0010711706,0.000056923192,0.000035702284,0.000072774565,0.001645352,0.000024914601],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.01340986,0.04230324,0.15403755,0.0014300626,0.0024371,0.004844331,0.0023739617,0.00046266435,0.006185861,0.0000037759605,0.23434836,0.53816324],"study_design_scores_gemma":[0.048704535,0.08515974,0.3612511,0.002766354,0.0018460167,0.00011517773,0.0013495659,0.0023802805,0.0008513202,0.0000059465197,0.49328515,0.002284833],"about_ca_topic_score_codex":0.000068640606,"about_ca_topic_score_gemma":0.0001986228,"teacher_disagreement_score":0.5358784,"about_ca_system_score_codex":0.00015097116,"about_ca_system_score_gemma":0.00073649175,"threshold_uncertainty_score":0.9997915},"labels":[],"label_agreement":null},{"id":"W4200084814","doi":"10.1007/s13311-021-01138-y","title":"Neurobiological Opportunities in Diabetic Polyneuropathy","year":2021,"lang":"en","type":"review","venue":"Neurotherapeutics","topic":"Pain Mechanisms and Treatments","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women and Children’s Health Research Institute; University of Alberta","funders":"Canadian Institutes of Health Research","keywords":"Medicine; Neuroscience; Polyneuropathy; Clinical trial; Schwann cell; Intensive care medicine; Diabetes mellitus; Neurology; Bioinformatics; Pathology; Psychology; Biology; Endocrinology","score_opus":0.29392474724820367,"score_gpt":0.3991596384296894,"score_spread":0.10523489118148571,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4200084814","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00007974992,0.99712926,0.000006852326,0.00011189014,0.0003262564,0.0008235113,0.000033080887,0.00007707714,0.0014123416],"genre_scores_gemma":[0.000048459697,0.9956714,0.000096941745,0.0022253012,0.00010850801,0.00011087183,0.00012407574,0.000121749326,0.0014927093],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9977353,0.00054428267,0.0005561645,0.0005500279,0.00020241561,0.0004118063],"domain_scores_gemma":[0.99888015,0.00023564794,0.00014853395,0.000551983,0.000033734203,0.00014998224],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0001253072,0.0005030514,0.0019476131,0.0002397,0.000036937225,0.00003219225,0.00015477266,0.00033455936,0.0001598888],"category_scores_gemma":[0.000048771453,0.00037319178,0.0004923889,0.00030205026,0.000064277825,0.000020822954,0.000053678214,0.0006740889,0.0000558222],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000060315815,0.00041762667,0.00004871393,0.002604261,0.00010757364,0.0051941937,0.0000148364825,8.2645336e-8,0.000009319371,0.0004032039,0.0000401033,0.9911541],"study_design_scores_gemma":[0.00044721962,0.0004223145,0.00003860121,0.0041182,0.0007795853,0.0005778524,0.000009145604,0.0000055619125,0.00000531005,0.000028351687,0.9933207,0.00024716827],"about_ca_topic_score_codex":0.0000022043937,"about_ca_topic_score_gemma":7.6273744e-7,"teacher_disagreement_score":0.9932806,"about_ca_system_score_codex":0.00006563844,"about_ca_system_score_gemma":0.0003293743,"threshold_uncertainty_score":0.999872},"labels":[],"label_agreement":null},{"id":"W4206431800","doi":"10.1007/s13311-021-01061-2","title":"Correction to: The Novel Small Molecule TRVA242 Stabilizes Neuromuscular Junction Defects in Multiple Animal Models of Amyotrophic Lateral Sclerosis","year":2021,"lang":"en","type":"erratum","venue":"Neurotherapeutics","topic":"Amyotrophic Lateral Sclerosis Research","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Treventis (Canada); Montreal Neurological Institute and Hospital; University of Toronto; St. Michael's Hospital; Université de Montréal; McGill University; Centre Hospitalier de l’Université de Montréal","funders":"","keywords":"Amyotrophic lateral sclerosis; Neurology; Neurosurgery; Neuroscience; Physical medicine and rehabilitation; Medicine; Psychology; Pathology; Surgery","score_opus":0.09503255745242717,"score_gpt":0.28231830757184695,"score_spread":0.18728575011941978,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4206431800","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9757842,0.0013141357,0.0013670665,0.002341588,0.014530765,0.003211896,0.00007389696,0.00014644365,0.0012300005],"genre_scores_gemma":[0.9818298,0.0023926997,0.00030726762,0.0028396759,0.0010408625,0.0002770383,0.00021147564,0.00036130377,0.010739856],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9955597,0.00049047463,0.00088008627,0.0010573361,0.0011906673,0.0008217367],"domain_scores_gemma":[0.99749297,0.0002588473,0.00027881507,0.0011983962,0.0005271608,0.000243795],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.00035531417,0.0006453973,0.0010407106,0.0004599382,0.00015205228,0.00010657809,0.0004693951,0.00059793296,0.00008914418],"category_scores_gemma":[0.0003523058,0.0005099223,0.0004940956,0.0012812769,0.00018283335,0.00011660052,0.00021339396,0.002532406,0.00001789471],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0023876706,0.0017919149,0.0034696057,0.0009068188,0.0003950029,0.00013568538,0.0011445906,0.011637578,0.9418305,0.00003571194,0.031780597,0.0044842944],"study_design_scores_gemma":[0.008678654,0.006872056,0.54517496,0.003923253,0.00092148036,0.0001942173,0.00015665837,0.35685983,0.01968619,0.000051285893,0.05582487,0.0016565076],"about_ca_topic_score_codex":0.0010207543,"about_ca_topic_score_gemma":0.0012058375,"teacher_disagreement_score":0.92214435,"about_ca_system_score_codex":0.0003342827,"about_ca_system_score_gemma":0.00056198577,"threshold_uncertainty_score":0.9997688},"labels":[],"label_agreement":null},{"id":"W4211170575","doi":"10.1007/bf03207044","title":"Therapeutic approaches and advances in pediatric stroke","year":2006,"lang":"en","type":"article","venue":"Neurotherapeutics","topic":"Blood Coagulation and Thrombosis Mechanisms","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"Fondation pour la Recherche Médicale; American Academy of Neurology","keywords":"Medicine; Intensive care medicine; Stroke (engine); Psychological intervention; Neurology; Disease; Clinical trial; Randomized controlled trial; Neurosurgery; Pediatric stroke; Neuroprotection; Ischemic stroke; Surgery; Pathology; Psychiatry; Ischemia; Internal medicine","score_opus":0.043309910320229315,"score_gpt":0.2720035971117422,"score_spread":0.2286936867915129,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4211170575","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95727795,0.016675767,0.0019716306,0.0018407282,0.00023340518,0.00078522495,0.000004963183,0.00017240335,0.021037942],"genre_scores_gemma":[0.9963669,0.0012805914,0.00058258185,0.0012081839,0.00014580476,0.000015464195,0.000003144908,0.00002771162,0.0003696138],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9992045,0.00003906067,0.00018926777,0.00021639856,0.00016783508,0.00018291944],"domain_scores_gemma":[0.9996997,0.000041879368,0.000045920944,0.00015400998,0.000016247204,0.00004225498],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0000771913,0.00012734541,0.00018917315,0.00013895554,0.0000342592,0.000018706383,0.000042146337,0.00007276734,0.000023377585],"category_scores_gemma":[0.0000028204697,0.00011252408,0.00003592552,0.0001910043,0.000034802077,0.000080170015,0.000008855196,0.00014839995,0.0000072855632],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016480061,0.0009775994,0.79689556,0.00023891202,0.000030865285,0.00002718446,0.00023119757,0.000111942245,0.01701276,0.06530388,0.000021304126,0.11898397],"study_design_scores_gemma":[0.0042802454,0.00057844893,0.9495435,0.000020919713,0.00022918092,0.00007182196,0.0001046612,0.0039191847,0.008153429,0.00940166,0.02334106,0.00035589645],"about_ca_topic_score_codex":0.0000045176985,"about_ca_topic_score_gemma":0.00002149475,"teacher_disagreement_score":0.1526479,"about_ca_system_score_codex":0.000011268111,"about_ca_system_score_gemma":0.000023038985,"threshold_uncertainty_score":0.4588599},"labels":[],"label_agreement":null},{"id":"W4213174645","doi":"10.1007/s13311-022-01197-9","title":"CRISPR-Cas9 Gene Therapy for Duchenne Muscular Dystrophy","year":2022,"lang":"en","type":"review","venue":"Neurotherapeutics","topic":"CRISPR and Genetic Engineering","field":"Biochemistry, Genetics and Molecular Biology","cited_by":63,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"Fonds de Recherche du Québec - Santé; Canadian Institutes of Health Research","keywords":"CRISPR; Genome editing; Duchenne muscular dystrophy; Cas9; Dystrophin; Computational biology; Genetic enhancement; Biology; Guide RNA; Muscular dystrophy; Gene; Genetics; Bioinformatics; Medicine","score_opus":0.063210282270666,"score_gpt":0.387382244489429,"score_spread":0.324171962218763,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4213174645","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00006308234,0.98658967,0.010639257,0.00001932624,0.0007847082,0.0015346295,0.00021906238,0.000042561955,0.000107708474],"genre_scores_gemma":[0.000027036775,0.9951532,0.0012744544,0.0004502774,0.00089171214,0.0008119252,0.00058658567,0.00029647836,0.00050835434],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99799335,0.00012057623,0.0004624134,0.0007519572,0.00020300872,0.00046869804],"domain_scores_gemma":[0.99871564,0.00005548986,0.0001651153,0.0009127323,0.00004781436,0.00010321496],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00016645099,0.0005812788,0.000809739,0.00010909039,0.00014992828,0.000049249953,0.0005506465,0.00034685998,0.000105839754],"category_scores_gemma":[0.000027218417,0.0005489221,0.000892351,0.00017121181,0.00004416016,0.0000017677652,0.000092874056,0.00031694,0.0000074372497],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000358277,0.00010043741,8.2822163e-7,0.0016117969,0.00046159243,0.000008906895,0.000018223023,0.00009257326,0.0048953756,0.00002643087,0.00073728955,0.9920107],"study_design_scores_gemma":[0.0005045741,0.00060774863,9.852617e-7,0.000068901776,0.00028286243,0.00006776605,0.0000049461582,0.000021773767,0.0022270093,0.0000107804,0.99566805,0.0005345851],"about_ca_topic_score_codex":0.0000024749681,"about_ca_topic_score_gemma":9.431155e-7,"teacher_disagreement_score":0.9949308,"about_ca_system_score_codex":0.000030658102,"about_ca_system_score_gemma":0.00016931909,"threshold_uncertainty_score":0.99969625},"labels":[],"label_agreement":null},{"id":"W4220815101","doi":"10.1007/s13311-022-01215-w","title":"Pharmacological Rescue with SR8278, a Circadian Nuclear Receptor REV-ERBα Antagonist as a Therapy for Mood Disorders in Parkinson's Disease","year":2022,"lang":"en","type":"article","venue":"Neurotherapeutics","topic":"Circadian rhythm and melatonin","field":"Neuroscience","cited_by":23,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"Ministry of Science and ICT, South Korea; Daegu Gyeongbuk Institute of Science and Technology; Ministry of Education; Ministry of Science, ICT and Future Planning; National Research Foundation of Korea; Korea Brain Research Institute; National Science Foundation","keywords":"Neurology; Medicine; Disease; Neuroscience; Parkinson's disease; Mood disorders; Circadian rhythm; Mood; Antagonist; Psychology; Psychiatry; Receptor; Internal medicine","score_opus":0.029502168256921403,"score_gpt":0.28174545232239256,"score_spread":0.25224328406547114,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4220815101","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98653436,0.0003280725,0.00002979023,0.008154318,0.00050879444,0.0024697108,0.00022122775,0.00019921933,0.0015544969],"genre_scores_gemma":[0.9822461,0.0012560615,0.00010017144,0.014904234,0.00012589806,0.00076461956,0.000008579911,0.00013515468,0.00045916956],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.99728787,0.0004152635,0.00029100085,0.0008777294,0.00043858265,0.00068953226],"domain_scores_gemma":[0.9989098,0.0002538202,0.00010338957,0.00039624498,0.000018575654,0.00031820184],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00019835163,0.00031436718,0.0002819947,0.000178435,0.00062178663,0.00009973753,0.00049171527,0.000067224275,0.0006192727],"category_scores_gemma":[0.00006528659,0.0002945736,0.0001491367,0.0006180962,0.00023682165,0.00013078358,0.00006059109,0.0005861108,0.0000364141],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.03210001,0.007237615,0.056645475,0.00016970713,0.00014483124,0.0006542312,0.008225272,0.0034166435,0.74579525,0.058404684,0.003123231,0.08408305],"study_design_scores_gemma":[0.0048894496,0.0015878762,0.008786417,0.0000108941285,0.00002750404,0.000046301626,0.00017794175,0.0015392915,0.011674795,0.00042863365,0.97034204,0.00048882654],"about_ca_topic_score_codex":0.000019994337,"about_ca_topic_score_gemma":0.000027056622,"teacher_disagreement_score":0.9672188,"about_ca_system_score_codex":0.00012675876,"about_ca_system_score_gemma":0.00021447105,"threshold_uncertainty_score":0.99995065},"labels":[],"label_agreement":null},{"id":"W4220947349","doi":"10.1007/s13311-021-01174-8","title":"Association Between Hippocampal Subfields and Clinical Symptoms of First-Episode and Drug Naive Schizophrenia Patients During 12 Weeks of Risperidone Treatment","year":2022,"lang":"en","type":"article","venue":"Neurotherapeutics","topic":"Schizophrenia research and treatment","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"Wu Jieping Medical Foundation","keywords":"Risperidone; Psychopathology; Schizophrenia (object-oriented programming); Drug-naïve; Hippocampal formation; Positive and Negative Syndrome Scale; Internal medicine; Medicine; Psychiatry; Neurology; Psychology; Psychosis; Drug","score_opus":0.02364161653858231,"score_gpt":0.29858694905776506,"score_spread":0.27494533251918274,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4220947349","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99785656,0.0004387561,0.000002752341,0.00080368394,0.0000861199,0.0006279113,0.00012498334,0.000020137311,0.000039071212],"genre_scores_gemma":[0.99847966,0.0009300226,0.00021166791,0.00005901298,0.000078866695,0.00004046025,0.000029850817,0.000026942966,0.0001434834],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983698,0.00020246826,0.0004416375,0.00028166597,0.00047323195,0.00023121155],"domain_scores_gemma":[0.99887246,0.0004336964,0.00023359028,0.00022901168,0.000076134485,0.00015509453],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018541467,0.00016700602,0.00046900864,0.00011380184,0.00014517472,0.000009568393,0.00006381305,0.000075751435,0.000054835462],"category_scores_gemma":[0.000058085483,0.00014525565,0.00011531743,0.0001186333,0.00008653813,0.000035980655,0.00007692666,0.00026228643,0.0000011135809],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0037929243,0.00069716846,0.9724645,0.000052881634,0.0007057015,0.000008911856,0.00026041313,0.0000019158517,0.00006266668,0.0000166033,0.000017529444,0.021918809],"study_design_scores_gemma":[0.014592999,0.0044287443,0.97803885,0.00002329424,0.00046219633,0.000005318734,0.000046286215,0.00009861694,0.0017227256,0.00007302529,0.0004121388,0.00009579555],"about_ca_topic_score_codex":0.0001365249,"about_ca_topic_score_gemma":0.00013432777,"teacher_disagreement_score":0.021823013,"about_ca_system_score_codex":0.00016129101,"about_ca_system_score_gemma":0.000053296713,"threshold_uncertainty_score":0.59233534},"labels":[],"label_agreement":null},{"id":"W4225279602","doi":"10.1007/s13311-022-01234-7","title":"Correction to: Pharmacological Rescue With SR8278, A Circadian Nuclear Receptor REV-ERBα Antagonist As A Therapy for Mood Disorders In Parkinson's Disease","year":2022,"lang":"en","type":"erratum","venue":"Neurotherapeutics","topic":"Coenzyme Q10 studies and effects","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Neurology; Medicine; Disease; Neuroscience; Antagonist; Mood; Circadian rhythm; Mood disorders; Neurosurgery; Psychiatry; Psychology; Receptor; Internal medicine","score_opus":0.011477778608640668,"score_gpt":0.27279905226152656,"score_spread":0.2613212736528859,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4225279602","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.60264176,0.03490967,0.00071503926,0.055287473,0.2249708,0.045138966,0.0038734546,0.00091237033,0.031550482],"genre_scores_gemma":[0.68751574,0.116483375,0.00048490282,0.046826195,0.010149818,0.007937993,0.003893007,0.0015507521,0.12515822],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.997568,0.00023456546,0.00028337233,0.0010253651,0.0002840854,0.00060462154],"domain_scores_gemma":[0.9990329,0.000059419945,0.00012784457,0.0004732177,0.00006433993,0.00024228694],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00016234684,0.00051991764,0.00042909678,0.00012050724,0.00037046333,0.000074947595,0.00040872802,0.00026814398,0.00017408442],"category_scores_gemma":[0.00008463022,0.0004801074,0.00024212686,0.00028700917,0.00010806588,0.000004511898,0.00012421644,0.00073428755,0.000009952359],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006839916,0.00047702267,0.0006514477,0.00007473168,0.00022606431,0.000011808201,0.00017885896,0.00016311652,0.010674441,0.000010454986,0.9747652,0.0059269825],"study_design_scores_gemma":[0.0019016758,0.0049963123,0.0019211005,0.000051171257,0.000077619115,0.000007007774,0.00010040199,0.00024254604,0.00045261328,0.000009021542,0.9896541,0.00058643],"about_ca_topic_score_codex":0.000100888254,"about_ca_topic_score_gemma":0.0009443586,"teacher_disagreement_score":0.21482098,"about_ca_system_score_codex":0.00010328975,"about_ca_system_score_gemma":0.0002962257,"threshold_uncertainty_score":0.99976504},"labels":[],"label_agreement":null},{"id":"W4229675824","doi":"10.1007/s13311-010-0001-5","title":"Fourth Annual Huntington Disease Clinical Research Symposium","year":2011,"lang":"en","type":"article","venue":"Neurotherapeutics","topic":"Genetic Neurodegenerative Diseases","field":"Neuroscience","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Huntington's disease; Neurology; Disease; Neurosurgery; Medicine; Psychiatry; Pathology","score_opus":0.2847253266958408,"score_gpt":0.4151798675026445,"score_spread":0.13045454080680374,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4229675824","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9867179,0.000037778507,0.00020167795,0.0007713689,0.00095234165,0.00067048415,0.0000874129,0.00020832858,0.010352733],"genre_scores_gemma":[0.99125975,0.0002576036,0.00030440826,0.00646827,0.00035769222,0.0000578067,0.0000015214781,0.00010130506,0.0011916241],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99490947,0.0018904532,0.00049905974,0.0010557149,0.00087702146,0.0007682622],"domain_scores_gemma":[0.9975885,0.00054690544,0.00011128708,0.0009691981,0.00023411661,0.0005499802],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00058103644,0.00026908325,0.00023298767,0.00018890642,0.00035800334,0.00008461897,0.0008128359,0.00008581635,0.0002499386],"category_scores_gemma":[0.0009216809,0.00025421372,0.000184671,0.00053324754,0.0007209093,0.00016426863,0.00018225884,0.000625011,0.00051422254],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018107495,0.0051368917,0.21416135,0.00010854471,0.000031594525,0.00041734427,0.0030405323,0.00010154429,0.7262795,0.025447689,0.0051986943,0.018265594],"study_design_scores_gemma":[0.0011344448,0.0011075215,0.13170037,0.000024248948,0.000065997345,0.000007760112,0.00011502563,0.00081126916,0.8077878,0.0027891328,0.05385549,0.0006009989],"about_ca_topic_score_codex":0.0000071222958,"about_ca_topic_score_gemma":0.000003307431,"teacher_disagreement_score":0.08246099,"about_ca_system_score_codex":0.000018752049,"about_ca_system_score_gemma":0.0002203492,"threshold_uncertainty_score":0.999991},"labels":[],"label_agreement":null},{"id":"W4231438074","doi":"10.1007/bf03215660","title":"Third Annual Huntington Disease Clinical Research Symposium","year":2010,"lang":"en","type":"article","venue":"Neurotherapeutics","topic":"Genetic Neurodegenerative Diseases","field":"Neuroscience","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre for Movement Disorders; University of British Columbia; University of Alberta","funders":"Istituto Auxologico Italiano; Leids Universitair Medisch Centrum; Institut National de la Santé et de la Recherche Médicale; Universiteit van Amsterdam; Universiteit Leiden; Assistance publique-Hôpitaux de Paris; University College London; University of Alberta","keywords":"Huntington's disease; Neurology; Disease; Neurosurgery; Medicine; Neuroscience; Psychology; Psychiatry; Pathology","score_opus":0.12608310812164425,"score_gpt":0.42090611751617796,"score_spread":0.2948230093945337,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4231438074","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9890219,0.000016033191,0.00004039848,0.003426038,0.0020876103,0.0006123918,0.0000955551,0.00021217075,0.0044879257],"genre_scores_gemma":[0.988812,0.00012807696,0.00015641881,0.008555034,0.00082272035,0.000055508008,0.0000022517213,0.00009385991,0.0013741067],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.995289,0.0013055697,0.00049712724,0.0011111329,0.0010338376,0.00076329283],"domain_scores_gemma":[0.99680173,0.0010642372,0.00010635497,0.0011609268,0.0002721488,0.00059460546],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00077006704,0.00025909155,0.0002336635,0.00017996742,0.00045927044,0.00019040162,0.0008980239,0.00012762095,0.00013536702],"category_scores_gemma":[0.00200406,0.0002539093,0.00018669298,0.0005394849,0.000918201,0.00016120344,0.00018914498,0.0014845282,0.0005433395],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001472035,0.0005854576,0.027806092,0.000015332755,0.0000031453847,0.00003649499,0.0001284595,0.0000236497,0.9617483,0.004579022,0.0016206377,0.0033062273],"study_design_scores_gemma":[0.00083359424,0.00041814338,0.09441361,0.000010218378,0.0000354981,0.000007883272,0.000034508852,0.00082855683,0.74523824,0.0015863138,0.15615143,0.00044198544],"about_ca_topic_score_codex":0.000003860152,"about_ca_topic_score_gemma":0.000009523215,"teacher_disagreement_score":0.21651003,"about_ca_system_score_codex":0.00001069473,"about_ca_system_score_gemma":0.0002859763,"threshold_uncertainty_score":0.9999913},"labels":[],"label_agreement":null},{"id":"W4244055264","doi":"10.1007/s13311-018-0641-4","title":"Abstracts of 20th Annual ASENT Meeting","year":2018,"lang":"en","type":"article","venue":"Neurotherapeutics","topic":"Alzheimer's disease research and treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Caprion (Canada)","funders":"","keywords":"Neurology; Library science; Computer science; Psychology; Neuroscience","score_opus":0.04529544985838818,"score_gpt":0.34859733264447634,"score_spread":0.30330188278608816,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4244055264","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9779828,0.0010473661,0.0000145294325,0.00049642584,0.000099104785,0.00036873104,0.000047740556,0.00005027096,0.019893013],"genre_scores_gemma":[0.9985399,0.00008487038,0.0003363788,0.00069035083,0.00019643112,0.000005656301,0.0000071129384,0.000025871439,0.000113386275],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989855,0.00003276804,0.00018910272,0.00016085374,0.0003405815,0.00029114963],"domain_scores_gemma":[0.9992239,0.000050151928,0.00006497686,0.0002454485,0.0001933833,0.00022214721],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000091077396,0.00010257915,0.00015669323,0.000062465595,0.000049768438,0.000006873841,0.000060003047,0.000042681047,0.00014730393],"category_scores_gemma":[0.00003283722,0.00008296964,0.000068448826,0.0001171361,0.0001552396,0.000037845082,0.000015456415,0.00009442149,0.0001292044],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008308045,0.013374669,0.6605204,0.0009114434,0.029965706,0.002175475,0.004465937,0.00003180046,0.08000158,0.0012085158,0.01081889,0.18821755],"study_design_scores_gemma":[0.008109444,0.0074635027,0.6197466,0.0003176674,0.0013895709,0.00016771154,0.00043544965,0.00053299696,0.3157801,0.0004279065,0.045193363,0.00043565242],"about_ca_topic_score_codex":0.00002897083,"about_ca_topic_score_gemma":0.0000047667127,"teacher_disagreement_score":0.23577853,"about_ca_system_score_codex":0.00002017538,"about_ca_system_score_gemma":0.00014158101,"threshold_uncertainty_score":0.33834037},"labels":[],"label_agreement":null},{"id":"W4250206073","doi":"10.1007/bf03206630","title":"The repair of complex neuronal circuitry by transplanted and endogenous precursors","year":2004,"lang":"en","type":"article","venue":"Neurotherapeutics","topic":"Neurogenesis and neuroplasticity mechanisms","field":"Neuroscience","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Leopold Schepp Foundation; Heart and Stroke Foundation of Canada; ALS Association; Alzheimer's Association; National Institutes of Health; National Science Foundation","keywords":"Neurogenesis; Neuroscience; Transplantation; Biology; Endogeny; Neural stem cell; Neuroplasticity; Mammalian brain; Stem cell; Medicine; Cell biology; Internal medicine","score_opus":0.07341754499152064,"score_gpt":0.2523337632319542,"score_spread":0.17891621824043358,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4250206073","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9972976,0.00013318352,0.0005622057,0.0002603858,0.00029722875,0.00045505934,0.0001290515,0.00018539953,0.00067987654],"genre_scores_gemma":[0.99561846,0.0012903439,0.000031269148,0.0029112333,0.000027762711,0.000013554004,0.0000013031465,0.00005958374,0.000046510253],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99811846,0.00023512602,0.00035460416,0.00048529622,0.00041407347,0.00039242575],"domain_scores_gemma":[0.9987235,0.00064334756,0.0001372055,0.00035645746,0.00002901559,0.00011044021],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009621896,0.00023908025,0.00021743917,0.000048115235,0.00036830123,0.00004743605,0.00034835123,0.000058871017,0.0000117609425],"category_scores_gemma":[0.000073392686,0.00018636759,0.00011221179,0.00022704742,0.0003562192,0.000063181775,0.000031949116,0.00022941896,0.000006690622],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008425016,0.00014472805,0.00008940779,0.000027373488,0.00000786087,0.00003657913,0.0001187146,0.000045843273,0.99408317,0.004598254,0.000018252582,0.0007455566],"study_design_scores_gemma":[0.00079704495,0.0005854739,0.0007642536,0.000012451426,0.000034218814,0.0003222324,0.000012120821,0.00023484626,0.9881648,0.0002963235,0.008614235,0.00016202655],"about_ca_topic_score_codex":0.0000054030243,"about_ca_topic_score_gemma":0.0000036503304,"teacher_disagreement_score":0.008595982,"about_ca_system_score_codex":0.000010537452,"about_ca_system_score_gemma":0.00004708801,"threshold_uncertainty_score":0.7599849},"labels":[],"label_agreement":null},{"id":"W4250358116","doi":"10.1007/s13311-016-0482-y","title":"Abstracts from HSG 2016: Discovering Our Future, the 23rd Annual Meeting of the Huntington Study Group (HSG)","year":2017,"lang":"en","type":"article","venue":"Neurotherapeutics","topic":"Advances in Oncology and Radiotherapy","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Centre for Movement Disorders","funders":"University of Rochester; Massachusetts General Hospital","keywords":"Huntington's disease; Group (periodic table); Neurology; Neurosurgery; Psychology; Medicine; Neuroscience; Internal medicine; Psychiatry; Physics","score_opus":0.022507649910625798,"score_gpt":0.3554737760079409,"score_spread":0.3329661260973151,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4250358116","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98793924,0.0006629447,0.00010231599,0.005213238,0.0029900488,0.0008266902,0.000023633998,0.00003874619,0.002203163],"genre_scores_gemma":[0.99405736,0.00039048158,0.00041298894,0.002283718,0.002231611,0.000015559266,0.0000013311569,0.00005177472,0.0005551605],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985719,0.00014465032,0.00037332642,0.00029755651,0.00033758886,0.00027498286],"domain_scores_gemma":[0.99795634,0.00018481052,0.0005369436,0.0012132247,0.00006153863,0.000047166122],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00035697332,0.00021382702,0.00033674142,0.00002611737,0.0007148702,0.000045777437,0.00070193893,0.00012610099,0.000012379724],"category_scores_gemma":[0.00010491611,0.00011476335,0.00013929575,0.000062871484,0.00019705725,0.00015785386,0.00010038633,0.0005773034,0.0000057554453],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012110304,0.0019546517,0.8358843,0.000071644106,0.0009369917,0.00007074033,0.012895429,0.00031623707,0.03222194,0.0003285332,0.0012303471,0.1128782],"study_design_scores_gemma":[0.002493754,0.0006527945,0.9183433,0.000107182015,0.00022826587,0.000017359896,0.005978273,0.00008340537,0.004378473,0.00024332994,0.067294456,0.00017942738],"about_ca_topic_score_codex":0.00015547547,"about_ca_topic_score_gemma":0.00019103628,"teacher_disagreement_score":0.11269878,"about_ca_system_score_codex":0.000032796932,"about_ca_system_score_gemma":0.000066360066,"threshold_uncertainty_score":0.5498276},"labels":[],"label_agreement":null},{"id":"W4250822096","doi":"10.1007/s13311-011-0083-8","title":"Fifth Annual Huntington Disease Clinical Research Symposium","year":2012,"lang":"en","type":"article","venue":"Neurotherapeutics","topic":"Biomedical Ethics and Regulation","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University of British Columbia","funders":"National Institutes of Health","keywords":"Accreditation; Continuing medical education; Medicine; Continuing education; Medical education; Family medicine; Neurology; Medical school; Psychiatry","score_opus":0.19232679859675278,"score_gpt":0.48294146285210454,"score_spread":0.29061466425535176,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4250822096","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.88161415,0.0012560119,0.0005039317,0.106174216,0.0023636585,0.0010003826,0.000027614762,0.00020739573,0.006852636],"genre_scores_gemma":[0.9900089,0.0004313517,0.00024428323,0.0059030103,0.0018286302,0.000009020655,0.000014323305,0.000037757563,0.0015227475],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.9980068,0.00028717605,0.0003076122,0.00021542906,0.00072856067,0.00045442494],"domain_scores_gemma":[0.99855214,0.00021995431,0.00004629901,0.00035501094,0.00021815005,0.0006084424],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016517695,0.0001005579,0.00017089998,0.00010003142,0.0001295109,0.000017645723,0.000093047434,0.000226017,0.00011222778],"category_scores_gemma":[0.00012111162,0.000076893564,0.00010635581,0.0002710734,0.0007634829,0.00007355885,0.00004269272,0.0008791502,0.00011439587],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015664009,0.004688633,0.7305114,0.00053443556,0.00015509511,0.000039125393,0.0038499373,0.0000036048139,0.012111562,0.030455021,0.00924745,0.20683733],"study_design_scores_gemma":[0.0007536232,0.0003035612,0.37395808,0.00004401668,0.000060903345,0.0000052775613,0.000053963216,0.00040810113,0.00019623883,0.00047902123,0.6236446,0.000092637216],"about_ca_topic_score_codex":0.0000047560266,"about_ca_topic_score_gemma":6.8189865e-7,"teacher_disagreement_score":0.6143971,"about_ca_system_score_codex":0.000023655371,"about_ca_system_score_gemma":0.00016475911,"threshold_uncertainty_score":0.3819519},"labels":[],"label_agreement":null},{"id":"W4253972953","doi":"10.1007/bf03207047","title":"New generation anticonvulsants for the treatment of epilepsy in children","year":2006,"lang":"en","type":"article","venue":"Neurotherapeutics","topic":"Epilepsy research and treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"Children's Hospital Foundation","keywords":"Tolerability; Medicine; Epilepsy; Dosing; Anticonvulsant; Pharmacokinetics; Adverse effect; Drug; Food and drug administration; Intensive care medicine; Neurology; Pharmacology; Psychiatry","score_opus":0.04757973367630625,"score_gpt":0.3293984351739187,"score_spread":0.28181870149761246,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4253972953","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99364257,0.0017242174,0.0013189916,0.0012659237,0.00005999773,0.0017463313,0.00001844789,0.000014235868,0.00020929684],"genre_scores_gemma":[0.99659693,0.0010869105,0.0009483401,0.00018177163,0.000314045,0.000064946325,0.00003596226,0.000020246474,0.0007508698],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99934506,0.00002405856,0.00017987248,0.00013706874,0.00013736282,0.00017659755],"domain_scores_gemma":[0.9995735,0.000090369394,0.00003805186,0.00022581502,0.000032159092,0.00004010011],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000041378607,0.00009773688,0.0001671999,0.000058279562,0.000035888617,0.00000922121,0.000043462478,0.00003564802,0.000029478431],"category_scores_gemma":[0.000004736333,0.00005887823,0.00008141642,0.00010351127,0.000027893,0.000017382607,0.000002222759,0.000036805242,0.000004553963],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021716784,0.000983239,0.8832185,0.0000074965515,0.0001131314,0.000004946092,0.00007561276,0.000059266233,0.014973238,0.0004671465,0.00031674505,0.09956346],"study_design_scores_gemma":[0.006451304,0.0030262503,0.91588426,0.000010163391,0.00013132072,0.000019864168,0.000006830233,0.002251429,0.06371678,0.00017876821,0.008257018,0.00006600049],"about_ca_topic_score_codex":0.00034842617,"about_ca_topic_score_gemma":0.00012084639,"teacher_disagreement_score":0.09949746,"about_ca_system_score_codex":0.000043922864,"about_ca_system_score_gemma":0.00008103446,"threshold_uncertainty_score":0.24009846},"labels":[],"label_agreement":null},{"id":"W4280527187","doi":"10.1007/s13311-022-01223-w","title":"Anti-complement Agents for Autoimmune Neurological Disease","year":2022,"lang":"en","type":"review","venue":"Neurotherapeutics","topic":"Myasthenia Gravis and Thymoma","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Immunology; Medicine; Neuromyelitis optica; Complement system; Disease; Autoantibody; Pathogenesis; Complement (music); Myasthenia gravis; Neurology; Autoimmune disease; Eculizumab; Immune system; Multiple sclerosis; Antibody; Biology; Internal medicine; Genetics","score_opus":0.2387985175770638,"score_gpt":0.415080907067691,"score_spread":0.17628238949062722,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4280527187","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00004096691,0.9937637,0.00007441858,0.0004444297,0.00072597037,0.004110643,0.00038431457,0.00014405287,0.00031154207],"genre_scores_gemma":[0.000019724572,0.9920418,0.00016064645,0.0044148043,0.00028035205,0.0008725338,0.00057770073,0.00019728285,0.0014351442],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99744195,0.00022247406,0.0007154612,0.00067209767,0.00045215097,0.0004958821],"domain_scores_gemma":[0.9983427,0.00024596756,0.0002815112,0.0008469259,0.000031392476,0.00025150683],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00018853981,0.0005325765,0.0017691904,0.00016399563,0.00020537946,0.000038951825,0.00037082017,0.00013449007,0.002339867],"category_scores_gemma":[0.000046155616,0.00040782164,0.0011139447,0.00023496803,0.00005916616,0.000017088765,0.000117692536,0.0005992442,0.0000468668],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010355229,0.0005194051,0.00006136678,0.0076797227,0.0002501788,0.0002754385,0.000014996094,7.0736064e-7,9.3620366e-7,0.0010181471,0.0010544338,0.9890211],"study_design_scores_gemma":[0.00087143114,0.000814548,0.00046250428,0.0005002327,0.002300256,0.000105414845,0.000001545586,0.00013001075,9.992031e-8,0.00007303994,0.9944383,0.00030264034],"about_ca_topic_score_codex":0.0000011610582,"about_ca_topic_score_gemma":1.2070953e-7,"teacher_disagreement_score":0.9933838,"about_ca_system_score_codex":0.00005453645,"about_ca_system_score_gemma":0.0002814876,"threshold_uncertainty_score":0.99983734},"labels":[],"label_agreement":null},{"id":"W4281694566","doi":"10.1007/s13311-022-01251-6","title":"Updates in IDH-Wildtype Glioblastoma","year":2022,"lang":"en","type":"review","venue":"Neurotherapeutics","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":91,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; University of Toronto; Sunnybrook Health Science Centre","funders":"","keywords":"Glioblastoma; Neurology; Medicine; Neurosurgery; Wild type; Brain tumor; Oncology; Internal medicine; Bioinformatics; Neuroscience; Cancer research; Biology; Pathology; Gene; Surgery; Genetics","score_opus":0.09257305351057138,"score_gpt":0.37100016459154844,"score_spread":0.27842711108097706,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4281694566","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000072471885,0.9964844,4.990296e-7,0.00014910837,0.00031849605,0.0012927976,0.00003544507,0.00007469612,0.0015720688],"genre_scores_gemma":[0.00005264694,0.9979028,0.000048038248,0.0010269497,0.000110351226,0.00043928862,0.000077024386,0.00014692881,0.00019595781],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9981661,0.00015573758,0.0005005612,0.0004700803,0.00032155335,0.00038597107],"domain_scores_gemma":[0.99890697,0.00023194286,0.00016573595,0.0005785157,0.000015489908,0.00010134645],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00010591743,0.0004317214,0.0014189215,0.00043111318,0.000061163715,0.000026354188,0.00018072996,0.00018363763,0.0013765038],"category_scores_gemma":[0.00002065991,0.00034282412,0.00044072335,0.00067450193,0.000035064026,0.000023252793,0.00006663583,0.0005991052,0.00020319385],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000023113196,0.00060812075,0.00018059522,0.0024587575,0.00018481897,0.0009614639,0.000028091798,5.9318114e-7,0.0000010199335,0.00013446568,0.0003929294,0.99502605],"study_design_scores_gemma":[0.00073487405,0.00060968293,0.000036131965,0.0015099496,0.0009428267,0.00037583138,0.0000068967465,0.000007170923,0.0000075983767,0.000017425376,0.99552786,0.00022374345],"about_ca_topic_score_codex":0.000011154182,"about_ca_topic_score_gemma":0.000014950905,"teacher_disagreement_score":0.99513495,"about_ca_system_score_codex":0.000215907,"about_ca_system_score_gemma":0.00022730342,"threshold_uncertainty_score":0.99990237},"labels":[],"label_agreement":null},{"id":"W4283695065","doi":"10.1007/s13311-022-01259-y","title":"Quantifying Patient Investment in Novel Neurological Drug Development","year":2022,"lang":"en","type":"article","venue":"Neurotherapeutics","topic":"Pharmaceutical Economics and Policy","field":"Economics, Econometrics and Finance","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; McGill University","funders":"Canadian Institutes of Health Research","keywords":"Medicine; Drug; Drug development; Clinical trial; Neurology; Drug trial; Neurosurgery; Intensive care medicine; Emergency medicine; Internal medicine; Pharmacology; Psychiatry","score_opus":0.1701863428192845,"score_gpt":0.2955142501117551,"score_spread":0.1253279072924706,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4283695065","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9848316,0.00060824456,0.00013239204,0.0034342995,0.0006761622,0.00035892206,0.000074491785,0.000043630094,0.00984028],"genre_scores_gemma":[0.9455669,0.000043310767,0.0006587786,0.05339094,0.000043475477,0.0001336526,0.00000707112,0.000034459485,0.00012143954],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"not_applicable","domain_scores_codex":[0.99841315,0.00003857912,0.000673129,0.0004276094,0.00005240197,0.00039515877],"domain_scores_gemma":[0.9994192,0.00006384614,0.0001813813,0.0002299869,0.000005771579,0.000099806035],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00034464552,0.00016429454,0.0002743056,0.00022189453,0.00017901436,0.000041881907,0.00028589903,0.000033877273,0.00045319513],"category_scores_gemma":[0.000014994636,0.00020331216,0.0000690201,0.00023544584,0.00003563935,0.00005986682,0.00017882141,0.0004171118,0.00013364873],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022477555,0.0030961037,0.22643495,0.000053228832,0.0001161956,0.00007904207,0.011034789,0.016620575,0.0011180392,0.7218569,0.0013292285,0.018036172],"study_design_scores_gemma":[0.0007750656,0.00010898037,0.015233625,0.000001417651,0.0000017151643,0.0000086206055,0.00003896183,0.015872015,0.00019184858,0.0037674739,0.96372783,0.00027243263],"about_ca_topic_score_codex":0.00002983945,"about_ca_topic_score_gemma":0.000020078089,"teacher_disagreement_score":0.9623986,"about_ca_system_score_codex":0.00019743382,"about_ca_system_score_gemma":0.00006109165,"threshold_uncertainty_score":0.8290829},"labels":[],"label_agreement":null},{"id":"W4295027319","doi":"10.1007/s13311-022-01290-z","title":"Lysosomal Pathogenesis of Parkinson's Disease: Insights From LRRK2 and GBA1 Rodent Models","year":2022,"lang":"en","type":"review","venue":"Neurotherapeutics","topic":"Parkinson's Disease Mechanisms and Treatments","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Weston Brain Institute","keywords":"LRRK2; Autophagy; Lysosome; Parkinson's disease; Glucocerebrosidase; Alpha-synuclein; Neuroscience; Neuropathology; Biology; Model organism; Disease; Cell biology; Medicine; Genetics; Biochemistry; Gene; Pathology; Enzyme","score_opus":0.0796837020472243,"score_gpt":0.3094343524265894,"score_spread":0.2297506503793651,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4295027319","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.002215845,0.9943232,0.00007817342,0.000024254574,0.00028655215,0.0014081511,0.0013335592,0.000076100056,0.00025419792],"genre_scores_gemma":[0.0034835911,0.9944775,0.00029136494,0.0003879897,0.00014367406,0.0003542468,0.00047989696,0.00020005042,0.00018168113],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9971464,0.0003005491,0.00063074974,0.0009040315,0.0006989472,0.00031932394],"domain_scores_gemma":[0.99799496,0.00018547064,0.00041129166,0.0009023634,0.0000429863,0.00046295096],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.000049386083,0.00067934295,0.0018924151,0.00026163057,0.00012881472,0.000030419755,0.00023352794,0.00020475913,0.0002740183],"category_scores_gemma":[0.0000131069055,0.0005557812,0.00065975304,0.00029028513,0.000078271834,0.00006679409,0.00013705163,0.00032192285,0.000011036573],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002022935,0.0009489945,0.00021799114,0.005192354,0.0012586812,0.00093550544,0.00008607128,0.0000064177398,0.000027962717,0.00042871071,0.000022238768,0.99067277],"study_design_scores_gemma":[0.0010156909,0.00025118075,0.0009680635,0.0015070001,0.007554063,0.000030872234,0.000010668542,0.00024722208,0.000009307228,0.0007180996,0.9873075,0.00038035322],"about_ca_topic_score_codex":0.00002908482,"about_ca_topic_score_gemma":0.0000032548176,"teacher_disagreement_score":0.99029243,"about_ca_system_score_codex":0.00012121052,"about_ca_system_score_gemma":0.00046087286,"threshold_uncertainty_score":0.99968934},"labels":[],"label_agreement":null},{"id":"W4297088603","doi":"10.1007/s13311-022-01281-0","title":"Effect of Admission Hyperglycemia on Safety and Efficacy of Intravenous Alteplase Before Thrombectomy in Ischemic Stroke: Post-hoc Analysis of the DIRECT-MT trial","year":2022,"lang":"en","type":"article","venue":"Neurotherapeutics","topic":"Acute Ischemic Stroke Management","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"Wu Jieping Medical Foundation","keywords":"Medicine; Post-hoc analysis; Stroke (engine); Occlusion; Neurology; Randomized controlled trial; Internal medicine; Diabetes mellitus; Anesthesia; Surgery","score_opus":0.008736826853478789,"score_gpt":0.2713180001091077,"score_spread":0.26258117325562896,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4297088603","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9950206,0.00015394097,0.0000058665305,0.0002923997,0.00012870094,0.0013261968,0.00011931095,0.000014585741,0.0029383625],"genre_scores_gemma":[0.99926424,0.00007393503,0.000036488178,0.00033278155,0.000027498278,0.00002134573,0.00002313824,0.000031503878,0.00018907926],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99806935,0.00029850478,0.0005656841,0.0003006292,0.0005747959,0.00019105499],"domain_scores_gemma":[0.99839234,0.000560456,0.00035110608,0.00059817714,0.000041174048,0.00005675718],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004192844,0.00020286793,0.0008040933,0.000336298,0.000048391074,0.0000026559705,0.00021956436,0.00006852563,0.00011640237],"category_scores_gemma":[0.00013248618,0.00014283985,0.00027307018,0.0008540865,0.00012313669,0.000016716687,0.00015474923,0.00037961354,2.649863e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.34276286,0.0019874002,0.023271887,0.0005733328,0.0032604602,0.00003578716,0.002786526,0.0016364682,0.52354723,0.00003329385,0.00035604372,0.099748716],"study_design_scores_gemma":[0.19255787,0.0775513,0.07338255,0.00034924393,0.0138882855,0.00003814071,0.000574739,0.0074889692,0.5976286,0.0000025141642,0.036005747,0.0005320694],"about_ca_topic_score_codex":0.000046985915,"about_ca_topic_score_gemma":0.000009106208,"teacher_disagreement_score":0.15020499,"about_ca_system_score_codex":0.00009287847,"about_ca_system_score_gemma":0.00008205378,"threshold_uncertainty_score":0.582484},"labels":[],"label_agreement":null},{"id":"W4308160335","doi":"10.1007/s13311-022-01317-5","title":"A Pilot Study of High-Definition Transcranial Direct Current Stimulation in Refractory Status Epilepticus: The SURESTEP Trial","year":2022,"lang":"en","type":"article","venue":"Neurotherapeutics","topic":"EEG and Brain-Computer Interfaces","field":"Neuroscience","cited_by":17,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"Natural Sciences and Engineering Research Council of Canada; Canadian Institutes of Health Research; Canada Foundation for Innovation; Manitoba Medical Service Foundation","keywords":"Transcranial direct-current stimulation; Status epilepticus; Medicine; Electroencephalography; Anesthesia; Adverse effect; Neurology; Intensive care unit; Stimulation; Clinical trial; Epilepsy; Internal medicine; Psychiatry","score_opus":0.11662460214987275,"score_gpt":0.3225064504596008,"score_spread":0.20588184830972805,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4308160335","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9961412,0.00006952643,0.000073830546,0.0001211613,0.0018056389,0.0014763466,0.00005342658,0.000056430858,0.00020243207],"genre_scores_gemma":[0.9993022,0.000042339172,0.00001008382,0.0003800543,0.00011129416,0.00010624545,0.0000030507915,0.000029005387,0.000015721494],"study_design_codex":"bench_or_experimental","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9967567,0.0015257602,0.0004660923,0.00038308903,0.0006046573,0.0002637332],"domain_scores_gemma":[0.9983262,0.0011072285,0.0001861545,0.00032305543,0.00002409788,0.000033273667],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003377404,0.00016590573,0.00023258368,0.0001476225,0.00020074725,0.00004309993,0.00034191663,0.000014634103,0.000066658075],"category_scores_gemma":[0.0000706294,0.00013222545,0.000051432544,0.00042759467,0.00006829363,0.00009595722,0.000049527793,0.0004935075,0.0000026049147],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.124052264,0.059866305,0.009396223,0.00013201417,0.00008821668,0.00010692175,0.04149122,0.07400144,0.58415973,0.0034621407,0.00030939982,0.102934144],"study_design_scores_gemma":[0.36586574,0.30088022,0.18392847,0.00016334839,0.0005141391,0.00005288953,0.0039895717,0.03382192,0.047299303,0.0057617035,0.055113643,0.0026090646],"about_ca_topic_score_codex":0.00017197659,"about_ca_topic_score_gemma":0.0001731278,"teacher_disagreement_score":0.5368604,"about_ca_system_score_codex":0.00005876786,"about_ca_system_score_gemma":0.0000765116,"threshold_uncertainty_score":0.53919977},"labels":[],"label_agreement":null},{"id":"W4362523966","doi":"10.1007/s13311-023-01367-3","title":"The Vessel Has Been Recanalized: Now What?","year":2023,"lang":"en","type":"review","venue":"Neurotherapeutics","topic":"Acute Ischemic Stroke Management","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Foothills Medical Centre; University of Calgary","funders":"","keywords":"Medicine; Thrombolysis; Excitotoxicity; Neurology; Stroke (engine); Tissue plasminogen activator; Clinical trial; Neurosurgery; Infarction; Intensive care medicine; Surgery; Pathology; Cardiology; Internal medicine; Myocardial infarction","score_opus":0.1677205324773144,"score_gpt":0.38169604358880516,"score_spread":0.21397551111149077,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4362523966","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[5.1999973e-7,0.98669267,0.000034130026,0.0038764752,0.0013700249,0.0021118608,0.000019928893,0.00027028736,0.0056241],"genre_scores_gemma":[1.197699e-7,0.953002,0.00009536401,0.002699874,0.0006835959,0.00027749996,0.000060640432,0.000310586,0.04287036],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99730706,0.00017380156,0.00075645756,0.0005769132,0.000626534,0.0005592237],"domain_scores_gemma":[0.997311,0.0006845162,0.00037597358,0.0014036725,0.00007786342,0.00014695086],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0003581416,0.000565944,0.0014370399,0.00017980553,0.00023867052,0.00036482874,0.00065234315,0.00030962264,0.00006429727],"category_scores_gemma":[0.00006958131,0.00035929825,0.00064657297,0.00065958645,0.00022005335,0.000066181994,0.00016677246,0.0008934209,0.0011562894],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000012273735,0.000026348358,0.0000012852504,0.0046612015,0.00088917185,0.000100538055,0.00002820633,9.977529e-8,0.0000010820861,0.00006387218,0.11372575,0.8804902],"study_design_scores_gemma":[0.0003352955,0.000102559876,0.0000027814094,0.006785891,0.003121968,0.00008475685,0.00004634658,0.000013788977,0.0000025722677,0.00001703301,0.98921895,0.00026806994],"about_ca_topic_score_codex":0.0000058074093,"about_ca_topic_score_gemma":0.000007790347,"teacher_disagreement_score":0.8802221,"about_ca_system_score_codex":0.00016088966,"about_ca_system_score_gemma":0.00039945872,"threshold_uncertainty_score":0.9998859},"labels":[],"label_agreement":null},{"id":"W4366603148","doi":"10.1007/s13311-023-01376-2","title":"The Promise of Niacin in Neurology","year":2023,"lang":"en","type":"review","venue":"Neurotherapeutics","topic":"Tryptophan and brain disorders","field":"Neuroscience","cited_by":64,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Brain Institute; University of Calgary","funders":"Canadian Institutes of Health Research","keywords":"Niacin; Medicine; Multiple sclerosis; Neurology; Pharmacology; Internal medicine; Immunology; Psychiatry","score_opus":0.1689015393039163,"score_gpt":0.3807627803969657,"score_spread":0.2118612410930494,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4366603148","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000095777126,0.99622786,0.0000020060668,0.00028941402,0.0006213727,0.001465934,0.000027312242,0.000108129294,0.0011621728],"genre_scores_gemma":[0.000030429603,0.9981665,0.0000026300318,0.0008349599,0.000046319343,0.00011918691,0.0000011035478,0.00011114898,0.00068771216],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99749666,0.0007199871,0.00064578553,0.00048480366,0.00024613724,0.00040662332],"domain_scores_gemma":[0.9969395,0.0020981142,0.00031418135,0.00059703423,0.000011645357,0.000039554052],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020428924,0.00030777798,0.00079866254,0.00020462678,0.00007842301,0.000033256147,0.0008672959,0.00023059946,0.000010896171],"category_scores_gemma":[0.0003473266,0.00020156814,0.00026894678,0.0009921405,0.00029418262,0.000026298747,0.00008329543,0.0006691102,0.00013214376],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000021172598,0.00006918708,0.000002716336,0.0023622615,0.0000099039735,0.000045280995,0.000059929138,0.0000020717969,0.0001224081,0.0019350852,0.0001558591,0.9952141],"study_design_scores_gemma":[0.00019905379,0.00010330173,0.000009534013,0.0004054762,0.000023754585,0.0000195853,0.0000030385256,0.000021842383,0.000102566795,0.00045714635,0.99850255,0.00015215407],"about_ca_topic_score_codex":0.000003985681,"about_ca_topic_score_gemma":0.000030121377,"teacher_disagreement_score":0.9983467,"about_ca_system_score_codex":0.000011698607,"about_ca_system_score_gemma":0.00016901855,"threshold_uncertainty_score":0.821971},"labels":[],"label_agreement":null},{"id":"W4379184638","doi":"10.1007/s13311-023-01393-1","title":"Axonal Transport Defect in Gigaxonin Deficiency Rescued by Tubastatin A","year":2023,"lang":"en","type":"article","venue":"Neurotherapeutics","topic":"Skin and Cellular Biology Research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"Canadian Institutes of Health Research","keywords":"Axoplasmic transport; Peripherin; HDAC6; Cell biology; Neurofilament; Biology; Organelle; Genetically modified mouse; Neuroscience; Proteasome; Transgene; Histone deacetylase; Chemistry; Histone; Biochemistry; Immunohistochemistry; Immunology","score_opus":0.02213742426014327,"score_gpt":0.29056812802633303,"score_spread":0.26843070376618977,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4379184638","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9966444,0.0007416723,0.00032541194,0.00027182643,0.00008746773,0.00024454127,0.00003936373,0.0000367481,0.0016085982],"genre_scores_gemma":[0.9966132,0.0005610953,0.000069609596,0.00056552753,0.00004877729,0.00005107866,0.00023143823,0.00003752033,0.0018217191],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99862504,0.00014711241,0.00020051298,0.00040141572,0.00017739038,0.0004485072],"domain_scores_gemma":[0.99956894,0.000030396597,0.000026950045,0.00027810712,0.000028933982,0.00006665148],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003185821,0.00014960894,0.00012849011,0.00009517354,0.000058615457,0.000010859324,0.00024363899,0.00016630176,0.000044236735],"category_scores_gemma":[0.000030188428,0.00014403647,0.000103071565,0.0003931434,0.000118644995,0.0000019108447,0.000029546332,0.00019415018,0.00006205826],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013972296,0.00009993012,0.04470616,0.000014460357,0.000018423429,0.00006857266,0.00006737133,0.000036402587,0.9484671,0.000055287186,0.0018161552,0.004510453],"study_design_scores_gemma":[0.0041145105,0.0020504552,0.074982785,0.000030003905,0.00003356979,0.00016291587,0.0002804774,0.0009076048,0.6022748,0.0003056815,0.31391385,0.0009433686],"about_ca_topic_score_codex":0.000016003278,"about_ca_topic_score_gemma":0.000051627245,"teacher_disagreement_score":0.3461923,"about_ca_system_score_codex":0.000008517368,"about_ca_system_score_gemma":0.00008275727,"threshold_uncertainty_score":0.58736366},"labels":[],"label_agreement":null},{"id":"W4386315625","doi":"10.1007/s13311-023-01428-7","title":"Neurosteroid Receptor Modulators for Treating Traumatic Brain Injury","year":2023,"lang":"en","type":"review","venue":"Neurotherapeutics","topic":"Traumatic Brain Injury and Neurovascular Disturbances","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Neurotrauma Foundation","funders":"","keywords":"Traumatic brain injury; Neuroactive steroid; Neuroscience; Neurology; Medicine; Drug development; Drug; Neurovascular bundle; Inflammation; Bioinformatics; Pharmacology; Receptor; Psychology; Internal medicine; Biology; Pathology; Psychiatry; GABAA receptor","score_opus":0.16733435868882454,"score_gpt":0.4001110816659343,"score_spread":0.23277672297710975,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386315625","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0003704907,0.98963237,0.00018835498,0.00047725654,0.0015125136,0.0063908226,0.0004035881,0.0007383606,0.000286253],"genre_scores_gemma":[0.000014682357,0.99151516,0.00059423037,0.002228639,0.00066012307,0.001001989,0.00021520241,0.0005911793,0.0031788067],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99631375,0.00034212222,0.0012996672,0.0009459146,0.00046844166,0.0006300896],"domain_scores_gemma":[0.99651456,0.001601388,0.0005402112,0.0010617103,0.000067848836,0.00021430982],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0004036223,0.00084382435,0.0026598654,0.00037758052,0.00019525812,0.00009529582,0.00038014236,0.00045777895,0.00005279817],"category_scores_gemma":[0.00037963604,0.0006878767,0.0016265637,0.0007359878,0.0001264196,0.00007657684,0.000038695274,0.0007067318,0.0001949259],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00005636416,0.00014346295,0.0000030857957,0.044469327,0.0005321622,0.00001430421,0.00015737879,5.4064503e-7,0.000039655686,0.00012283128,0.002939816,0.9515211],"study_design_scores_gemma":[0.00076488813,0.000937073,0.000013304718,0.009779226,0.0020536839,0.00010905176,0.000024328641,0.00008448267,0.000038358863,0.000065281296,0.98562217,0.0005081327],"about_ca_topic_score_codex":0.0000019014753,"about_ca_topic_score_gemma":0.0000016394055,"teacher_disagreement_score":0.98268235,"about_ca_system_score_codex":0.00008168218,"about_ca_system_score_gemma":0.00024180397,"threshold_uncertainty_score":0.99955726},"labels":[],"label_agreement":null},{"id":"W4387241943","doi":"10.1007/s13311-023-01436-7","title":"D1R-5-HT2AR Uncoupling Reduces Depressive Behaviours via HDAC Signalling","year":2023,"lang":"en","type":"article","venue":"Neurotherapeutics","topic":"Receptor Mechanisms and Signaling","field":"Biochemistry, Genetics and Molecular Biology","cited_by":12,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Centre for Addiction and Mental Health","funders":"Basic and Applied Basic Research Foundation of Guangdong Province; Sanming Project of Medicine in Shenzhen; Shenzhen-Hong Kong Institute of Brain Science; National Natural Science Foundation of China","keywords":"Dopamine; Dopamine receptor D2; CREB; Antidepressant; Medicine; Pharmacology; Neuroscience; Biology; Internal medicine; Biochemistry; Transcription factor","score_opus":0.024501476230572864,"score_gpt":0.2771207227478541,"score_spread":0.25261924651728124,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387241943","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98911005,0.0004860044,0.009103593,0.000113099886,0.0005474105,0.00022645133,0.000013172408,0.0001093675,0.00029085248],"genre_scores_gemma":[0.9968966,0.00039275072,0.0008026893,0.00062212464,0.000464671,0.000029280654,0.00008528188,0.000093304785,0.0006132649],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9986168,0.00005300638,0.0002436118,0.00045708095,0.00022633585,0.00040313104],"domain_scores_gemma":[0.9994137,0.000026917478,0.00010116702,0.0002781963,0.00008126304,0.000098711935],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018043067,0.00022124298,0.00016676656,0.00007881774,0.00018791686,0.0000595856,0.00027403995,0.0001844395,0.00007425624],"category_scores_gemma":[0.000018532373,0.00022079986,0.00013231544,0.0002143635,0.000047035654,0.000005591539,0.000068713794,0.00016854145,0.000038861694],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000027877155,0.000026053682,0.00044311298,0.0000060952393,0.00004165464,0.000013308199,0.00008242591,0.002534586,0.9890532,0.00003100238,0.00016969324,0.0075710043],"study_design_scores_gemma":[0.0003181216,0.000215791,0.00014260733,0.00001731344,0.00003726863,0.0000115327575,0.00008046029,0.0031408567,0.988565,0.000250805,0.006948549,0.00027168845],"about_ca_topic_score_codex":0.000011320207,"about_ca_topic_score_gemma":0.0000053935937,"teacher_disagreement_score":0.008300904,"about_ca_system_score_codex":0.000009599249,"about_ca_system_score_gemma":0.000046554127,"threshold_uncertainty_score":0.9003957},"labels":[],"label_agreement":null},{"id":"W4389902954","doi":"10.1016/j.neurot.2023.10.005","title":"Thalamo-cortical evoked potentials during stimulation of the dentato-rubro-thalamic tract demonstrate synaptic filtering","year":2023,"lang":"en","type":"article","venue":"Neurotherapeutics","topic":"Neurological disorders and treatments","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"Society of British Neurological Surgeons; National Institute of Neurological Disorders and Stroke; National Institutes of Health; Congress of Neurological Surgeons","keywords":"Neuroscience; Stimulation; Thalamus; Neurology; Psychology; Medicine","score_opus":0.03634472159732587,"score_gpt":0.2960762473304396,"score_spread":0.2597315257331137,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389902954","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99826926,0.000047748737,0.00004581673,0.0005729835,0.00017051889,0.0005353721,0.00000772079,0.00011425469,0.0002363159],"genre_scores_gemma":[0.99918455,0.000092782066,0.00003790444,0.00042320255,0.000027581069,0.000016674381,0.000004852885,0.000035892375,0.00017655794],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9987569,0.00010882648,0.0003132369,0.00024902332,0.00029154422,0.00028047015],"domain_scores_gemma":[0.99937534,0.00012429662,0.000097559736,0.00030597008,0.00003375042,0.000063069136],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00006726611,0.0001626477,0.00024569384,0.0000721282,0.000120101126,0.000016770224,0.000111649555,0.00008238798,0.000057791847],"category_scores_gemma":[0.000047959827,0.000110105415,0.00016901358,0.00032784103,0.000084640014,0.0000451355,0.00003726386,0.00022185381,0.000036278398],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023837553,0.0005036374,0.38560322,0.00012023189,0.00018970289,0.00025047013,0.000107014755,0.001237027,0.60928154,0.00007098609,0.0000073705637,0.0023904087],"study_design_scores_gemma":[0.0015717595,0.00029087078,0.96001863,0.000042045278,0.00022194695,0.000058708345,0.000023485645,0.005861197,0.031258382,0.0005495088,0.000013990799,0.00008946397],"about_ca_topic_score_codex":0.0000046233313,"about_ca_topic_score_gemma":0.0000017830531,"teacher_disagreement_score":0.5780232,"about_ca_system_score_codex":0.000016638394,"about_ca_system_score_gemma":0.0000250678,"threshold_uncertainty_score":0.44899684},"labels":[],"label_agreement":null},{"id":"W4389955829","doi":"10.1016/j.neurot.2023.10.008","title":"Spreading depolarization suppression from inter-astrocytic gap junction blockade assessed with multimodal imaging and a novel wavefront detection scheme","year":2023,"lang":"en","type":"article","venue":"Neurotherapeutics","topic":"Connexins and lens biology","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre; Canada Research Chairs; University of Toronto; Krembil Foundation","funders":"Canadian Institutes of Health Research; Canada Foundation for Innovation; Fondation Brain Canada","keywords":"Depolarization; Medicine; Neuroscience; Anesthesia; Internal medicine; Biology","score_opus":0.01678943739828877,"score_gpt":0.24956234727582594,"score_spread":0.23277290987753715,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389955829","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.86809975,0.000063166226,0.13121584,0.00012265058,0.00021722172,0.00017308477,0.000012535329,0.000059445872,0.00003629484],"genre_scores_gemma":[0.99804074,0.000058797916,0.0011844379,0.00026730695,0.00020499266,0.000018734292,0.00013185054,0.000040797175,0.000052362186],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9990883,0.000051270225,0.00015188757,0.00040306128,0.000084303065,0.0002211672],"domain_scores_gemma":[0.9995809,0.000026503616,0.00007616309,0.0002123154,0.00005136758,0.00005271429],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00006379608,0.00017009128,0.00011940726,0.00007985813,0.00011839629,0.00004742339,0.00007221745,0.00011812453,0.0000065252593],"category_scores_gemma":[0.00002083921,0.00014992125,0.00003364987,0.00011590292,0.000055981713,0.000010354852,0.000055303444,0.00013276577,0.0000035619876],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019756441,0.000032890035,0.024848495,0.0000068700765,0.000032751097,0.000002976508,0.00004940002,0.000062489584,0.9584458,0.000005830853,0.000007137814,0.016307788],"study_design_scores_gemma":[0.0022235687,0.00046472595,0.062074494,0.000042767384,0.00006221915,0.000055921737,0.00020587677,0.101512015,0.82450795,0.000029026989,0.008483707,0.00033773185],"about_ca_topic_score_codex":0.00009286408,"about_ca_topic_score_gemma":0.0001208763,"teacher_disagreement_score":0.13393787,"about_ca_system_score_codex":0.000016275926,"about_ca_system_score_gemma":0.000026478785,"threshold_uncertainty_score":0.61136115},"labels":[],"label_agreement":null},{"id":"W4389978758","doi":"10.1016/j.neurot.2023.10.001","title":"Development of small-molecule Tau-SH3 interaction inhibitors that prevent amyloid-β toxicity and network hyperexcitability","year":2023,"lang":"en","type":"article","venue":"Neurotherapeutics","topic":"Alzheimer's disease research and treatments","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Center for Research Resources; National Institute of Neurological Disorders and Stroke; BrightFocus Foundation; Center for Clinical and Translational Science, University of Alabama at Birmingham; National Institute on Aging; Comprehensive Cancer Center, University of Alabama at Birmingham; National Science Foundation; Weston Brain Institute; National Center for Advancing Translational Sciences; University of Alabama; National Cancer Institute; National Institutes of Health","keywords":"Amyloid (mycology); Small molecule; Neuroscience; Alzheimer's disease; Chemistry; Tau protein; SH3 domain; Pharmacology; Biochemistry of Alzheimer's disease; Dementia; Amyloid precursor protein; Cell biology; Biochemistry; Biology; Medicine; Disease; Signal transduction; Internal medicine; Proto-oncogene tyrosine-protein kinase Src","score_opus":0.07356649362867763,"score_gpt":0.33173717585643164,"score_spread":0.258170682227754,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389978758","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99797165,0.0005667238,0.000051983887,0.00025708243,0.00011316004,0.0006591474,0.000006955119,0.0000845998,0.00028867967],"genre_scores_gemma":[0.9986209,0.0002267343,0.00070739735,0.0002280906,0.00006732031,0.00004914911,0.000021734222,0.00003031722,0.000048355545],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987417,0.00008222939,0.00025669538,0.00028362777,0.00031694744,0.00031882062],"domain_scores_gemma":[0.9993194,0.000092864895,0.00007767533,0.00024481385,0.000064066044,0.00020117639],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018077513,0.00016252144,0.00024667554,0.0000814335,0.00010263732,0.000016258435,0.000057520734,0.000065307715,0.000034843266],"category_scores_gemma":[0.000021629754,0.0001384709,0.000074004056,0.00027186234,0.00008225413,0.000049397884,0.000061303384,0.00015807559,0.000025264355],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003505288,0.007064959,0.70773464,0.0014616617,0.012555045,0.0003451042,0.0048286757,0.00015962572,0.051965103,0.0001370351,0.0012770533,0.20896581],"study_design_scores_gemma":[0.0051910803,0.0013662316,0.68106717,0.00040862587,0.0007112685,0.000057094683,0.000755647,0.002697996,0.29902124,0.00033418828,0.00785931,0.0005301431],"about_ca_topic_score_codex":0.00000999102,"about_ca_topic_score_gemma":0.00002429594,"teacher_disagreement_score":0.24705616,"about_ca_system_score_codex":0.00006377141,"about_ca_system_score_gemma":0.00016061342,"threshold_uncertainty_score":0.56466794},"labels":[],"label_agreement":null},{"id":"W4390582466","doi":"10.1016/j.neurot.2023.e00308","title":"Neurostimulation treatments for epilepsy: Deep brain stimulation, responsive neurostimulation and vagus nerve stimulation","year":2024,"lang":"en","type":"article","venue":"Neurotherapeutics","topic":"Neurological disorders and treatments","field":"Medicine","cited_by":87,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Hospital for Sick Children","funders":"Canadian Institutes of Health Research; Fondation Brain Canada","keywords":"Vagus nerve stimulation; Neurostimulation; Deep brain stimulation; Epilepsy; Neuroscience; Neurology; Neuromodulation; Medicine; Epilepsy surgery; Psychology; Thalamus; Drug Resistant Epilepsy; Brain stimulation; Anesthesia; Vagus nerve; Stimulation; Parkinson's disease; Internal medicine","score_opus":0.04023982136082227,"score_gpt":0.3363173984898263,"score_spread":0.296077577129004,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4390582466","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9711378,0.001042903,0.017814405,0.005623307,0.00051466044,0.0031815039,0.00007024248,0.0004203381,0.00019481777],"genre_scores_gemma":[0.9920915,0.00009108352,0.0008308855,0.0057152486,0.00014622687,0.000110851455,0.00022161691,0.00010934379,0.000683269],"study_design_codex":"design_other","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9980628,0.00014177534,0.00042766755,0.00072863325,0.00029919096,0.00033993777],"domain_scores_gemma":[0.99808806,0.0012246725,0.000089759706,0.00030305586,0.00013329677,0.00016112994],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.000107823376,0.00035956723,0.00034382142,0.00025224872,0.00021396155,0.00013629539,0.000054822718,0.00017761294,0.000042899504],"category_scores_gemma":[0.00022436354,0.0003090724,0.00016004151,0.00036630692,0.00007393519,0.00022819084,0.000020928022,0.00019568986,0.00002179969],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0137672685,0.0025423602,0.36425224,0.0007861727,0.0012282565,0.0009650649,0.0018456319,0.085846044,0.08903912,0.006277853,0.0017150557,0.43173495],"study_design_scores_gemma":[0.0045816517,0.0033247578,0.4126434,0.00004913778,0.0006674373,0.000044439705,0.000009181035,0.56803685,0.0004243351,0.006977981,0.0029930593,0.0002477529],"about_ca_topic_score_codex":0.000006402757,"about_ca_topic_score_gemma":0.0000029586572,"teacher_disagreement_score":0.48219082,"about_ca_system_score_codex":0.000058254653,"about_ca_system_score_gemma":0.00005301728,"threshold_uncertainty_score":0.99993616},"labels":[],"label_agreement":null},{"id":"W4391708210","doi":"10.1016/j.neurot.2024.e00330","title":"Neuromodulation techniques – From non-invasive brain stimulation to deep brain stimulation","year":2024,"lang":"en","type":"review","venue":"Neurotherapeutics","topic":"Transcranial Magnetic Stimulation Studies","field":"Neuroscience","cited_by":105,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; University of Toronto","funders":"","keywords":"Neuromodulation; Vagus nerve stimulation; Transcranial direct-current stimulation; Deep brain stimulation; Brain stimulation; Neuroscience; Transcranial magnetic stimulation; Medicine; Stimulation; Neurology; Neurosurgery; Psychology; Vagus nerve; Parkinson's disease; Surgery; Internal medicine","score_opus":0.10171612732022119,"score_gpt":0.3783639368406021,"score_spread":0.2766478095203809,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4391708210","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0009596642,0.88539314,0.08343162,0.0040018638,0.00437768,0.015889952,0.0010469705,0.0032847573,0.0016143256],"genre_scores_gemma":[0.008569006,0.97231936,0.0038937896,0.010963331,0.001576304,0.00076700264,0.000219541,0.00080672844,0.00088492647],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9943523,0.0007608258,0.0014030781,0.0018949532,0.0009763657,0.0006124789],"domain_scores_gemma":[0.99327177,0.004939812,0.0004572905,0.0009939063,0.00012425074,0.00021294918],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00022817281,0.0011393612,0.0016182612,0.00089840265,0.00029201698,0.0003874959,0.0006726217,0.0005625459,0.0001271059],"category_scores_gemma":[0.0010908854,0.0010644634,0.0005859156,0.0018446135,0.00013049778,0.0002631738,0.00015472042,0.00082256895,0.0007938134],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000050238534,0.0001066425,0.0000071757677,0.0018782326,0.00006529459,0.000054424334,0.0007492314,0.002267072,0.014269038,0.00022447512,0.0007867449,0.9795414],"study_design_scores_gemma":[0.0005318716,0.0006206194,0.0003021253,0.003216235,0.0012499209,0.000023702523,0.000008408447,0.013082254,0.0006820667,0.0013370321,0.9776928,0.0012529872],"about_ca_topic_score_codex":0.000031698957,"about_ca_topic_score_gemma":0.000040496547,"teacher_disagreement_score":0.9782885,"about_ca_system_score_codex":0.0002077046,"about_ca_system_score_gemma":0.00020177993,"threshold_uncertainty_score":0.9999842},"labels":[],"label_agreement":null},{"id":"W4391811274","doi":"10.1016/j.neurot.2024.e00331","title":"Repetitive transcranial magnetic stimulation as a treatment for Alzheimer's disease: A randomized placebo-controlled double-blind clinical trial","year":2024,"lang":"en","type":"article","venue":"Neurotherapeutics","topic":"Transcranial Magnetic Stimulation Studies","field":"Neuroscience","cited_by":24,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Riverview Hospital; University of Manitoba","funders":"National Health and Medical Research Council; Medical Research Council; Weston Brain Institute","keywords":"Transcranial magnetic stimulation; Context (archaeology); Medicine; Randomized controlled trial; Neurology; Placebo; Dorsolateral prefrontal cortex; Randomization; Psychology; Stimulation; Physical medicine and rehabilitation; Physical therapy; Internal medicine; Cognition; Prefrontal cortex; Psychiatry","score_opus":0.20972227862582107,"score_gpt":0.4334726704731932,"score_spread":0.22375039184737214,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4391811274","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.83548534,0.010102666,0.02763673,0.011908571,0.012530532,0.09299763,0.00045900355,0.0021403232,0.0067392234],"genre_scores_gemma":[0.99091816,0.00071043323,0.00031155327,0.0012006075,0.0011095668,0.004279309,0.0000109355315,0.00012853331,0.0013309286],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99540716,0.0009901434,0.0013652856,0.0011652722,0.00058610336,0.00048603825],"domain_scores_gemma":[0.9883966,0.0106709935,0.00016609978,0.00042248148,0.00010670576,0.00023711605],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00072283053,0.00053249,0.0012824541,0.00023225741,0.00027527212,0.00029977612,0.00022786454,0.00017355719,0.00036315303],"category_scores_gemma":[0.0006095119,0.00041301054,0.0013018498,0.0003702028,0.00047397212,0.00015324265,0.000012561484,0.00023148752,0.000106057974],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9703793,0.0006062629,0.0000041785697,0.000023095388,0.00025501358,0.00004812337,0.0005682851,0.0003666682,0.0022682205,0.006894809,0.000018099032,0.01856794],"study_design_scores_gemma":[0.92229635,0.0044383244,0.000051585284,0.00003910452,0.0032387078,0.000007479831,0.000011194181,0.057926256,0.00040101548,0.0022506064,0.008971346,0.0003680327],"about_ca_topic_score_codex":0.000015482494,"about_ca_topic_score_gemma":0.0000074970435,"teacher_disagreement_score":0.15543282,"about_ca_system_score_codex":0.000048343816,"about_ca_system_score_gemma":0.0003154533,"threshold_uncertainty_score":0.99983215},"labels":[],"label_agreement":null},{"id":"W4393144140","doi":"10.1016/j.neurot.2024.e00351","title":"Extended interval dosing of natalizumab: More evidence in support","year":2024,"lang":"en","type":"editorial","venue":"Neurotherapeutics","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Natalizumab; Dosing; Multiple sclerosis; Medicine; Monoclonal antibody; Neurology; Immunology; Monoclonal; Pharmacology; Internal medicine; Antibody","score_opus":0.10631867683023467,"score_gpt":0.4162998796895021,"score_spread":0.30998120285926745,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4393144140","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0040551554,0.00975886,0.000031411324,0.002847493,0.9782044,0.0023038697,0.0005267267,0.00023903472,0.0020330218],"genre_scores_gemma":[0.059985556,0.03683296,0.0008007962,0.0011953553,0.89056724,0.0003132495,0.00024589873,0.00068840914,0.009370507],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9960157,0.00014123837,0.00078748446,0.00069194665,0.0018533613,0.0005102326],"domain_scores_gemma":[0.99721086,0.0013741903,0.00017499687,0.00071445305,0.00040536458,0.00012014721],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0005226588,0.00042617664,0.0010021119,0.000536297,0.00003181796,0.000052154013,0.0003961351,0.0005338539,0.00016653948],"category_scores_gemma":[0.0021526096,0.00036797163,0.00028363784,0.00048082386,0.00034814002,0.00009271186,0.00024759708,0.0020191486,0.000055392647],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008595985,0.00023612667,0.00035147803,0.0046048043,0.00031759194,0.0004819757,0.0013712446,0.0000015511357,0.008104138,0.000007798871,0.96779907,0.015864601],"study_design_scores_gemma":[0.0013766516,0.0010716853,0.0015734284,0.0054415786,0.00024325387,0.0000140257325,0.000080240374,0.00035166097,0.0023956771,0.00002127591,0.9871255,0.00030501658],"about_ca_topic_score_codex":0.00011114502,"about_ca_topic_score_gemma":0.000048507536,"teacher_disagreement_score":0.087637156,"about_ca_system_score_codex":0.00027973074,"about_ca_system_score_gemma":0.00078538473,"threshold_uncertainty_score":0.9998772},"labels":[],"label_agreement":null},{"id":"W4393927260","doi":"10.1016/j.neurot.2024.e00343","title":"High-definition transcranial direct current stimulation desynchronizes refractory status epilepticus","year":2024,"lang":"en","type":"article","venue":"Neurotherapeutics","topic":"EEG and Brain-Computer Interfaces","field":"Neuroscience","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"Natural Sciences and Engineering Research Council of Canada; Canadian Institutes of Health Research; Canada Foundation for Innovation; Manitoba Medical Service Foundation","keywords":"Electroencephalography; Status epilepticus; Transcranial direct-current stimulation; Epilepsy; Psychology; Alpha (finance); Medicine; Stimulation; Neuroscience; Anesthesia; Audiology; Surgery","score_opus":0.06014445244328697,"score_gpt":0.30897413394898077,"score_spread":0.2488296815056938,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4393927260","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97273535,0.0022856651,0.013315081,0.0005994457,0.0065385737,0.0005705698,0.00016243801,0.0011090446,0.00268385],"genre_scores_gemma":[0.9973778,0.0008683325,0.00034550347,0.00074750086,0.00046677006,0.000016310822,0.000009592453,0.00006381018,0.00010439129],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.99810034,0.00023467305,0.00031089058,0.00057162455,0.00037272018,0.00040977023],"domain_scores_gemma":[0.9989345,0.0006419778,0.00005163945,0.00024664166,0.000030311467,0.00009491507],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009672751,0.00024828335,0.00019201872,0.00015549453,0.00013646878,0.00029036863,0.00019194263,0.00007992619,0.00016706642],"category_scores_gemma":[0.00004283966,0.00021972686,0.00011210573,0.00029950612,0.0001115228,0.00030346506,0.000017391014,0.00038616455,0.00018153532],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011788234,0.00029086208,0.00009479218,0.00016177694,0.000019397154,0.00006110859,0.0011749892,0.0010085364,0.64714575,0.007880569,0.00043948658,0.34160483],"study_design_scores_gemma":[0.0017452023,0.0017054689,0.0026689977,0.00038105366,0.00015939235,0.000057102283,0.000025434567,0.058368713,0.4396295,0.0065009757,0.48777038,0.0009878039],"about_ca_topic_score_codex":0.0000109030425,"about_ca_topic_score_gemma":0.0000066020802,"teacher_disagreement_score":0.48733088,"about_ca_system_score_codex":0.000079720216,"about_ca_system_score_gemma":0.000101687125,"threshold_uncertainty_score":0.8960202},"labels":[],"label_agreement":null},{"id":"W4393951118","doi":"10.1016/j.neurot.2024.e00348","title":"Neuroscience fundamentals relevant to neuromodulation: Neurobiology of deep brain stimulation in Parkinson's disease","year":2024,"lang":"en","type":"article","venue":"Neurotherapeutics","topic":"Neurological disorders and treatments","field":"Medicine","cited_by":29,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; University of Toronto","funders":"","keywords":"Deep brain stimulation; Neuroscience; Neuromodulation; Subthalamic nucleus; Parkinson's disease; Context (archaeology); Neurology; Psychology; Disease; Medicine; Biology; Stimulation; Pathology","score_opus":0.040365152057271106,"score_gpt":0.3254725352349606,"score_spread":0.2851073831776895,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4393951118","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9861157,0.00024936337,0.000759402,0.011440633,0.00037157926,0.00078927947,0.00001657987,0.00008675002,0.00017069571],"genre_scores_gemma":[0.97950536,0.000073052914,0.0001073671,0.020109534,0.000029497272,0.000027421504,0.000008675736,0.000031036954,0.00010805382],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99863833,0.00011303035,0.00030070916,0.0004964499,0.0002059441,0.00024551965],"domain_scores_gemma":[0.99932855,0.00018617237,0.000038007285,0.00026753216,0.000022282145,0.00015747816],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00007375034,0.00016677749,0.00022355455,0.00021356413,0.00003251107,0.000025454166,0.00009266867,0.000047864178,0.00005043929],"category_scores_gemma":[0.00009205563,0.0001386112,0.000081738704,0.00057649525,0.000075761156,0.00006700306,0.00003232078,0.00016269117,0.000020272459],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021177058,0.0020856445,0.6553518,0.00039335957,0.000038001308,0.001618918,0.0005644529,0.014016445,0.22944234,0.0021676258,0.0003541652,0.091849536],"study_design_scores_gemma":[0.0008042405,0.0016241755,0.94511247,0.00004256038,0.00004528015,0.000011457511,0.000005039663,0.031810317,0.00064267276,0.0013488511,0.018427536,0.00012541637],"about_ca_topic_score_codex":0.000004471639,"about_ca_topic_score_gemma":0.000005834243,"teacher_disagreement_score":0.28976065,"about_ca_system_score_codex":0.000022137458,"about_ca_system_score_gemma":0.000039490984,"threshold_uncertainty_score":0.5652401},"labels":[],"label_agreement":null},{"id":"W4395478983","doi":"10.1016/j.neurot.2024.e00364","title":"Diffusion and functional MRI in surgical neuromodulation","year":2024,"lang":"en","type":"review","venue":"Neurotherapeutics","topic":"Neurological disorders and treatments","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"National Institute of Neurological Disorders and Stroke; National Institutes of Health","keywords":"Neuromodulation; Deep brain stimulation; Connectomics; Medicine; Diffusion MRI; Neuroscience; Movement disorders; Neurology; Neurosurgery; Physical medicine and rehabilitation; Neuroradiology; Connectome; Psychology; Magnetic resonance imaging; Psychiatry; Functional connectivity; Radiology; Pathology; Parkinson's disease; Disease","score_opus":0.091954885004163,"score_gpt":0.3583059276518354,"score_spread":0.2663510426476724,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4395478983","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0005275403,0.99710935,0.000004605016,0.0003735507,0.00025948914,0.0007525271,0.000011736691,0.00006171342,0.0008994845],"genre_scores_gemma":[0.00029612638,0.9981912,0.0000113713,0.00061132386,0.00010057122,0.00004760787,0.00005707888,0.000060237133,0.0006245013],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.998768,0.00009425343,0.00031410868,0.00046335877,0.00018871298,0.00017160102],"domain_scores_gemma":[0.99958676,0.00010028268,0.000052250685,0.0001746295,0.000011090329,0.00007498474],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000039462622,0.00029527815,0.0007461815,0.00018385173,0.000027081345,0.000027545528,0.000031215488,0.00023096737,0.000063149244],"category_scores_gemma":[0.000005713121,0.0001903147,0.00020035122,0.00025592727,0.000045431054,0.000019442334,0.00003431873,0.0005080254,0.00006620404],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000042864816,0.00031663015,0.00034375663,0.0035507204,0.00006488032,0.0009276566,0.000008154906,4.566458e-7,0.0000014997028,0.00028287314,0.00011920517,0.9943413],"study_design_scores_gemma":[0.0006365786,0.00032751338,0.0009767342,0.001100536,0.00082093,0.00024281803,5.2106975e-7,0.0001429746,7.388645e-8,0.00039828016,0.9952266,0.00012643372],"about_ca_topic_score_codex":0.0000022222466,"about_ca_topic_score_gemma":0.0000014803842,"teacher_disagreement_score":0.9951074,"about_ca_system_score_codex":0.000025137768,"about_ca_system_score_gemma":0.000045918852,"threshold_uncertainty_score":0.77608085},"labels":[],"label_agreement":null},{"id":"W4396770818","doi":"10.1016/j.neurot.2024.e00371","title":"Neuromodulation: Update on current practice and future developments","year":2024,"lang":"en","type":"editorial","venue":"Neurotherapeutics","topic":"Neurological disorders and treatments","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Western Hospital; University of Toronto; Ontario Brain Institute","funders":"National Institutes of Health","keywords":"Neuromodulation; Current (fluid); Neurology; Neuroscience; Medicine; Neurosurgery; Psychology; Engineering; Psychiatry; Central nervous system","score_opus":0.02286352551513185,"score_gpt":0.33263268049040584,"score_spread":0.309769154975274,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4396770818","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0006342777,0.0068161325,0.0000077445475,0.012561742,0.97459406,0.0009426751,0.00012742958,0.00021212916,0.0041037956],"genre_scores_gemma":[0.001184781,0.050227262,0.00032189113,0.020045696,0.92575556,0.00010121023,0.000565306,0.00029516124,0.0015031074],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99786013,0.000095941716,0.00028622782,0.0007333367,0.00075439573,0.0002699738],"domain_scores_gemma":[0.9989362,0.00032056734,0.00011970282,0.00034215665,0.0001374177,0.00014397249],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00006877715,0.00043804807,0.00039939125,0.00012203446,0.0000846518,0.000101806916,0.000094491465,0.00042501994,0.00004202513],"category_scores_gemma":[0.00011092314,0.00032963837,0.00009400195,0.00017548172,0.000049658527,0.00005525107,0.00004926772,0.0014528366,0.00023421849],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000614556,0.00058726274,0.00005990527,0.00028332326,0.00018568938,0.0006301324,0.000055674715,4.9984317e-7,0.000011310773,0.00026564903,0.856576,0.14072998],"study_design_scores_gemma":[0.0011610527,0.0009611591,0.00039600712,0.0000928462,0.0005314105,0.000017302595,0.0000037389575,0.000018228771,0.000008252565,0.0004760494,0.9961179,0.00021608602],"about_ca_topic_score_codex":0.0000010741192,"about_ca_topic_score_gemma":5.539136e-7,"teacher_disagreement_score":0.1405139,"about_ca_system_score_codex":0.000041538144,"about_ca_system_score_gemma":0.00016462746,"threshold_uncertainty_score":0.99991554},"labels":[],"label_agreement":null},{"id":"W4400385291","doi":"10.1016/j.neurot.2024.e00388","title":"Reversal of cognitive deficits in FUSR521G amyotrophic lateral sclerosis mice by arimoclomol and a class I histone deacetylase inhibitor independent of heat shock protein induction","year":2024,"lang":"en","type":"article","venue":"Neurotherapeutics","topic":"Amyotrophic Lateral Sclerosis Research","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dassault Systèmes (Canada); McGill University; Université Laval; Université de Montréal; Université du Québec à Montréal; Montreal Neurological Institute and Hospital","funders":"Fonds de recherche du Québec – Nature et technologies; Health Canada; Mitacs; Consejo Nacional de Ciencia y Tecnología; Fondation Brain Canada; Faculty of Medicine, McGill University; ALS Society of Canada; McGill University; BioMarin Pharmaceutical; Merck","keywords":"Histone deacetylase inhibitor; Histone deacetylase 5; Histone deacetylase; Amyotrophic lateral sclerosis; Neurology; Heat shock protein; Neuroscience; Medicine; Psychology; Internal medicine; Biology; Histone; Genetics; Disease; Gene","score_opus":0.036467547543848365,"score_gpt":0.29796377729502,"score_spread":0.26149622975117165,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4400385291","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99522716,0.0017499836,0.000059168004,0.001237339,0.0001234136,0.0014091047,0.00006311257,0.000048681057,0.00008201481],"genre_scores_gemma":[0.99863327,0.00047934856,0.00010293515,0.00023873609,0.000077576624,0.000076381395,0.000019620531,0.00007363998,0.00029852198],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99768764,0.00020821393,0.0005860954,0.00050470687,0.00063734804,0.00037599294],"domain_scores_gemma":[0.9992765,0.00012256231,0.000083421626,0.00019818173,0.00017070632,0.00014859383],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002444509,0.0002641905,0.00049299916,0.00034882335,0.00003832582,0.000031386207,0.000098303295,0.00026387634,0.00005562386],"category_scores_gemma":[0.00006563805,0.00023781518,0.00009451629,0.000564952,0.00029673212,0.00015268505,0.00006898831,0.0007576092,0.0000075753483],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010735702,0.00038854606,0.0028543258,0.0005472099,0.000095023424,0.000048218302,0.000987462,0.000007773729,0.9888898,0.00004560787,0.00006456792,0.00499789],"study_design_scores_gemma":[0.007679869,0.0046022795,0.10521223,0.005261694,0.00031679624,0.00016836896,0.00029567184,0.0031735955,0.8721683,0.00013158922,0.00043213484,0.0005574507],"about_ca_topic_score_codex":0.00041668606,"about_ca_topic_score_gemma":0.000036936268,"teacher_disagreement_score":0.11672148,"about_ca_system_score_codex":0.00021286176,"about_ca_system_score_gemma":0.00017909856,"threshold_uncertainty_score":0.9697822},"labels":[],"label_agreement":null},{"id":"W4402070332","doi":"10.1016/j.neurot.2024.100438","title":"Corrigendum to “Repetitive transcranial magnetic stimulation as a treatment for Alzheimer's disease: A randomized placebo-controlled double-blind clinical trial” [Neurotherapeutics 21 (3) (2024) e00331]","year":2024,"lang":"en","type":"erratum","venue":"Neurotherapeutics","topic":"Transcranial Magnetic Stimulation Studies","field":"Neuroscience","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Red River College; University of Manitoba; Riverview Hospital","funders":"National Health and Medical Research Council; Weston Brain Institute","keywords":"Transcranial magnetic stimulation; Double blind; Neurology; Medicine; Placebo; Randomized controlled trial; Neurosurgery; Clinical trial; Neuroscience; Stimulation; Psychology; Physical medicine and rehabilitation; Psychiatry; Internal medicine; Pathology; Alternative medicine","score_opus":0.20853894939596204,"score_gpt":0.4177818953661513,"score_spread":0.20924294597018925,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402070332","genre_codex":"editorial","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.010043568,0.035187066,0.017416708,0.02481231,0.54716295,0.31221497,0.006421047,0.0038569507,0.042884417],"genre_scores_gemma":[0.08151816,0.016996566,0.0012968829,0.028844504,0.022056505,0.05161353,0.0004957072,0.0030532158,0.79412496],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9866689,0.002475154,0.003824186,0.0035876688,0.0019082346,0.001535851],"domain_scores_gemma":[0.9891865,0.0068692,0.00092337,0.0015946326,0.0004978363,0.00092844607],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.0012539927,0.002311395,0.00498918,0.001007292,0.0006286912,0.0008060031,0.0010460359,0.0011655884,0.0010893989],"category_scores_gemma":[0.0012267453,0.0019566137,0.0035574338,0.0011710499,0.00087741396,0.00016577305,0.000084025014,0.0016513586,0.0006113344],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9686496,0.0015645596,0.0000019344257,0.00015339079,0.0011738966,0.00015612059,0.0009611885,0.00035721506,0.0005715861,0.0014621334,0.015215501,0.009732865],"study_design_scores_gemma":[0.62331635,0.007955115,0.000015799962,0.00017388939,0.010154005,0.000012619698,0.000019583109,0.011425215,0.00007064262,0.0010706257,0.34463868,0.0011474869],"about_ca_topic_score_codex":0.000046064106,"about_ca_topic_score_gemma":0.00006712469,"teacher_disagreement_score":0.7512405,"about_ca_system_score_codex":0.00023687548,"about_ca_system_score_gemma":0.001721201,"threshold_uncertainty_score":0.99982375},"labels":[],"label_agreement":null},{"id":"W4402694701","doi":"10.1016/j.neurot.2024.e00452","title":"Advancements in surgical treatments for Huntington disease: From pallidotomy to experimental therapies","year":2024,"lang":"en","type":"review","venue":"Neurotherapeutics","topic":"Genetic Neurodegenerative Diseases","field":"Neuroscience","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Rehabilitation Institute; Toronto Western Hospital; University Health Network","funders":"","keywords":"Pallidotomy; Neurology; Neurosurgery; Huntington's disease; Medicine; Disease; Neuroscience; Parkinson's disease; Surgery; Psychology; Deep brain stimulation; Pathology; Psychiatry","score_opus":0.1344569353527399,"score_gpt":0.423432112704522,"score_spread":0.28897517735178213,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402694701","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.010754359,0.98119444,0.000017664075,0.00007457726,0.0010756914,0.0049893763,0.0016578842,0.00014089032,0.00009511557],"genre_scores_gemma":[0.0016673972,0.99158657,0.00018815622,0.0010964776,0.00032174133,0.0037824616,0.00008557462,0.00032224527,0.00094940123],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.996002,0.00043198885,0.00072794285,0.0016975815,0.0005065845,0.0006338751],"domain_scores_gemma":[0.9982886,0.00053470605,0.00017125413,0.00068148365,0.00002318716,0.00030079545],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.000052645722,0.00089354627,0.001172934,0.00031910746,0.00010952365,0.0002189316,0.00065112644,0.00013137904,0.000099469304],"category_scores_gemma":[0.000057265646,0.0007289601,0.0005906819,0.0005315607,0.00008541704,0.00007866809,0.00014093448,0.00026950426,0.00024253022],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000390517,0.0022853857,0.00012650441,0.0034240722,0.00030446847,0.00039168098,0.0005814552,0.0000389702,0.0059809242,0.00052705733,0.0003163173,0.98563266],"study_design_scores_gemma":[0.000717418,0.00025011325,0.000014859603,0.0017470772,0.0006737561,0.000001937428,0.000013655041,0.000030777323,0.009912992,0.000105234794,0.98593634,0.0005958249],"about_ca_topic_score_codex":0.0000046838636,"about_ca_topic_score_gemma":0.0000026376001,"teacher_disagreement_score":0.98562,"about_ca_system_score_codex":0.00017006807,"about_ca_system_score_gemma":0.00020077807,"threshold_uncertainty_score":0.9995161},"labels":[],"label_agreement":null},{"id":"W4402740022","doi":"10.1016/j.neurot.2024.e00418","title":"Neuropathology Evaluation of Olney Lesions in Regulatory Drug Development Toxicology Studies","year":2024,"lang":"en","type":"article","venue":"Neurotherapeutics","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Greenfield Research (Canada)","funders":"","keywords":"Neuropathology; Neurology; Medicine; Drug; Drug development; Neurochemistry; Toxicology; Pharmacology; Internal medicine; Biology; Psychiatry","score_opus":0.17460154155608504,"score_gpt":0.4482295772712218,"score_spread":0.2736280357151368,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402740022","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9850433,0.010795348,0.0000067098526,0.0018958768,0.00086229213,0.0005117365,0.0000021779497,0.000046629164,0.00083594763],"genre_scores_gemma":[0.9968603,0.00068533595,0.0001494313,0.0013824926,0.000072511466,0.00009583281,0.0000048798893,0.00002329598,0.0007258808],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9988704,0.00024361517,0.00028579705,0.00023055074,0.00021214884,0.00015751839],"domain_scores_gemma":[0.99951446,0.00017415552,0.000037926933,0.00013865488,0.000101110985,0.00003366357],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00044133217,0.000114024166,0.00025420793,0.00022949334,0.000025765788,0.0000030487577,0.000044458007,0.000056649922,0.00012934789],"category_scores_gemma":[0.000026906357,0.000098056415,0.00004433182,0.00020596899,0.000104398845,0.00002474306,0.000020113472,0.00016308225,0.000016258715],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006400099,0.001606974,0.0325301,0.0007745668,0.00079461094,0.00063797564,0.017941043,0.00039117568,0.31779385,0.0019342866,0.003760427,0.62119496],"study_design_scores_gemma":[0.009889716,0.0021223752,0.5625305,0.00049688603,0.0022931863,0.00048840325,0.00087701646,0.0057475823,0.18810926,0.0017324936,0.22520478,0.0005078191],"about_ca_topic_score_codex":0.0000027858064,"about_ca_topic_score_gemma":0.000065130065,"teacher_disagreement_score":0.6206871,"about_ca_system_score_codex":0.00016875892,"about_ca_system_score_gemma":0.0004348537,"threshold_uncertainty_score":0.39986244},"labels":[],"label_agreement":null},{"id":"W4403143170","doi":"10.1016/j.neurot.2024.e00456","title":"Improvement in edema and cognitive recovery after moderate traumatic brain injury with the neurosteroid prodrug NTS-104","year":2024,"lang":"en","type":"article","venue":"Neurotherapeutics","topic":"Traumatic Brain Injury and Neurovascular Disturbances","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Neurotrauma Foundation","funders":"","keywords":"Traumatic brain injury; Brain edema; Neuroactive steroid; Medicine; Neurology; Anesthesia; Prodrug; Neurosurgery; Neuroscience; Internal medicine; Pharmacology; Psychology; Psychiatry; GABAA receptor; Receptor","score_opus":0.02262964687797601,"score_gpt":0.27884657074468894,"score_spread":0.2562169238667129,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403143170","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9839352,0.0017187209,0.0003311732,0.011756333,0.00019359554,0.0015349066,0.000024153598,0.00009195808,0.00041397425],"genre_scores_gemma":[0.97591287,0.00019162982,0.000049811835,0.02265549,0.00008334336,0.00029345223,0.0000038427906,0.00007067957,0.00073890836],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.998425,0.0001594186,0.0002991846,0.00050116034,0.00031498523,0.000300234],"domain_scores_gemma":[0.99916786,0.00037771653,0.00004786551,0.00029790902,0.00003420251,0.000074458],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00027417397,0.00027786996,0.00030142322,0.000114254995,0.00007118596,0.00016815438,0.000084264924,0.00006518632,0.000029534951],"category_scores_gemma":[0.00003014481,0.00016910395,0.000081776045,0.00029157664,0.00021241062,0.00016713925,0.000024898722,0.0004650893,0.000011464122],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0118185235,0.00096420484,0.0033298635,0.0035208494,0.0010330289,0.0014761518,0.0124938,0.000029542718,0.031034784,0.0003651994,0.0010935589,0.93284047],"study_design_scores_gemma":[0.026836898,0.03938187,0.6922633,0.013577382,0.0049086977,0.0042466815,0.0061785094,0.02503828,0.09493448,0.005424498,0.082842626,0.004366774],"about_ca_topic_score_codex":0.000005912138,"about_ca_topic_score_gemma":0.000045259523,"teacher_disagreement_score":0.9284737,"about_ca_system_score_codex":0.000021618855,"about_ca_system_score_gemma":0.00007859307,"threshold_uncertainty_score":0.68958586},"labels":[],"label_agreement":null},{"id":"W4405244150","doi":"10.1016/j.neurot.2024.e00498","title":"PET in neurotherapeutic discovery and development","year":2024,"lang":"en","type":"review","venue":"Neurotherapeutics","topic":"Neurological disorders and treatments","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre for Addiction and Mental Health","funders":"Canadian Institutes of Health Research; Azrieli Foundation; Canada Research Chairs","keywords":"Neurology; Neurosurgery; Neuroscience; Psychology; Computer science; Psychiatry","score_opus":0.10802486133457818,"score_gpt":0.37354766933894157,"score_spread":0.2655228080043634,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405244150","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00019652763,0.99715084,0.000006257775,0.00016865187,0.00022357596,0.001351592,0.000013619948,0.000087121705,0.00080183236],"genre_scores_gemma":[0.00010468886,0.99462384,0.000096836164,0.0034724914,0.000063815954,0.0001790957,0.00002509439,0.00015135627,0.0012827748],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99807245,0.000107208405,0.00053988537,0.0007025377,0.00021971765,0.00035821664],"domain_scores_gemma":[0.999374,0.00010311246,0.00008244745,0.0003258141,0.000010360487,0.00010426716],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00006247969,0.0005660502,0.0013491561,0.00030005578,0.000037480502,0.00009630514,0.00010786955,0.00016402046,0.000016017106],"category_scores_gemma":[0.00000765533,0.0003713544,0.00020977399,0.00031518238,0.000080118814,0.000047835027,0.000060444243,0.00071107206,0.00013684445],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00002526497,0.00029047977,0.000098420714,0.009064608,0.00021310517,0.0017860205,0.0000406248,5.3562392e-8,0.0000011949132,0.00008935594,0.000032220956,0.9883587],"study_design_scores_gemma":[0.00054546195,0.0003111444,0.00015390896,0.0028656225,0.0010000446,0.0003590437,0.000003356046,0.000005757205,7.2015126e-7,0.00015197208,0.9943342,0.00026876864],"about_ca_topic_score_codex":0.0000023708649,"about_ca_topic_score_gemma":0.0000057355583,"teacher_disagreement_score":0.994302,"about_ca_system_score_codex":0.000058935708,"about_ca_system_score_gemma":0.00026008047,"threshold_uncertainty_score":0.9998738},"labels":[],"label_agreement":null},{"id":"W4405396532","doi":"10.1016/j.neurot.2024.e00510","title":"A brain-penetrant bispecific antibody lowers oligomeric alpha-synuclein and activates microglia in a mouse model of alpha-synuclein pathology","year":2024,"lang":"en","type":"article","venue":"Neurotherapeutics","topic":"Parkinson's Disease Mechanisms and Treatments","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network","funders":"Parkinsonfonden; Magnus Bergvalls Stiftelse; Knut och Alice Wallenbergs Stiftelse; VINNOVA; Uppsala Universitet; Åhlén-stiftelsen; Science for Life Laboratory; Parkinson's Foundation; Vetenskapsrådet; Konung Gustaf V:s och Drottning Victorias Frimurarestiftelse; Alzheimerfonden; Gun och Bertil Stohnes Stiftelse","keywords":"Alpha-synuclein; Microglia; Penetrant (biochemical); Neuroscience; Neurology; Alpha (finance); Chemistry; Medicine; Pathology; Cell biology; Immunology; Biology; Parkinson's disease; Inflammation","score_opus":0.02791335793689521,"score_gpt":0.2980636655086304,"score_spread":0.2701503075717352,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405396532","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99474174,0.0024896557,0.00057598215,0.0009535728,0.00015937253,0.0006035498,0.00015248495,0.0001156839,0.0002079881],"genre_scores_gemma":[0.99466836,0.0020250939,0.0011358744,0.0014381745,0.00003438075,0.000035773508,0.000020096331,0.000119991964,0.00052224495],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9982036,0.00008259572,0.00039919346,0.00062737474,0.00025233027,0.00043491667],"domain_scores_gemma":[0.9992039,0.00011082595,0.00007632463,0.00039225855,0.000040120864,0.00017652006],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0001292801,0.00034824922,0.00054761616,0.00043446882,0.000045160803,0.000043458687,0.00012004358,0.00014746773,0.00006064729],"category_scores_gemma":[0.000015663873,0.0003076454,0.00014930534,0.00036477984,0.00015672352,0.000102255886,0.00003910358,0.00027520617,0.000020570556],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00041578792,0.0006465465,0.0036808033,0.00022670202,0.00020613417,0.0008167386,0.0005711158,0.00004185799,0.9816183,0.00056502,0.000049598413,0.011161397],"study_design_scores_gemma":[0.010874508,0.0030920599,0.02553519,0.0006665042,0.0008454712,0.0005862836,0.0003651316,0.10339767,0.8265255,0.0022159289,0.024781978,0.0011137944],"about_ca_topic_score_codex":0.00003257259,"about_ca_topic_score_gemma":0.000009535647,"teacher_disagreement_score":0.15509282,"about_ca_system_score_codex":0.00006584273,"about_ca_system_score_gemma":0.00012440211,"threshold_uncertainty_score":0.9999376},"labels":[],"label_agreement":null},{"id":"W4406080747","doi":"10.1016/j.neurot.2024.e00512","title":"Inducers and modulators of protein aggregation in Alzheimer's disease - Critical tools for understanding the foundations of aggregate structures","year":2025,"lang":"en","type":"review","venue":"Neurotherapeutics","topic":"Alzheimer's disease research and treatments","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"Canadian Institutes of Health Research; BrightFocus Foundation","keywords":"Aggregate (composite); Neurology; Neuroscience; Neurosurgery; Disease; Protein aggregation; Alzheimer's disease; Psychology; Medicine; Biology; Nanotechnology; Psychiatry; Cell biology; Pathology; Materials science","score_opus":0.20016040088607961,"score_gpt":0.43051116759762104,"score_spread":0.23035076671154142,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406080747","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00034722371,0.99416333,0.0002905175,0.00023360514,0.000054005337,0.0045116595,0.00032956532,0.0000119470105,0.000058154903],"genre_scores_gemma":[0.09743155,0.9016391,0.00019927605,0.000056676807,0.00003812157,0.00045129232,0.00012786804,0.00005003554,0.0000060680854],"study_design_codex":"design_other","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.9984845,0.00018601613,0.0004968768,0.0002917569,0.00030777615,0.00023308504],"domain_scores_gemma":[0.9981352,0.0010653172,0.00020200344,0.0003554715,0.00010197715,0.00014004785],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012980327,0.00025826803,0.00076709845,0.0002902106,0.00008776644,0.000038843446,0.00011787991,0.0001317802,0.000009899754],"category_scores_gemma":[0.00041404148,0.00017516507,0.00025510372,0.00036442498,0.00034226992,0.00008866329,0.000032374584,0.00022108309,2.8522294e-7],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003507868,0.0003234445,0.00018310398,0.021687834,0.005741679,0.000021529884,0.0000946872,0.0000036687682,0.0000041585026,0.039593764,0.000008601634,0.93198675],"study_design_scores_gemma":[0.024142874,0.006057722,0.005694975,0.2571528,0.16817333,0.00011907724,0.0013523786,0.003599893,0.0008334846,0.35274023,0.17639232,0.0037409079],"about_ca_topic_score_codex":0.0000070652327,"about_ca_topic_score_gemma":0.0000039723864,"teacher_disagreement_score":0.92824584,"about_ca_system_score_codex":0.00009093309,"about_ca_system_score_gemma":0.0009774345,"threshold_uncertainty_score":0.7143024},"labels":[],"label_agreement":null},{"id":"W4406872799","doi":"10.1016/j.neurot.2025.e00527","title":"Evaluating pathogenicity of variants of unknown significance in APP, PSEN1, and PSEN2","year":2025,"lang":"en","type":"article","venue":"Neurotherapeutics","topic":"Genomics and Rare Diseases","field":"Biochemistry, Genetics and Molecular Biology","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Instituto de Salud Carlos III; Canadian Institutes of Health Research; Deutsches Zentrum für Neurodegenerative Erkrankungen; Fonds de Recherche du Québec - Santé; Fondation Brain Canada; Ministry of Science and ICT, South Korea; Ministry of Health and Welfare; Korea Health Industry Development Institute; Korea Dementia Research Center; Japan Agency for Medical Research and Development; Fleni; National Institute on Aging; Alzheimer's Association","keywords":"Pathogenicity; PSEN1; Neurology; Biology; Genetics; Computational biology; Neuroscience; Medicine; Pathology; Disease; Alzheimer's disease; Presenilin; Microbiology","score_opus":0.023364646843402025,"score_gpt":0.3285196340895656,"score_spread":0.3051549872461636,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406872799","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9977058,0.001194456,0.00034266798,0.000044164797,0.000057885147,0.00016975205,0.000027098004,0.0000024168994,0.00045576645],"genre_scores_gemma":[0.99873364,0.00035458774,0.00052188814,0.00025966272,0.000014082958,0.000006236061,0.0000054064635,0.000008765476,0.00009570689],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.999371,0.00006566889,0.00021110648,0.0001887638,0.00006289718,0.00010057093],"domain_scores_gemma":[0.9996224,0.00002439794,0.00007729108,0.0001975539,0.000058321937,0.000020040303],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012687697,0.00007988628,0.00013075862,0.000042054526,0.00001698651,0.0000042450893,0.00009346529,0.00006369847,0.0000028857853],"category_scores_gemma":[0.000044412423,0.00007911888,0.000038825758,0.00009773166,0.00006756719,0.0000011137049,0.0000385332,0.000042577787,1.2286634e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000081293685,0.00008729266,0.0088752555,0.000063983854,0.000023700559,0.0000013444499,0.000035392288,0.0001788486,0.9814291,0.00039184894,0.000008698465,0.008823213],"study_design_scores_gemma":[0.0025411695,0.00090979313,0.2833231,0.000105791725,0.00011061232,0.000008519535,0.00013760087,0.004009407,0.70261437,0.0016491157,0.0042611845,0.00032934602],"about_ca_topic_score_codex":0.000014952878,"about_ca_topic_score_gemma":0.000015595362,"teacher_disagreement_score":0.2788148,"about_ca_system_score_codex":0.0000031708903,"about_ca_system_score_gemma":0.00009703276,"threshold_uncertainty_score":0.3226374},"labels":[],"label_agreement":null},{"id":"W4407010294","doi":"10.1016/j.neurot.2025.e00528","title":"Cardiovascular safety of transcutaneous spinal cord stimulation in cervical spinal cord injury","year":2025,"lang":"en","type":"article","venue":"Neurotherapeutics","topic":"Spinal Cord Injury Research","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Glenrose Rehabilitation Hospital; University of British Columbia; International Collaboration On Repair Discoveries","funders":"Congressionally Directed Medical Research Programs; British Columbia Knowledge Development Fund; Canadian Institutes of Health Research; U.S. Department of Defense; University of British Columbia; Rick Hansen Foundation; Foundation for Physical Therapy; Michael Smith Health Research BC; Paralyzed Veterans of America; Morton Cure Paralysis Fund; Paralyzed Veterans of America Research Foundation; Wings for Life; Craig H. Neilsen Foundation","keywords":"Medicine; Neurosurgery; Spinal cord; Spinal cord injury; Neurology; Spinal cord stimulation; Anesthesia; Surgery","score_opus":0.05906561295796957,"score_gpt":0.3944765450841373,"score_spread":0.33541093212616774,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4407010294","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9868268,0.0017136822,0.005179286,0.0011706903,0.0003151371,0.0014158989,0.000018518289,0.00007752218,0.0032824895],"genre_scores_gemma":[0.9975484,0.00036185302,0.0006643864,0.0010369566,0.000083160216,0.000020725585,0.000007111337,0.000040596355,0.0002368284],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99761623,0.00019865141,0.0006103746,0.00042751798,0.00074905844,0.00039816886],"domain_scores_gemma":[0.9988705,0.00007013063,0.000059415746,0.0006661703,0.00022812637,0.00010564801],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00037587376,0.00023163327,0.00063640793,0.0004408566,0.00005403577,0.000015450498,0.00022812524,0.00018657836,0.000112606074],"category_scores_gemma":[0.00007676925,0.00022865132,0.0003495665,0.0009769547,0.00017371055,0.00005244266,0.00003526973,0.0006446127,0.000015548907],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.22916384,0.00051006424,0.025108064,0.00075191597,0.00040971927,0.00031224577,0.000019221912,0.0001601102,0.031004282,0.0009352009,0.00003419357,0.7115911],"study_design_scores_gemma":[0.007885903,0.08857401,0.78091156,0.0011138842,0.00092205795,0.0003868952,0.00009536229,0.0060157687,0.020636916,0.0007537355,0.0921175,0.000586401],"about_ca_topic_score_codex":0.0000830325,"about_ca_topic_score_gemma":0.000015339368,"teacher_disagreement_score":0.7558035,"about_ca_system_score_codex":0.00015978682,"about_ca_system_score_gemma":0.0003022856,"threshold_uncertainty_score":0.932413},"labels":[],"label_agreement":null},{"id":"W4407629658","doi":"10.1016/j.neurot.2025.e00552","title":"First-year treatment response predicts the following 5-year disease course in patients with relapsing-remitting multiple sclerosis","year":2025,"lang":"en","type":"article","venue":"Neurotherapeutics","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Cegep de Saint Jerome; Centre Intégré de Santé et Services Sociaux de Chaudière-Appalache; Université de Montréal","funders":"Kaohsiung Chang Gung Memorial Hospital; Department of Neurology, University of Pittsburgh; Universitair Ziekenhuis Antwerpen; Razi University; Hacettepe Üniversitesi; Università di Catania; Sultan Qaboos University; Hôpitaux Universitaires de Genève; Isfahan University of Medical Sciences; Postgraduate Institute of Medical Education and Research, Chandigarh; Debreceni Egyetem; University of Western Australia; Universität Basel","keywords":"Relapsing remitting; Multiple sclerosis; Neurology; Medicine; Neurosurgery; Disease; Internal medicine; Surgery; Psychiatry","score_opus":0.0415018880982408,"score_gpt":0.29228164122189715,"score_spread":0.25077975312365636,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4407629658","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9921246,0.0003362971,0.000053481817,0.004904362,0.00018672891,0.0020304224,0.00003446595,0.000100064615,0.00022956016],"genre_scores_gemma":[0.99756604,0.0002935358,0.00042136956,0.0008802602,0.000046438625,0.00019359653,0.0000094583065,0.000058810852,0.00053047395],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99771374,0.00030710732,0.00033574167,0.00046776666,0.00064518815,0.00053046946],"domain_scores_gemma":[0.9977385,0.0011599114,0.0000772528,0.00072525215,0.00012729892,0.00017179878],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003906298,0.00029337604,0.00036007538,0.00017676972,0.00036775324,0.00006093084,0.00018820989,0.00007105247,0.000014879758],"category_scores_gemma":[0.0008332737,0.00018599992,0.0001560305,0.00058639,0.00017904774,0.0000811867,0.00007497842,0.00032011812,0.000012194945],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008755567,0.00089294603,0.98565495,0.000045853612,0.00027151933,0.000017668252,0.00062354736,0.00020178498,0.00028863963,0.000011338318,0.00017457712,0.003061615],"study_design_scores_gemma":[0.012597527,0.0007742568,0.98005277,0.00080547493,0.00022856027,1.8043093e-7,0.0002542373,0.0015982309,0.00017512597,0.0000067979586,0.0033653404,0.00014147657],"about_ca_topic_score_codex":0.000043963802,"about_ca_topic_score_gemma":0.00009365846,"teacher_disagreement_score":0.0056021526,"about_ca_system_score_codex":0.0003106301,"about_ca_system_score_gemma":0.0002719663,"threshold_uncertainty_score":0.7584857},"labels":[],"label_agreement":null},{"id":"W4409599793","doi":"10.1016/j.neurot.2025.e00588","title":"Role of soluble biomarkers in treating multiple sclerosis and neuroinflammatory conditions","year":2025,"lang":"en","type":"review","venue":"Neurotherapeutics","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; Montreal Neurological Institute and Hospital; Ottawa Hospital","funders":"","keywords":"Multiple sclerosis; Neurology; Medicine; Neuroinflammation; Neuroscience; Immunology; Psychology; Psychiatry; Inflammation","score_opus":0.10859107567836004,"score_gpt":0.3639297090295445,"score_spread":0.25533863335118445,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409599793","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0006679239,0.99559575,0.0000024849076,0.00005771978,0.000076460004,0.001981561,0.0001148976,0.000051607196,0.0014515886],"genre_scores_gemma":[0.00068064965,0.998445,0.00024776644,0.00007821984,0.000039122206,0.00024634195,0.000036748675,0.000067505345,0.00015865335],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9977981,0.00027112855,0.00076476176,0.0004781738,0.00030917226,0.00037870795],"domain_scores_gemma":[0.99761266,0.0014747921,0.00024383511,0.00047034444,0.000090171874,0.0001081878],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00020698905,0.00038774498,0.0016409808,0.00070153864,0.00009391701,0.000023077031,0.00015716314,0.00021647246,0.00002385021],"category_scores_gemma":[0.00046691162,0.00034067375,0.0003014175,0.00063512794,0.00027444365,0.000047372352,0.00012523143,0.00048197652,0.0000043868768],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000037691327,0.00017671866,0.0037417132,0.023226732,0.0005017321,0.000010005006,0.000119644945,9.245657e-7,0.0019312946,0.000023838988,0.00009950479,0.9701302],"study_design_scores_gemma":[0.0031793257,0.00034222918,0.014046617,0.05033139,0.0014600051,0.000029240005,0.0001941029,0.00050819264,0.0002243204,0.000017952983,0.92914337,0.00052326906],"about_ca_topic_score_codex":0.00005900327,"about_ca_topic_score_gemma":0.000068919675,"teacher_disagreement_score":0.96960694,"about_ca_system_score_codex":0.00008040388,"about_ca_system_score_gemma":0.00035348875,"threshold_uncertainty_score":0.9999045},"labels":[],"label_agreement":null},{"id":"W4409676323","doi":"10.1016/j.neurot.2025.e00598","title":"Maternal oxytocin administration mitigates nociceptive, social, and epigenetic impairments in adolescent offspring exposed to perinatal trauma","year":2025,"lang":"en","type":"article","venue":"Neurotherapeutics","topic":"Neuroendocrine regulation and behavior","field":"Psychology","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Children's Hospital; Vancouver Island University","funders":"American Copy Editors Society: The Society for Editing; National Health and Medical Research Council","keywords":"Oxytocin; Offspring; Nociception; Epigenetics; Administration (probate law); Medicine; Neurology; Psychology; Neuroscience; Pregnancy; Internal medicine; Biology; Gene; Genetics","score_opus":0.05591727501920256,"score_gpt":0.3746570765158625,"score_spread":0.3187398014966599,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409676323","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99658966,0.000046298806,0.000088344,0.0019741843,0.0002885323,0.0005493099,0.000010070814,0.00004934263,0.00040424147],"genre_scores_gemma":[0.9962622,0.000005108016,0.0001046463,0.0016426848,0.00003999642,0.000070124755,0.0000020392536,0.00002421542,0.0018489821],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988928,0.00011661998,0.00027808195,0.0003227058,0.0001222938,0.00026751086],"domain_scores_gemma":[0.9997004,0.000023523497,0.000049061564,0.00014027345,0.000025660247,0.000061036015],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000042428837,0.00016267838,0.00016088289,0.00017287211,0.00007725418,0.000054346634,0.00010973607,0.000049102924,0.0001361253],"category_scores_gemma":[0.0000029830549,0.00017778555,0.000043230753,0.000188841,0.00004931697,0.00003903228,0.000027144946,0.00014975508,0.00002148187],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005319001,0.0007162881,0.72637206,0.00009026298,0.000040029885,0.00029898548,0.00202932,0.000008382913,0.13276744,0.00060592586,0.00025697108,0.13628243],"study_design_scores_gemma":[0.0012036103,0.00021963142,0.9625047,0.000027718872,0.000017231243,0.000035479923,0.00022050683,0.000025993084,0.030992156,0.000028812243,0.0045973687,0.00012679253],"about_ca_topic_score_codex":0.000020243555,"about_ca_topic_score_gemma":0.000051197287,"teacher_disagreement_score":0.23613262,"about_ca_system_score_codex":0.00004077074,"about_ca_system_score_gemma":0.00002250603,"threshold_uncertainty_score":0.72498846},"labels":[],"label_agreement":null},{"id":"W4410553749","doi":"10.1016/j.neurot.2025.e00614","title":"Systemic nimodipine affects pericyte calcium signaling, resting hemodynamics and neurovascular coupling in healthy mouse brain","year":2025,"lang":"en","type":"article","venue":"Neurotherapeutics","topic":"Intracranial Aneurysms: Treatment and Complications","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"Canadian Institutes of Health Research; College of Medicine, Drexel University; Health Canada; University of Manitoba; Government of Canada; Natural Sciences and Engineering Research Council of Canada; Fondation Brain Canada; Manitoba Medical Service Foundation; Azrieli Foundation; Research Manitoba","keywords":"Nimodipine; Neurology; Medicine; Hemodynamics; Neurovascular bundle; Pericyte; Calcium; Neuroradiology; Neuroscience; Cardiology; Internal medicine; Chemistry; Psychology; Pathology; Psychiatry","score_opus":0.024216717792477097,"score_gpt":0.2981946778478301,"score_spread":0.273977960055353,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4410553749","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9898418,0.0008888343,0.0028352833,0.0049514202,0.000113639704,0.0009256859,0.000004243312,0.00013773554,0.00030134234],"genre_scores_gemma":[0.9936727,0.00017461272,0.00041735632,0.0051515005,0.000068369685,0.000059520607,0.000012186507,0.000042733896,0.00040101213],"study_design_codex":"bench_or_experimental","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99875814,0.00006604523,0.0002991578,0.0003948488,0.00016452339,0.00031726787],"domain_scores_gemma":[0.99921376,0.000219922,0.000072277915,0.0003433878,0.00006480926,0.00008587101],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001536532,0.00021562325,0.00034258366,0.00020685735,0.00015491038,0.00003980194,0.00009079928,0.00009838956,0.0000037722928],"category_scores_gemma":[0.00005570893,0.00020831276,0.00007260642,0.00041603725,0.000060783314,0.000041151594,0.000028203347,0.00032671244,0.0000039056536],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017842955,0.001263188,0.16225415,0.0023556375,0.00025710315,0.000525829,0.0010167208,0.009572831,0.80108905,0.008578042,0.00012711949,0.0111760525],"study_design_scores_gemma":[0.011569376,0.0024520364,0.061538488,0.0010107409,0.0004965237,0.0009090056,0.00031969036,0.9085735,0.008785744,0.0004572421,0.0031164812,0.0007711913],"about_ca_topic_score_codex":0.000056009892,"about_ca_topic_score_gemma":0.000017647684,"teacher_disagreement_score":0.89900064,"about_ca_system_score_codex":0.00009256015,"about_ca_system_score_gemma":0.00011498794,"threshold_uncertainty_score":0.8494748},"labels":[],"label_agreement":null},{"id":"W4411711915","doi":"10.1016/j.neurot.2025.e00631","title":"Pediatric multiple sclerosis: Improving outcome through high-efficacy therapies","year":2025,"lang":"en","type":"review","venue":"Neurotherapeutics","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation","funders":"National Institutes of Health; Canadian Institutes of Health Research; Epilepsy Society; Sick Kids Foundation; Hospital for Sick Children; Alexion Pharmaceuticals; Garry Hurvitz Centre for Brain and Mental Health; Ontario Institute for Regenerative Medicine; Canadian Society of Nephrology; Rare Disease Foundation; University of Toronto; Biogen; National Multiple Sclerosis Society","keywords":"Multiple sclerosis; Neurology; Medicine; Neurosurgery; Surgery; Psychiatry","score_opus":0.25547195321131905,"score_gpt":0.4074172453468631,"score_spread":0.15194529213554403,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411711915","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000076800054,0.9926978,0.00020934203,0.00028888395,0.0009347053,0.0045841034,0.00018341727,0.00047018673,0.00055481057],"genre_scores_gemma":[0.00029116796,0.9931527,0.001683767,0.0011620019,0.0012270203,0.00066759554,0.000074778516,0.00028972334,0.0014512666],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9945044,0.0004924516,0.0015730849,0.001264968,0.0010518145,0.0011132698],"domain_scores_gemma":[0.99465406,0.0026543569,0.00056824525,0.0016291244,0.000280173,0.0002140231],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00037576217,0.0012061605,0.0037863974,0.0006331132,0.00038350114,0.00016173067,0.0007720195,0.0006420915,0.000113909424],"category_scores_gemma":[0.0011678932,0.0009071838,0.0013525225,0.0014147499,0.00023629663,0.00013833234,0.00036253504,0.0018168571,0.00018227927],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000045990033,0.00046767484,0.0009237274,0.04278059,0.000715703,0.000024954552,0.0001947645,7.9136674e-7,0.000021544245,0.000052047653,0.0005495947,0.9542226],"study_design_scores_gemma":[0.0026093288,0.00033709343,0.002787651,0.0065472308,0.0035618849,0.000014851529,0.00003818066,0.000016978558,0.000009085146,0.000009623788,0.983328,0.0007401089],"about_ca_topic_score_codex":0.00007789843,"about_ca_topic_score_gemma":0.00001156238,"teacher_disagreement_score":0.9827784,"about_ca_system_score_codex":0.00028244688,"about_ca_system_score_gemma":0.0008082916,"threshold_uncertainty_score":0.99933785},"labels":[],"label_agreement":null},{"id":"W4412796687","doi":"10.1016/j.neurot.2025.e00690","title":"Montelukast alleviates neuroinflammation and improves motor functions in the line 61 model of Parkinson's disease: An exploratory study","year":2025,"lang":"en","type":"article","venue":"Neurotherapeutics","topic":"Parkinson's Disease Mechanisms and Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Intégré de Santé et de Services Sociaux des Laurentides","funders":"Österreichische Forschungsförderungsgesellschaft; Austrian Science Fund","keywords":"Neuroinflammation; Neurology; Parkinson's disease; Medicine; Neuroscience; Disease; Montelukast; Physical medicine and rehabilitation; Psychology; Internal medicine","score_opus":0.04015394069713703,"score_gpt":0.2942930477013025,"score_spread":0.2541391070041655,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412796687","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99664766,0.00066316203,0.0006185938,0.00060457224,0.00006899383,0.0012388248,0.000039700048,0.00003977269,0.00007871748],"genre_scores_gemma":[0.9984455,0.00017372394,0.00009124235,0.0008675311,0.000029150977,0.00018295532,0.0000137567,0.00002218386,0.00017396806],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989502,0.0001444102,0.00025032225,0.000292976,0.00021406803,0.00014801283],"domain_scores_gemma":[0.99930114,0.000060492264,0.00007065257,0.0004184281,0.000062296494,0.000086983724],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013828346,0.0001718528,0.00021139653,0.00015783685,0.000100155754,0.000036624322,0.00009419227,0.000037419795,0.0000036230938],"category_scores_gemma":[0.000025986365,0.0001249307,0.000053396045,0.00019408324,0.000055744604,0.000115589064,0.000022384558,0.00013024872,0.0000011996564],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008635434,0.029471451,0.6171299,0.0009742688,0.0011135661,0.0003976881,0.015280636,0.003644165,0.20799665,0.0026197096,0.00016764704,0.11256886],"study_design_scores_gemma":[0.005394152,0.0022404816,0.7967538,0.0000826229,0.0008817381,0.0000033713204,0.0026924077,0.18508819,0.0012029008,0.0011857846,0.004261162,0.00021338416],"about_ca_topic_score_codex":0.000008433268,"about_ca_topic_score_gemma":0.00007119592,"teacher_disagreement_score":0.20679376,"about_ca_system_score_codex":0.00001796131,"about_ca_system_score_gemma":0.000120272554,"threshold_uncertainty_score":0.5094526},"labels":[],"label_agreement":null},{"id":"W4413163974","doi":"10.1016/j.neurot.2025.e00648","title":"Azetukalner, a Novel, Potent KV7 Potassium Channel Opener in Development for the Treatment of Focal Onset Seizures, Primary Generalized Tonic-Clonic Seizures, and Major Depressive Disorder","year":2025,"lang":"en","type":"article","venue":"Neurotherapeutics","topic":"Coordination Chemistry and Organometallics","field":"Chemistry","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Xenon Pharmaceuticals (Canada)","funders":"","keywords":"Potassium channel opener; Neurology; Tonic (physiology); Medicine; Epilepsy; Potassium channel; Neuroscience; Anesthesia; Psychology; Internal medicine","score_opus":0.021845232564918937,"score_gpt":0.26805739982324567,"score_spread":0.24621216725832673,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4413163974","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9656223,0.018091448,0.0061012446,0.0063951733,0.00031953573,0.0016007214,0.00036700934,0.000091998074,0.0014105586],"genre_scores_gemma":[0.98702085,0.0021760142,0.0010963924,0.0014939281,0.000083113584,0.00072077307,0.00015813185,0.00006931488,0.007181459],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.99850804,0.000028369283,0.00048127447,0.00044373213,0.00019845307,0.00034015687],"domain_scores_gemma":[0.99897045,0.0003016135,0.00015582713,0.00042688887,0.00008451351,0.000060726146],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.000100013225,0.00032495032,0.00038053436,0.00007449292,0.00020740651,0.00005364935,0.0002913409,0.00017580777,0.00006706788],"category_scores_gemma":[0.000024457007,0.00024708346,0.000116806325,0.00021067566,0.00010730018,0.00004840352,0.00007703394,0.0001502205,6.0486457e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004570561,0.011777691,0.013207781,0.0030319288,0.0038986243,0.00011540094,0.0062869517,0.0054517114,0.568498,0.0029264253,0.0013258285,0.37890908],"study_design_scores_gemma":[0.0142091215,0.00016979343,0.0048437454,0.00011734867,0.0004198449,0.000058344493,0.0002766272,0.005801121,0.47824326,0.00031733472,0.49492243,0.00062101684],"about_ca_topic_score_codex":0.00004662629,"about_ca_topic_score_gemma":0.00015954433,"teacher_disagreement_score":0.4935966,"about_ca_system_score_codex":0.00018550208,"about_ca_system_score_gemma":0.00031620899,"threshold_uncertainty_score":0.99999815},"labels":[],"label_agreement":null},{"id":"W4413164614","doi":"10.1016/j.neurot.2025.e00665","title":"PANK activators for the treatment of pantothenate kinase-associated neurodegeneration","year":2025,"lang":"en","type":"article","venue":"Neurotherapeutics","topic":"Neurological diseases and metabolism","field":"Neuroscience","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Viron Therapeutics (Canada)","funders":"","keywords":"Neurodegeneration; Neurology; Medicine; Neuroscience; Internal medicine; Psychology; Disease","score_opus":0.06583208994169588,"score_gpt":0.3226082226125227,"score_spread":0.25677613267082683,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4413164614","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9925851,0.00032190903,0.0016041396,0.0022050436,0.0009860947,0.0015094456,0.00012969469,0.00010265362,0.00055592053],"genre_scores_gemma":[0.9912657,0.0015085302,0.000017230472,0.0062648184,0.000048554375,0.0001646694,0.0000018649031,0.000021046359,0.00070756406],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99891454,0.00016767262,0.00022170879,0.00031393123,0.00014752797,0.00023463315],"domain_scores_gemma":[0.99855506,0.00093643984,0.000110429704,0.00031776784,0.000042913118,0.00003738025],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00004748098,0.00016110468,0.00019081843,0.000053823485,0.0001999348,0.000036540732,0.00021317253,0.00005548673,0.000016210379],"category_scores_gemma":[0.00018884326,0.000098421195,0.00017859445,0.00029582757,0.00010253882,0.000041963875,0.000010835844,0.0000593284,0.0000021319981],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00037311882,0.0010369597,0.0006415503,0.000013714645,0.000034639863,0.0000026515888,0.00012049558,0.00039693908,0.90909743,0.03021922,0.0001373188,0.057925988],"study_design_scores_gemma":[0.0016750701,0.000851215,0.009252573,0.000005189843,0.00016658772,5.358502e-7,0.000014462535,0.004118612,0.7992006,0.002553773,0.18203686,0.00012454375],"about_ca_topic_score_codex":0.000006198503,"about_ca_topic_score_gemma":0.0000028164413,"teacher_disagreement_score":0.18189953,"about_ca_system_score_codex":0.000017511618,"about_ca_system_score_gemma":0.000042248572,"threshold_uncertainty_score":0.40135},"labels":[],"label_agreement":null},{"id":"W4413324183","doi":"10.1016/j.neurot.2025.e00713","title":"Hypoperfusion intensity ratio is associated with follow-up infarct volume in medium vessel occlusions: A multicenter multinational study","year":2025,"lang":"en","type":"article","venue":"Neurotherapeutics","topic":"Acute Ischemic Stroke Management","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"National Institute of Nursing Research; National Medical Research Council; National Institutes of Health; Else Kröner-Fresenius-Stiftung; Congressionally Directed Medical Research Programs; Stryker; Genentech; AstraZeneca; National Institute of Neurological Disorders and Stroke; American Heart Association","keywords":"Perfusion; Medicine; Cardiology; Intensity (physics); Neurology; Internal medicine; Neuroradiology; Multinational corporation; Volume (thermodynamics); Neurosurgery; Multicenter study; Radiology; Business; Randomized controlled trial","score_opus":0.019412680540918097,"score_gpt":0.2846021786619711,"score_spread":0.26518949812105297,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4413324183","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98621196,0.000049099966,0.00067931064,0.008453206,0.00039690343,0.002105972,0.000012061791,0.000098845674,0.0019926562],"genre_scores_gemma":[0.9731457,0.000022804988,0.00032385346,0.018368304,0.00003744547,0.00008158464,0.000030820684,0.000035690904,0.007953779],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981627,0.00010718955,0.00041756354,0.00044958608,0.0005661473,0.00029680392],"domain_scores_gemma":[0.9988996,0.00014592065,0.00011945,0.0004130421,0.00035528012,0.000066741566],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00028150887,0.00025257136,0.00039688623,0.0003167453,0.000111088455,0.0000313548,0.0001839714,0.00010359272,0.00013553526],"category_scores_gemma":[0.0003096291,0.00021014629,0.00006691906,0.00060555484,0.00007683647,0.00008283076,0.00017884868,0.0004283674,0.000020267498],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001507485,0.0025409323,0.9616809,0.000040302082,0.00059056265,0.00016626279,0.0036427851,0.000024997751,0.011730164,0.000012514554,0.015608131,0.002454953],"study_design_scores_gemma":[0.017651899,0.00074580323,0.9341217,0.0002981158,0.00048704108,0.000007910188,0.0013805678,0.022857292,0.0027726782,0.000009228198,0.019414414,0.0002533326],"about_ca_topic_score_codex":0.00006902875,"about_ca_topic_score_gemma":0.00012715225,"teacher_disagreement_score":0.02755919,"about_ca_system_score_codex":0.00023388087,"about_ca_system_score_gemma":0.00016265045,"threshold_uncertainty_score":0.8569517},"labels":[],"label_agreement":null},{"id":"W4414118670","doi":"10.1016/j.neurot.2025.e00737","title":"Antibody targeting TDP-43 mitigates pathogenic pathways induced by the cerebrospinal fluid of ALS","year":2025,"lang":"nl","type":"article","venue":"Neurotherapeutics","topic":"Amyotrophic Lateral Sclerosis Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval; Bombardier (Canada)","funders":"Canadian Institutes of Health Research; ALS Society of Canada","keywords":"Amyotrophic lateral sclerosis; Antibody; Genetically modified mouse; Cerebrospinal fluid; Transgene; Spinal cord; Neurodegeneration; Monoclonal antibody; Microglia","score_opus":0.04013907537505696,"score_gpt":0.3307332902045313,"score_spread":0.29059421482947434,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414118670","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9754111,0.011614239,0.00028750458,0.0070391633,0.00086401403,0.0017767911,0.00020129085,0.00009066875,0.0027152158],"genre_scores_gemma":[0.98787254,0.0037848132,0.000094774965,0.005273165,0.00033326837,0.000047746573,0.000084789346,0.00012163899,0.0023872496],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9947994,0.0008580824,0.001225256,0.00079465954,0.0011377741,0.0011848458],"domain_scores_gemma":[0.9971544,0.0006524527,0.00036584298,0.0011348483,0.0004508214,0.00024163513],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00091304607,0.0005941724,0.0008958251,0.00019628987,0.00042598977,0.00013019433,0.00095706084,0.00046080013,0.0008649334],"category_scores_gemma":[0.00034172187,0.0004298322,0.0003939171,0.0011449603,0.0005966115,0.000117367155,0.00027319015,0.00134664,0.00023063591],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003112005,0.0004243581,0.010476821,0.00041094978,0.00041630078,0.000020507472,0.0004957383,0.000008539516,0.97838783,0.00051966327,0.0023035759,0.0062245224],"study_design_scores_gemma":[0.008065506,0.0044376454,0.21075627,0.0023498014,0.0012193181,0.00003694674,0.0012071094,0.006438284,0.70780724,0.0010584751,0.055414177,0.0012092389],"about_ca_topic_score_codex":0.00018495283,"about_ca_topic_score_gemma":0.000003310448,"teacher_disagreement_score":0.2705806,"about_ca_system_score_codex":0.00014959685,"about_ca_system_score_gemma":0.00062138116,"threshold_uncertainty_score":0.99981534},"labels":[],"label_agreement":null},{"id":"W4415946501","doi":"10.1016/j.neurot.2025.e00777","title":"Restoration neurite growth by removing the blockage of endosome trafficking in Alzheimer-like mice","year":2025,"lang":"en","type":"article","venue":"Neurotherapeutics","topic":"Alzheimer's disease research and treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Canadian Institutes of Health Research; National Institutes of Health; National Natural Science Foundation of China; Eisai; China Pharmaceutical University; Genentech; IXICO; Servier; Brin Wojcicki Foundation; Northern California Institute for Research and Education; University of California, San Diego; Pfizer; Biogen; BioClinica; Synarc; University of Southern California; Medpace; U.S. Department of Defense; Eli Lilly and Company; Bristol-Myers Squibb; Meso Scale Diagnostics; Alzheimer's Disease Neuroimaging Initiative; Novartis Pharmaceuticals Corporation; Alzheimer's Association","keywords":"Neurite; Endosome; Long-term potentiation; Synapse; Gene knockdown; Hippocampal formation; Synaptic plasticity","score_opus":0.030991674503109953,"score_gpt":0.31679545112335583,"score_spread":0.28580377662024586,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4415946501","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.966557,0.025933662,0.000077813515,0.0037579583,0.00017195713,0.0011970067,0.000025057583,0.00006999887,0.0022095195],"genre_scores_gemma":[0.9970118,0.0005633802,0.00007065857,0.0021969255,0.000030604402,0.000027464437,0.00001496062,0.000025216308,0.00005898681],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9987362,0.000161973,0.00028291324,0.0002389543,0.00031290317,0.00026703917],"domain_scores_gemma":[0.99924654,0.00021707686,0.00007282093,0.00031000288,0.000083090184,0.00007044304],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014252047,0.00014875225,0.00021174624,0.00016030196,0.00008293667,0.000022441554,0.00014123118,0.00006467298,0.000011706275],"category_scores_gemma":[0.00003747699,0.000113106624,0.00007979834,0.0004887057,0.00010238951,0.000069297676,0.000025255351,0.0002594365,0.0000055639903],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00838569,0.00973357,0.4233927,0.0010300274,0.025749434,0.0013816319,0.005182268,0.00019774653,0.3292784,0.007152379,0.011669834,0.17684631],"study_design_scores_gemma":[0.04630366,0.0060281972,0.35893077,0.0027131452,0.011900309,0.00027340127,0.0019015451,0.026968857,0.46890152,0.0032765425,0.07080596,0.0019960804],"about_ca_topic_score_codex":0.00007922197,"about_ca_topic_score_gemma":0.00002228953,"teacher_disagreement_score":0.17485024,"about_ca_system_score_codex":0.00003603251,"about_ca_system_score_gemma":0.00015608314,"threshold_uncertainty_score":0.46123543},"labels":[],"label_agreement":null}]}